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Resumo 
 
 
Actualmente o transplante de tecido do próprio doente ou de um dador continua a ser a 
técnica mais utilizada para tratar defeitos ósseos provocados por doenças ou acidentes. No 
entanto, esta prática apresenta sérias limitações devido à escassez de dadores, ao risco de 
transmissão de doenças e/ou de rejeição imunológica e também devido ao problema da lesão 
dos tecidos envolventes que normalmente ocorre no local de onde é removido o tecido para 
transplante. O elevado número de pessoas em todo o Mundo que são afectadas por estes 
problemas, bem como os consequentes custos sócio-económicos, são razões acrescidas para 
a necessidade de desenvolver terapias alternativas para tratar a perda ou mau funcionamento 
de tecido ósseo. 
A Engenharia de Tecidos é uma área científica em contínua expansão. Os desenvolvimentos 
conseguidos por esta área têm contribuído significativamente para diversos avanços no 
campo da Medicina Regenerativa. Esta ciência interdisciplinar combina os conhecimentos de 
diversas outras áreas, tão distintas como a Engenharia de Materiais e a Biologia, com o 
objectivo de desenvolver substitutos sintéticos para tecidos humanos. Para se atingir este 
objectivo utilizam-se, de uma forma genérica, combinações específicas de células e de um 
material de suporte tridimensional com propriedades adequadas, gerando um material híbrido 
cujas características podem ainda ser moduladas através do sistema de cultura usado.  
 
A presente tese é centrada no desenvolvimento de estratégias de engenharia de tecido ósseo 
baseadas na cultura in vitro de células previamente “semeadas” num suporte tridimensional 
(“scaffold”). Esta estratégia permite que as células adiram ao suporte, proliferem e segreguem 
matriz extracelular específica do tecido ósseo, até se obter um substituto artificial funcional 
com características do tecido original, que pode finalmente ser transplantado para tratar o 
defeito em causa. Para que uma estratégia deste tipo seja bem sucedida, pelo menos três 
componentes fundamentais devem ser cuidadosamente estudados: o material de suporte 
(scaffold), as células a usar e o sistema de cultura in vitro. Daí que os principais objectivos 
desta tese estejam relacionados com estes três aspectos, nomeadamente: 
 
• Desenvolvimento de scaffolds biodegradáveis a partir de polímeros à base de amido 
de milho que induzam a adesão e proliferação celular e que apresentem propriedades 
adequadas, tais como a porosidade e interconectividade entre poros, de forma a 
proporcionar um ambiente que favoreça o desenvolvimento in vitro de um material 
híbrido com características similares ao osso humano. 
• Estudo da utilização de células da medula óssea como uma potencial fonte de células 
para engenharia do tecido ósseo, uma vez que estas células podem ser facilmente 
recolhidas do próprio paciente a tratar por métodos não-invasivos (biopsia) e em 
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quantidades suficientes. Além disso, tratando-se de uma fonte de células autólogas 
(obtidas do próprio paciente) permitem evitar os riscos de transmissão de doenças 
contagiosas e/ou de rejeição pelo sistema imunológico. 
• Estudo da influência das condições de cultura in vitro geradas por um bioreactor de 
perfusão (em comparação com os métodos tradicionais de cultura em condições 
estáticas) no desenvolvimento dos materiais híbridos, compostos pelas células e 
scaffolds, assim como as interacções do ambiente proporcionado por este sistema de 
cultura com as diferentes estruturas/arquitecturas e porosidades dos scaffolds 
utilizados. 
 
Estes objectivos convergem para o objectivo geral desta tese que consistiu no 
desenvolvimento de uma terapia de engenharia do tecido ósseo alternativa ás existentes e 
com potencial para vir a ser posteriormente utilizada na prática clínica. Este objectivo foi 
avaliado através do estudo da funcionalidade dos materiais híbridos obtidos em diferentes 
condições de cultura in vitro (e utilizando diferentes scaffolds), partindo do principio que o 
sistema de perfusão poderia eventualmente superar as limitações de difusão típicas dos 
sistema de cultura estática e simultaneamente proporcionar estímulos mecânicos ás células, 
semelhantes aos encontrados em condições fisiológicas. 
 
O trabalhou desenvolvido permitiu propor várias metodologias de processamento que 
conduziram à obtenção de scaffolds com propriedades e estruturas porosas muito 
interessantes. De um modo geral, estes scaffolds permitem a adesão, proliferação e 
diferenciação das células de medula óssea, quando cultivadas em condições estáticas ou no 
bioreactor de perfusão. Foi demonstrado que a estrutura porosa dos scaffolds e especialmente 
a interconectividade entre poros, afecta a homogeneidade do tecido formado. A porosidade 
dos scaffolds influencia o desenvolvimento sequencial das células osteoblásticas e, em 
combinação com as condições de cultura usadas pode influenciar a funcionalidade dos 
“tecidos” formados in vitro. 
Os resultados obtidos salientam a importância do sistema de cultura utilizado em estratégias 
de engenharia de tecido ósseo como a que é proposta nesta tese. De facto, o bioreactor  de 
perfusão contribui significativamente para melhorar a funcionalidade dos materiais 
híbridos/tecidos desenvolvidos in vitro, uma vez que combina factores biológicos e mecânicos 
que proporcionam um melhor desenvolvimento das células contidas no scaffolds, conduzindo 
á obtenção de um tecido mineralizado semelhante ao osso humano. Os resultados obtidos 
demonstram que a cultura de células de medula óssea em scaffolds biodegradáveis á base de 
amido de milho num bioreactor de perfusão, pode também constituir um modelo para o estudo 
de mecanismos biológicos associados ao processo de formação de tecido ósseo, o que por 
sua vez pode contribuir para  a avaliação e melhoria de estrategias de engenharia de tecidos 
do osso. 
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Abstract 
 
 
There is a very significant and well-known clinical need for the establishment of alternative 
therapies for the treatment of bone tissue loss or failure resulting from injury or disease, as the 
transplantation of tissues in these patients is severely limited by donor scarcity and is highly 
associated to the risk of immune rejection and disease transfer. The always evolving field of 
tissue engineering has brought a number of significant advances to regenerative medicine. 
This interdisciplinary science combines the knowledge and experience of many different fields, 
from materials science to biology, in order to develop tissue-like substitutes. This is generally 
achieved through a specific interplay between cells and scaffolds (and in some cases, growth 
factors), which can also be modulated by the culturing system used.  
 
This thesis focuses on bone tissue engineering approaches based on culturing cells-scaffold 
constructs in vitro, allowing the seeded cells to proliferate and secrete tissue specific 
extracellular matrix (ECM) until obtaining a functional tissue-like substitute that can be 
transplanted to the tissue defect to be treated. To achieve the success of such tissue 
engineering approach, there are at least three key issues that must be carefully studied: the 
scaffold material, the cells and the culturing environment. Therefore, the main objectives 
proposed for this thesis address these three aspects: 
- Development of appropriate starch-based scaffolds capable of inducing the attachment 
and proliferation of the seeded cells, and exhibiting adequate properties, such as 
porosity and pore interconnectivity, in order to provide an appropriate environment for 
the in vitro development of bone-like tissue.  
- Studying the use of bone marrow cells as a reliable cell source for bone tissue 
engineering application, as that can be readily available (in sufficient amounts) and 
obtained by simple procedures (biopsy) from the same patient, avoiding the risk risks of 
disease transmission and/or immune rejection. 
- Studying the influence of in vitro culturing conditions, namely flow perfusion, on the 
development of cell-scaffolds constructs, as well as the interactions of the environment 
provided by this culturing method with different scaffolds architectures and porosities.  
 
These objectives converge to the main goal of this thesis, which is the development of an 
improved bone tissue engineering therapy. This was assessed by the functionality of the tissue 
engineering constructs obtained under different in vitro culturing conditions (and from different 
scaffolds), in the light of using flow perfusion bioreactor having the potential to mitigate 
diffusion limitations typical of static culturing and simultaneously provide physiological-like 
stimulus to the seeded cells.  
- 10 - 
 
This work allowed for the development of a range of processing methodologies leading to 
scaffolds with different properties and porous structures, also depending on the synthetic 
component of the starch-based polymeric blend.  
In general, these starch-based scaffolds allowed for the adhesion, proliferation and 
differentiation of marrow stromal cells towards the osteoblastic phenotype, under static and 
flow perfusion conditions. It was demonstrated that scaffold architecture and especially pore 
interconnectivity affect the homogeneity of the formed tissue. The scaffolds porosity influences 
the sequential development of osteoblastic cells and in combination with the culture conditions 
may affect the functionality of in vitro formed tissues. 
The work developed also emphasized the importance of the culturing system in bone tissue 
engineering approaches such as the one proposed in this thesis.  Flow perfusion augments the 
functionality of scaffold/cell constructs grown in vitro as it combines both biological and 
mechanical factors that enhance cell differentiation and cell organization within the construct, 
towards the development of bone-like mineralized tissue. Additionally, this study also shows 
that flow perfusion bioreactor culture of marrow stromal cells combined with the use of 
appropriate starch based biodegradable scaffolds may also constitute a useful model to study 
bone formation and assess bone tissue engineering strategies in vitro. 
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Chapter I 
 
GENERAL INTRODUCTION* 
 
 
 
 
Tissue engineering offers the possibility to help in the regeneration of tissues damaged by 
disease or trauma and, in some cases, to create new tissues and replace failing or 
malfunctioning organs.[1-7] This is achieved through the use of degradable biomaterials to 
either induce surrounding tissue and cell ingrowth or to serve as temporary scaffold for 
transplanted cells to attach, grow, and maintain differentiated functions.[3-5,7-17] In any case, 
the role of the biomaterial scaffold is temporary, but crucial to the success of the strategy. 
Cells and culturing methodologies are also critical issues in bone tissue engineering 
approaches. Finally it is important to recognize the characteristics and mechanisms of this 
tissue as this information is crucial to help designing improved combinations of scaffolds, 
cells and culturing methodologies towards the ultimate goal of bone tissue engineering, 
i.e., the development of bone-like substitutes. 
 
 
 
 
 
* This chapter is based on the following publications: 
 
ME Gomes, RL Reis. Biodegradable Polymers and Composites in Biomedical Applications. From Catgut to 
Tissue Engineering: Part II- Biodegradable polymers in temporary replacement and advanced tissue 
regeneration. International Materials Reviews (2004) 49: 274-285 
 
ME Gomes, AJ Salgado, RL Reis. Bone Tissue Engineering Using Starch Based Scaffolds Obtained by 
Different Methodologies. In Polymer Based Systems on Tissue Engineering, Replacement and 
Regeneration, Eds: RL Reis and D Cohn, NATO/ASI Series, Drodercht , Kluwer Press (2002) 221-249. 
 
ME Gomes, RL Reis, AG Mikos, Injectable Polymeric Scaffolds for bone tissue engineering. In 
Biodegradable Systems for Tissue Engineering and Regenerative Medicine, Eds: RL Reis and J San 
Roman, Boca Raton, CRC Press (2004) 29-38 
 
ME Gomes, PB Malafaya, RL Reis. Two Promising Methods for the Fabrication of Biodegradable Scaffolds 
for Bone Tissue Engineering. In Biodegradable Systems for Tissue Engineering and Regenerative 
Medicine, Eds: RL Reis and J San Roman, Boca Raton, CRC Press (2004) 53-65 
 
AJ Salgado, ME Gomes, RL Reis. Tissue Engineering of Mineralized Tissues: The Essential Elements.  In 
Learning From Nature How To Design New Implantable Materials: From Biomineralization Fundamentals 
To Biomimetic Materials And Processing Routes, Eds: RL Reis and S Weiner, NATO/ASI Series, Drodercht, 
Kluwer Press (2004) 205-222 
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1. TISSUE ENGINEERING APPROACHES FOR THE REGENERATION OF BONE 
 
 
1.1. Bone tissue 
 
Bone is a dynamic tissue which undergoes remodeling as it is constantly being resorbed 
and rebuilt (or formed), following injury.[18-20] In spite of being capable of self-regeneration 
after injuries or to remodel in relation to local stresses, in case of severe injury, the fracture 
repair mechanism of bone can fail and thus bone does not heal correctly and does not 
regain its mechanical function [3,7,20-24]. Such clinical scenarios are known as fibrous non-
unions and require additional treatment to aid the healing process.[7] 
Moreover, bone tissue can suffer from several diseases, most of which are due to an 
imbalance between the breakdown and formation of bone resulting in systemic or local 
bone loss. These include: osteoporosis, hyperparathyroidism, hypercalcemia and 
malignancy, Paget’s disease, metastatic disease in bone, local destruction of bone in the 
jaws in periodontal disease, periarticular bone loss in rheumatoid arthritis, bone loss in 
immobilization due to the absence of mechanical stimuli, and bone loss associated to 
glucocorticoid treatment.[20] All of these conditions could be helped by blocking bone 
resorption, but this is not always possible. In such situations, bone tissue engineering can 
bring up the ultimate solution and hope for many patients suffering from these problems. 
For developing tissue engineering strategies to regenerate bone, it is productive to 
frequently review bone anatomy[22,25-27] and to revisit the concepts of bone formation and 
repair. Understanding the mechanisms of bone formation as well as the manner by which 
this extraordinary tissue repairs or regenerates, considering the contribution of each its 
natural components and its functions, should be the basis for attempting to develop new 
strategies for bone tissue regeneration [27,28].  
 
 
1.1.1. Overview of bone biology 
 
Bone is a natural composite material containing approximately 60% mineral, 10% water 
and 30% collagenous matrix.[29] This fascinating material provides at least four principal 
functions in the human body. The first is that bone provides a structural framework, against 
which the muscles can contract to move the body and against which the various organs 
can maintain their relative position in the body.[7,22,23,30] Another function of the skeletal 
system is to provide a mineral (predominantly calcium and phosphate) reservoir for the 
rest of the body.[22,23,30] A third principal function of the bone is to provide protection for the 
Chapter I: General Introduction 
- 19 - 
most vital internal organs.[22,23,30] A fourth function of the bone is to provide milieu (via 
marrow) [22,23] for the development of the immune system. To fulfill these functions, bone is 
continuously broken down and rebuilt.[20,31] Resorption is carried out by osteoclasts that 
dissolve bone mineral and digest bone matrix and which are derived from the bone marrow 
mononuclear cells (preosteoclasts) that line the bone-forming surfaces.[20,21,30,32] Bone 
resorption takes place at a specialized area of the osteoclastic cell membrane called the 
“ruffled border”.  
Osteoblasts are the bone-forming cells.[20,21,30,33] They are cuboidal, plump cells that are 
organized in layers and act in coordinated fashion to generate the matrix.[20] They work 
together to produce the lamellar structure characteristic of bone. Osteoblasts secrete the 
bone matrix, which subsequently proceeds to mineralize extracellularly.[20,30,34] Osteoblasts 
originate from mesenchymal stem cells/precursor cells in response to an inducing event 
and undergo differentiation, a stepwise process that can be defined by a temporal 
sequence of expression of genes encoding osteoblast phenotype markers divided in three 
distinct periods: a growth period (proliferation), a period of matrix development and a 
mineralization period.[35] During this process, the cells start producing characteristic 
products of osteoblasts, including all the constituents of extracellular matrix, such as type I 
collagen, which constitutes 90% of the matrix and noncollagenous proteins, such as 
osteopontin, osteonectin, bone sialoprotein, biglycan, matrix gla protein, decorin, and 
osteocalcin.[20,36] Osteoblasts are also very rich in alkaline phosphatase, which participates 
in the mineralization process. Osteoblasts deposit about 0.5µm of matrix per day and their 
forming periods last about 100 days. Some of the osteoblasts are then buried within the 
matrix which they formed and are called osteocytes, other become flattened cells on the 
surface of the bone and are called lining cells.[20,30] Osteocytes communicate with each 
other through projections, which join in gap junctions and may provide communication 
across the bone. [20] This brings up the second function of osteoblast lineage cells, which is 
the regulation of bone metabolism and remodeling. Osteoblastic cells respond to several 
bone resorptive stimuli (including, for example, parathyroid hormone) and also to a 
significant number of growth factors (and produce some of them).[20] 
 
Macroscopically, the bone of the mature skeleton consists of cortical (or compact) bone 
(80%) and  cancellous (or trabecular) bone (20%).[19,22,30] Compact bone is distinguished 
from trabecular bone by the spatial orientation of its mineral and organic components, and 
by its characteristic locations in the skeleton. Compact bone comprises the outer tubular 
shell of the long bones, and the outer surface of the small bones and flat bones. It is much 
more dense than trabecular bone, and it consists of parallel cylindrical units called osteons 
(or Harversian systems). Compact bone is anisotropic, and the orientation of the osteons 
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determines, to a great extend, the directionality of its mechanical properties.[19,22] 
Trabecular bone is less dense than compact bone and is comprised of an array of plates 
and rodes of bone tissue and forms an open-cell foam. The orientation of the plates and 
rodes of the bone is such that the trabecular bone is also anisotropic. It optimizes 
resistance to usual stresses that occur in its particular location.[19,22] 
 
 
1.1.2. Bone formation and calcification 
 
Bone formation occurs by intramembranous or endochondral processes. In the 
intramembraneous process, bone formation begins when mesemchymal progenitors 
condense (form clusters of cells) and differentiate directly into osteoblasts, while in the 
endochondral ossification process the same progenitors first form a cartilage template that 
is later replaced by bone.[22,30,37] Intramembraneous ossification is mainly responsible for 
the development of flat bones from the skull and for the addition of bone on the periosteal 
surfaces of long bones [22,37]. Endochondral ossification occurs in the formation of long 
bones, vertebrae and fracture repair.[22,37] Besides the different processes on bone 
formation, also distinct embryonic lineages are involved in forming the different parts of the 
skeleton. A third type of bone development, called appositional formation, occurs during 
enlargement of bone and during remodeling.[38] In this case, osteoblasts attach to existing 
bone and secrete matrix, often in layers. All three types of formation occur constantly and 
a particular bone can be formed through any combination of these developmental 
schemes.[38] 
 
Independently of the bone formation process that occurs, the collagen matrix secreted by 
the osteoblasts undergoes mineralization.[22,35,38-40] As osteoblasts are separated by 
calcifying matrix, they are entrapped in spaces called the lacunae. These entrapped 
osteoblasts - the osteocytes – gradually loose their ability to produce matrix.[20,22] These 
cells communicate with other osteocytes via long processes (canaliculi), which are 
organized before calcification.  There is a delay between the formation of the matrix and its 
mineralization, which is believed to occur so that there is spatial separation between 
calcified bone and the overlaying cells. Matrix mineralization occurs in two steps 
correspondent to the nucleation and growth of calcium phosphate crystals. The nucleation 
can be homogenous or heterogeneous.[22,38] In homogenous nucleation, the formation of 
crystal is due to supersaturation of the local environment with the appropriate ions. The 
heterogeneous nucleation occurs only at surfaces where the interaction between the 
surface and the ions lowers the interfacial energy requirement so that nucleation can 
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proceed at concentrations that are less than that of supersaturation. After nucleation, 
amorphous calcium phosphate may be the first to precipitate, which is then converted into 
octacalcium phosphate and finally to hydroxyapatite.[38]  
As woven bone is formed and calcified, it is remodeled to form mature lamellar bone[22]. On 
a larger scale, both woven and lamellar bone can be found in either trabecular or cortical 
bone. Lamellar bone is generated more slowly than woven bone and is less 
mineralized.[20,22] 
 
 
1.1.3. Bone formation and regeneration: the importance of the mechanical environment  
 
Bone has enormous capacity for growth, regeneration and remodeling. The mechanical 
environment is one of the major factors involved in these processes. Mechanical loading of 
physiological relevance magnitudes has been shown directly to initiate bone modeling in 
animal models,[41-45] although this is not the only factor contributing to these changes.[46] In 
contrast, lack of load has been shown to promote tissue atrophy and bone loss.[41,43] In 
fact, during growth and development, the skeleton optimizes its architecture by subtle 
adaptations to the thousands of repetitive mechanical loads to each it is exposed daily. 
The mechanisms for adaptation involve a multistep process of cellular 
mechanotransduction[44,46-48] that includes: i) mechanocoupling: conversion of mechanical 
forces into local mechanical signals, such as fluid shear stress, that initiate a response by 
bone cells; ii) biochemical coupling: transduction of a mechanical signal to a biochemical 
response involving pathways within the cell membrane and cytoskeleton; iii) cell-to-cell 
signaling from the sensor cells (probably osteocytes and bone lining cells) to effector cells 
(osteoblasts and osteoclasts) using prostaglandins and nitric oxide as signaling 
molecules[46,47,49]; and iv) effector response: either bone formation or resorption to cause 
appropriate architectural changes. These architectural changes tend to adjust and improve 
the bone structure to its prevailing mechanical environment[47]. 
 
The repair and regeneration of bone can be characterized as a symphony of cellular 
activity [50,51] beginning with an acute inflammatory response followed by granulation tissue 
infiltration, recruitment, proliferation and differentiation of osteogenic cells, matrix formation 
and mineralization, and eventual remodeling. The process occurs within the context of 
biological and mechanical signals. Biologically, the regulation of the repair is accomplished 
through the expression of a cascade of growth factors, hormones, and cytokines[50,51] that 
condition the wound and directly influence cell migration, proliferation, differentiation and 
synthesis. Similarly, mechanical forces transmitted via the extracellular matrices being 
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assembled, influence the patterning of this cellularly orchestrated activity. From a 
hierarchical perspective, the success of the repair or regeneration of bone will depend on 
the regeneration of the necessary molecular signaling cascades, the availability and 
viability of progenitor cells, nutritional support, and appropriate mechanical 
environment.[50,51] 
 
In summary, the goal of a bone tissue engineer is to exploit the body’s natural ability to 
repair injured bone with new bone tissue.[22,27,52] In general, bone tissue engineering 
strategies should attempt to provide the reconstruction region with appropriate initial 
mechanical properties, encourage new bone to form in the region, and then gradually 
degrade to allow the new bone to remodel and assume the mechanical support 
function.[22,27]  
 
 
1.2. Tissue engineering strategies 
 
Conventional approaches in bone repair have involved biological grafts such as 
autogenous bone or autografts,[53-55] allogenic bone or allografts[53,56] and xenografts.[53] 
Currently, autografts are the most often used in clinical settings, as they do not represent 
risk of immune rejection or disease transfer.[53,54,57] However, the limited availability of 
autografts and the risks of morbidity have fueled the continuously growing interest in the 
development of alternative approaches to bone repair based on tissue engineering 
strategies.[27,53,55,57,58] 
As stated before, the ultimate goal of tissue engineering is to replace, repair or enhance 
the biological function of damaged, absent or dysfunctional elements of a tissue or an 
organ. This goal is accomplished using cells that are manipulated through their 
extracellular environment to develop engineered tissues that can function as living 
biological substitutes for tissues that are lacking.[59] Many different strategies may be used 
to develop these engineered tissues. The selection of the best strategy for developing 
hybrid materials for the regeneration of a specific tissue defect is determined by several 
factors, such as the technical feasibility, required properties of the implant and the 
interaction of the host with the graft.[59] Basically, three general strategies (which are 
schematically represented in Figure I.1) have been adopted for the creation of new 
tissue[60-64]. These strategies are described bellow. 
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1.2.1. Cell self-assembly 
 
The Cell self-assembly approach corresponds to the direct in vivo implantation of isolated 
cells or cell substitutes[60-65] and its based on cells synthesizing their own matrix. This 
approach avoids the complications of surgery, allows replacement of only those cells that 
supply the needed function and permits manipulation of cells before infusion. Its potential 
limitations include failure of the infused cells to maintain their function in the recipient, and 
immunological rejection.[60-62] For other authors[66] this approach involves a layer of cells 
secreting their own matrix, which over a period of in vitro culturing becomes a sheet and 
the formation of multiple layers like can eventually result in the formation of skin substitutes 
or blood vessels, for example. However, it is well known that many cell types are 
anchorage dependent (their function is dependent upon specific cell-substrate 
interactions), and therefore their direct transplantation or in vitro culturing without a 
scaffold, as suggested in this approach, results is cell death or loss of function.[24,61]  
 
 
1.2.2. Acellular scaffold 
 
This approach is based on the direct in vivo implantation of biomaterials[24,61-65,67,68] and 
relies on the ingrowth of tissue and cells into a porous material; this process, by which the 
regeneration is affected by ingrowth from surrounding tissue, is known as tissue 
induction[24] In many cases, in this approach, the matrix (polymeric scaffold) is loaded with 
growth factors or any other therapeutic agent. With this approach, the issue of cell 
sourcing is eliminated but its success depends on the infiltration and recruitment of the 
appropriate type of cells from the body in order to populate the construct and thus facilitate 
a proper tissue repair. In the case of bone, this three-dimensional process depends on the 
chemical surface properties of the implant, its three-dimensional structure and porosity, 
and its rate and mechanism of degradation.[34] These are the properties of the materials 
that may enhance the attachment, migration and distribution of cells responsible for the 
bone-healing response throughout the volume of the graft site, i.e., the osteoconduction 
behaviour. When porous osteoconductive structures are implanted into or adjacent to 
bone, cells from surrounding tissues migrate into available void volume of the matrix. The 
process is characterized by an initial ingrowth of fibrovascular tissue and new blood 
vessels.[34,68] This tissue invades the void volume of the scaffold and is latter followed by 
bone formation.  
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1.2.3. Cell-seeded polymeric scaffolds 
 
In this approach, the temporary scaffold provides an adhesive substrate for the implanted 
cells and a physical support to organize the formation of the new tissue.[24,60-65,67,69,70] 
Transplanted cells adhere to the scaffold, proliferate, secrete their own extracellular 
matrices (ECM), and stimulate new tissue formation. During this process, the scaffold 
gradually degrades and is eventually eliminated.[62,64,68-73] 
This is considered by many as the classic tissue engineering approach and is the most 
widely studied for bone regeneration. This results mainly from the statement that all 
successful bone healing requires the presence of a sufficient amount of osteoblastic 
progenitor cells,[22,34,64,74] which is limited in many clinical settings. These settings include 
sites of large bone defects, sites containing extensive scar tissue from previous surgery or 
trauma, sites of previous infection or radiation, sites in which the bone may be diseased or 
sites with compromised vascularity.[34] There are also systemic conditions such as diabetes 
or metabolic bone disease and pharmaceutical agents such as nicotine, systemic 
glucocorticoids or chemeotherapy, that limit the number or function of progenitor 
cells.[20,34,74] In these cases, that are common in clinical practice, the implantation of an 
osteoconductive material alone or even an osteoconductive scaffold loaded with one or 
more osteoinductive growth factor may not be enough to induce a reliable and optimal 
bone-healing response.[22,34,64,74]  
Therefore, the key for successful repair/regeneration of bone is to provide the repair site 
with sufficient osteogenic progenitor cells in a suitable scaffold to ensure osteoblastic 
differentiation and optimal biosynthetic activity of bone matrix and growth and 
differentiation factors. Exclusion of interfering tissues, promotion of vascular penetrance, 
and provision of appropriate mechanical and other instructional cues must be engineered. 
As one gains more information about the identity and reactivity of all the triggering factors, 
it may be possible to orchestrate massive bone regeneration by clever combinations of 
scaffolds and such instructional agents.[75] 
 
The experimental work described in this thesis is based on the last approach that 
corresponds to in vitro culturing of cell-scaffolds constructs prior to implantation. Therefore, 
the reminder of this chapter will focus only on the three main issues involved in this 
approach: i) the polymeric scaffolds, ii) the cells sources and iii) the culturing system.  
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Figure I.1: Schematic representation of the three main generic tissue engineering approaches that 
may be used to regenerate a tissue defect. a) Cell self-assembly b) acellular scaffold c) cell-seeded 
polymeric scaffold. 
 
 
 
2.  DESIGN AND PROCESSING OF SCAFFOLDS FOR BONE TISSUE ENGINEERING 
 
 
2.1. Scaffold requirements  
 
The requirements for a scaffold material to be considered suitable for tissue engineering 
applications are complex and in many cases there is no consensus among the 
biomaterials research community about the specific demands that are required for a 
particular application. These requirements depend mainly on the tissue to be restored and 
on the location and size of the defect to be treated. Nevertheless, there are some general 
key characteristics that a scaffold material must possess: 
Injection of cells into 
the tissue defect 
tissue 
defect 
Implantation of a biodegradabe 
porous scaffold 
In vitro cell seeding into a 
biodegradable porous scaffold 
prior to implantation 
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i) biocompatibility[1,3,7,11,24,67,76-80] both in as-implanted and degraded form, i.e., the scaffolds 
and their degradation products should not invoke an adverse immune response or toxicity;  
ii) appropriate mechanical properties[1,3,7,23,65,67,76-79,81-84] to provide the correct stress 
environment for the neo-tissue; this is particularly important for the regeneration of hard 
tissues, such as bone.  
iii) controlled degradation rate[3,7,11,24,61,67,76,78,80,81,84]: because tissues regenerate at 
different rates, the degradation rates should be adjustable to match the rate of tissue 
regeneration, since strength decreases as the material degrades over time;  
iv) appropriate pore size and morphology[1,3,7,11,24,61,67,78,79,81,84]: porosity, pore size and pore 
structure are important factors that are associated with nutrient supply to transplanted and 
regenerated cells. Small diameter pores are preferable to yield high surface area per 
volume, as long as the pore size is greater than the diameter of a cell in suspension 
(typically 10 µm). There is a lack of consensus regarding the optimal pore size for 
maximum tissue ingrowth and/or for an optimal cell growth, but is generally accepted that 
this depends on the tissue that is intended to restore/substitute. In the case of bone 
regeneration, some authors defend that a maximal tissue ingrowth is attained with a pore 
size ranging from 200 to 400 µm,[67] for others it should be from 100 to 150 µm,[3] or from 
100 to 350 µm,[85] for example. Interconnectivity between pores is highly desirable when 
compared to the isolated pores, since an interconnected pore network structure enhances 
the diffusion rates to and from the centre of the scaffold and facilitates 
vascularization,[1,3,7,24,67,78,79,81,84,86,87] thus improving oxygen and nutrient supply and waste 
removal.  
v) appropriate surface chemistry for cell attachment, proliferation and 
differentiation[1,3,7,24,67,77-79,81,84,86,87]: because most organ-cell types are anchorage 
dependent, they require the presence of a suitable substrate to retain their ability to 
proliferate and perform differentiated functions since cell adhesion is the pre-requisite for 
further cellular functions, such as spreading, proliferation, migration and biosynthetic 
activity. Therefore, the surface characteristics of materials, whether their topography, 
chemistry, surface energy or wettabbility, play an essential role in cell adhesion on 
biomaterials.[88-90] However, it is very rare that any biomaterial with good bulk properties for 
a specific use in the biomedical field also possesses the required surface 
characteristics[91,92] for that application. It follows that most of the biomaterials need surface 
modification to acquire surface characteristics that allow for an adequate cell 
adhesion.[91,92] These surface modifications include, for example, roughening, coating, 
blending and grafting.[91,92] 
vi) easily sterilized [24,76] either by exposure to high temperatures, ethylene oxide vapour, or 
gamma radiation and remain unaffected by one of these techniques.  
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vii) easily processed into three-dimensional shapes of irregular geometry[3,7,11,61,67,76-78] that 
can be maintained after implantation. In some cases, a scaffold with unique three-
dimensional geometry is required to fit an irregular defect. The regenerated tissue is 
therefore expected to take the shape of the initial scaffold.  
 
 
2.2. Scaffolding materials – the starch based polymers 
 
In scaffold-based tissue engineering strategies, the successful regeneration of tissues from 
matrix-producing connective tissue cells or anchorage dependent cells (e.g. osteoblasts) 
relies on the use of a suitable scaffold. Therefore, the design and production of an 
appropriate scaffold material is the first, and one of the most important stages in hard 
tissue engineering strategies based on seeding and culturing an appropriate type of cell 
onto the constructs prior to implantation. In this critical stage, the selection of the most 
adequate raw material is a primary consideration. There are many biocompatible materials 
available among metals, ceramics and polymers. However, the criteria of biodegradability 
excludes the use of all metals and most ceramics as scaffolds materials.[3,24] Although 
biodegradable/bioresorbable ceramic materials, such as tri-calcium phosphate and sea 
coral, have been used with some success[3,24] as scaffold materials (mainly in orthopaedic 
applications), they usually present at least one of the following limitations: first they are 
usually not only quite brittle but also difficult to process into porous materials with complex 
shapes, and second, it is currently not possible to generate matrices with clinically useful 
degradation rates from most of the available ceramics. Polymers, on the other hand, are 
ductile and easily formed into any shape. Traditionally, in spite of the wide range of 
biodegradable polymers available (currently available natural and synthetic polymers and 
their properties can be found elsewhere[93]), there is a strong tendency to choose those 
that have history of regulatory approval, i.e., materials which were primarily developed for 
other applications, instead of letting the application guide the choice of the material.[77] For 
these reasons, the most widely used polymers in tissue engineering have been the poly( -
hydroxy acids) of the aliphatic polyesters, i.e. polyglycolic acid (PGA), polylactic acid (PLA) 
and copolymers (PLGA) of these materials. This has created additional difficulties for the 
development of new materials with improved properties, specifically tailored for tissue 
engineering applications.  
 
It is believed, that the best biodegradable polymer for biomedical applications, including 
those related with tissue engineering, may be found taking steps towards the development 
of new biomaterials that combine the most favorable properties of synthetic and natural 
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polymers.[61,87,94] Biodegradable blends of corn starch with several synthetic polymers,  
including the ones produced by Novamont (Novara, Italy), have been originally proposed 
by the University of Minho researchers as potential alternatives to the commonly used 
biodegradable polymers, for a variety of biomedical applications.[95-144] These materials are 
based on blends of corn starch (in amounts varying from 30 up to 50 %wt) with 
poly(ethylene vinyl alcohol) (SEVA-C), cellulose acetate (SCA), poly(ε-caprolactone) 
(SPCL) and poly-lactic acid (SPLA).[95,145,146] 
These polymers can be designed into distinct material formats and/or different properties 
by tailoring the synthetic component of the starch-based blend, their processing methods, 
and the incorporation of additives and reinforcement materials. These polymeric blends 
are degraded by hydrolytic processes and several enzymes[136,147-149] can also be involved 
in the process, mainly alpha-amylase, beta-amylase, alpha-glucosidase and other 
debranching enzymes.[136,148,149] The biocompatibility and non-immunogenecity of starch-
based polymers has been well demonstrated by several in vitro [118,125,134,143,150-152] and in 
vivo studies[106,153]. For all these reasons, together with their low cost and abundance of 
raw materials, starch-based polymers have been suggested for a wide range of biomedical 
applications, such as, for example,  partially degradable bone cements,[99,109,140-142] as 
systems for controlled release of drugs[98,103,104,109]  as bone substitutes in the orthopaedic 
field [96,97,116,122,130] or as scaffolds for tissue engineering,[100,110,120,121,123,128,143,144,154] as it is 
also proposed in this thesis. 
 
 
2.3. Scafolds processing methodologies 
 
In order to meet all the necessary requirements, scaffold materials must be fabricated from 
polymers with adequate properties but the establishment of basic requisites and design 
constrains its not an easy task and requires a deep knowledge about all the materials 
features that can interfere with cells/tissues-scaffold interactions. The selection of the 
appropriate tissue engineering approach will help define the most adequate scaffold 
design and the correspondent required properties, which must be able to induce the 
desired tissue response.[59,155] Three-dimensional porous structures have been recognized 
as the most appropriate design to sustain cell adhesion and proliferation, although several 
specific applications in tissue engineering may take advantage of other design formats or 
combination of different materials designs.[77] 
 
As discussed in previous section, besides the obvious demands of biocompatibility and 
biodegradability, an ideal tissue engineering scaffold should exhibit appropriate 
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mechanical properties[1,3,7,23,65,67,76-79,81-84] and a suitable degradation rate.[7,24,76,80,81,156] 
Furthermore, the scaffold must possess adequate porosity, interconnectivity and 
permeability to allow the ingress of cells and nutrients[7,80,81,156] as well as the appropriate 
surface chemistry for enhanced cell attachment and proliferation.[11,61,81,156] For most 
applications, tissue engineering scaffolds must provide cell anchorage sites, mechanical 
stability and structural guidance and, when implanted, provide an adequate interface to 
respond to physiological and biological changes in order to integrate with the surrounding 
native tissue. Taking into account these requisites, the processing technology used to 
produce the scaffolds is mainly expected to provide the maximal control over macro and 
microstructural properties of the scaffold without negatively affecting the other properties 
that provide good scaffold-cells interactions such as toxicity and/or surface 
chemistry/topography.[157] Other important requirements for a scaffold fabrication method 
include the process accuracy and reproducibility, i.e., the methods should be able to 
produce scaffolds with consistent properties and physical forms when using the same 
processing parameters. 
However, the properties of the scaffold are also dependent on the natural or synthetic 
material selected for its production. For the selection of the most appropriate scaffold 
material for a given application, besides the intrinsic properties of the wide range of 
materials available, it is also important to consider that each material or combination of 
materials has a different degree of processability and processing requirements. 
 
The development of matrices to serve as templates for cell attachment/suspension and 
delivery has progressed at a tremendous rate in the past years and a wide range of 
methodologies have been developed. Usually, these methods involve either melting or 
solvent casting processing. Melt processing involves heating the polymer above the glass 
transition temperature (Tg) or the melting temperature(Tm) and depends on melt viscosity. 
Solvent processing depends on polymer solubility in various organic solvents and on the 
solvent volatility.[3,24] Among these processing techniques are methods such as solvent 
casting and particulate leaching,[15,67,158-160] membrane lamination,[10,67] fiber 
bonding,[80,87,161-164] phase separation/inversion,[67,165] melt based technologies,[7,100,121,123,158] 
microparticles aggregation,[166,167] and micro-wave baking and expansion,[103] just to cite 
some examples. More recently highly reproducible 3-D scaffolds have been obtained using 
rapid prototyping technologies such as fused deposition modelling (FDM) and 3-D 
printing.[80,168-170] 
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The methodologies developed so far, have been applied to fabricate scaffolds for tissue 
engineering with different levels of success.  In general, most of these methods present 
other main limitations such as[157]: 
i) Manual intervention: most of the techniques available rely on manual-based procedures 
which are practically impossible to transform in industrial scaled-up methods. Therefore 
the processes become labour intensive and time consuming. Furthermore, the process is 
very dependent on the user skills and the reproducibility of results is very difficult to 
achieve. 
ii) The use of toxic organic solvents: The use of toxic solvents in technologies based in the 
casting of polymeric solutions may affect the biocompatibility of the resulting scaffold due 
to retention of harmful residues.  
iii) Use of porogens: the methods based on porogen leaching are usually limited to the 
production of thin scaffolds to facilitate the total removal of the porogens, which can have a 
cytotoxic effect on the contacting cells. Furthermore, it is difficult to avoid the 
agglomeration of the porogen particles leading to non-uniform porosity and pore size. 
iv) Geometric limitations: several techniques use moulds or containers to cast scaffolds 
that only allow for obtaining thin membranes and/or basic and uniform scaffolds 
geometries.  
 
Nevertheless, one of the major problems of the scaffolds produced by most of the methods 
currently available is their poor mechanical properties and/or inadequate porosity. 
Obviously, it is very difficult to optimise these two properties simultaneously, since the 
mechanical properties are usually decreased with increasing porosity. However these are 
very important aspects for the regeneration of hard tissues because scaffolds are required 
to provide structural support for the neo-tissues and porosity and interconnectivity of the 
structures is essential to allow for cell proliferation within constructs with significant sizes. 
Therefore, the search for better methods of producing porous scaffolds, so that physical 
and chemical properties can be simultaneously optimised, is still an important and 
challenging issue especially in hard tissue engineering research. 
Chapter I: General Introduction 
- 31 - 
 
Table I.1. Some examples of scaffolds aimed at applications in bone tissue engineering, based on 
different biodegradable polymers which were developed in recent years using different processing 
methodologies.  
 
Processing method Used polymers 
 
References* 
Hyluronic acid [171] Fiber bonding 
SPCL [105,135] 
Electrospinning PCL [172] 
PLLA,PLGA [3,61,158-160,173-175] 
PLGA/PEG [176] 
Solvent casting-particle leaching 
SCA [123] 
PLGA [177-179] Supercritical fluid technologies 
PLG/PGA/PLLA [179] 
Melt based technologies PLLA,PLGA,PGA [3,158] 
Injection molding and extrusion with blowing agents SEVA-C, SCA [100,121,123]  
Compression moulding-particle leaching SCA [121,123] 
PLGA [1,67,165] High pressure CO2 
PLA [180] 
PLLA [1,158] 
PLGA [181] 
Freeze-drying 
PLG [182] 
PLA [3,166,167,183] Aggregation of microparticles 
PLAGA [3,166,167,183] 
PPF [158,184,185] In-situ polymerization 
  
Microwave processing SEVA-C [103] 
Rapid prototyping   
FDM PCL [168-170]  
3D printing  Blend of Corn starch, 
dextran and gelatin  
[186] 
* Selected from works published between 1997 and 2004 
PGA: Poly(glycolic acid); PLA: poly(lactic acid); PLG: poly(D,L-lactide-co-glycolide); PEG: polyethylene-glycol; PE: 
polystyrene; SEVA-C: starch/ethylene vinyl alcohol blend; SCA: starch/cellulose acetate blend; SPCL: starch/ Poly (ε-
caprolactone); PPF: poly(propylene fumarate); PCL: Poly(ε-caprolactone); 
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In the following sections two different scaffold processing methods will be described with 
more detail, namely melt molding and fiber bonding, as  these were the methodologies that 
were used to obtain the starch-based scaffolds that were more extensively studied under 
the scope of this PhD thesis, namely the scaffolds that were selected for the in vitro tissue 
engineering studies. A more detailed description of other processing technologies may be 
found elsewhere.[120,155] 
 
 
2.3.1. Fiber bonding 
 
The most important advantageous features of scaffolds obtained by fiber bonding 
processes, i.e., fiber meshes (which consist of individual fibers either woven or knitted into 
three-dimensional patterns of variable pore size), are a large surface area for cell 
attachment and a rapid diffusion of nutrients which enhances cell survival and 
growth.[3,24,61,67,158] This, of course, results from a high interconnectivity among pores. A 
drawback of these scaffolds might be the difficulty in controlling accurately the porosity 
[3,24,67,158]. Several studies demonstrate that scaffolds obtained by fiber bonding processes, 
have adequate structure for use in tissue engineering strategies that use bioreactor 
cultures, probably because they provide highly interconnected porosity that enables to 
create hydrodynamic micro-environments with minimal diffusion constrains that closely 
resemble natural interstitial fluid conditions in vivo allowing to achieve large and well 
organized cell communities. On the contrary, most of the porous obtained with other 
methodologies exhibit lower interconnectivity which is very likely to generate complex fluid 
flow pathways thought the scaffolds and that does not allow for the distribution of cells 
throughout the whole construct. Fiber bonding methods include a great variety of 
processing methods that involve the knitting or physical bonding (by means of casting or 
compression procedures) of fibers prefabricated by wet or dry spinning from polymeric 
solutions or by melt spinning.  
 
Polyglycolic acid (PGA) non-woven meshes have been widely used in tissue engineering 
studies particularly concerning applications in cartilage reconstruction.[11,65,163,164,187-190] 
These meshes are produced by extrusion of PGA into fibers with 13µm of diameter which 
are subsequently stretched and relaxated at high temperatures, crimped and cut, carded 
into lofty web and finally needled to for a non woven mesh. Theses meshes are 
commercially available and are produced by Albany International (Mansfield, MA, USA).[11] 
 
Chapter I: General Introduction 
- 33 - 
However, in spite of their wide use as scaffolds in tissue engineering, some authors 
believe that non-woven fibrous matrices require modification of their microstructure to 
organize cells in three-dimensional space with spatially balanced proliferation and 
differentiation in order to promote functional tissue development. In addition, the potential 
lack of structural stability for in vivo use has motivated the development of fiber bonding 
methods to modify this type of non-woven meshes into interconnected fiber networks with 
different shapes. For example, Mikos et al.,[3,24,61,67,158,191] developed a method of producing 
interconnected fiber networks by a fiber bonding technique that involves the casting of a 
PLLA solution over a non-woven mesh of PGA fibers. Solvent evaporation results in a 
composite material that consists of non-bonded PGA fibers embedded into a PLLA matrix. 
Fiber bonding occurs during a post treatment at a temperature above Tm of PGA. Finally 
the PLLA matrix is selectively dissolved in a non-solvent for PGA, and a network of bonded 
PGA fibers is released. However, stipulations concerning the choice of the solvent, 
immiscibility of the two polymers, and their relative melting temperatures restricts the 
general application of the technique to other polymers.[24,67,158] In addition, this method of 
fiber bonding does not address the problem of creating scaffolds with complex three-
dimensional shapes, but it has proven successful for producing hollow tubes that have 
been proposed for use in intestine regeneration.[24,67,158] 
 
A different method was developed by Li et al. [161], which is based on the thermal 
compression of non-woven polyethylene terephthalate (PET). It was found that a more 
uniformly distributed pore size resulted from thermal compression and the isotropic nature 
of non-woven fabrics was preserved because of the proportional reduction of the pore by 
compression. The thermally compressed fabric matrices with two different pore sizes (15 
and 20 µm in pore radius) were used to culture human trophoblast ED27 and NIH 3T3 
cells. It was found that cells cultured in the different pore-size PET matrices had different 
cell spatial organization and proliferation rates. The smaller pores in the matrix allowed for 
cells to spread better and proliferate faster, while cells in the larger pores tended to form 
large aggregates and had lower proliferation rate. According to the authors, this thermal 
compression technique can also be applied to other synthetic fibrous matrices, including 
biodegradable polymers used in tissue engineering, to modify the microstructure according 
to their viscoelastic properties. 
 
In spite of a lot of work on fiber meshes has been focused on the use of synthetic polymers 
like the above mentioned PGA,[11,65,82,163,164,187-190] PLA[82] and polyethylene PET,[161] some 
natural origin polymers, such as hyluronic acid,[171,192] collagen[193,194] and blends of starch 
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with polycaprolactone (as it will be described in this thesis)  have also been employed in 
the fabrication of fiber meshes for tissue engineering applications. 
For example, a non-woven mesh based on the benzyl ester of hyaluronic acid (HYAFF 11) 
was investigated for application as a scaffolds material for the culture of human nasoseptal 
chondrocytes in tissue-engineering procedures of cartilage reconstruction [171]. The non-
woven cell carrier allowed good viability and adhesion of the cells without any surface 
treatment with additional substances.[171] Another  study, by Saldanha & Grande [193] has 
assessed properties of collagen as a scaffolding biomaterial for ligament replacements.  
 
 
Fiber meshes may also be obtained in single step methods such as electrospinning. 
Electrospinning generates fibers with very small diameters (ranging from several microns 
down to 100 nm or less) which mimic the nanometer scales of the fibers that compose the 
extracellular matrix of native tissues.[195] In electrospinning, a polymeric solution or melt is 
injected with an electrical potential to create a charge imbalance and placed in proximity 
with a grounded target. At a critical voltage, a charge imbalance begins to overcome the 
surface tension of the polymer source, forming an electrical charged jet. The jet within the 
electrical field is directed toward the grounded target, during which time the solvent 
evaporates and fibers are formed. Electrospinning produces a single continuous filament 
that collects on the grounded target as a non-woven fabric.[196] 
This technology has been used to process several natural and synthetic bioabsorbable 
polymers for biomedical applications [197] as for example, Poly(glycolic acid) [198],  
Poly(lactic acid),[199] Poly(D,L-lactide-co-glycolide),[200] Polycaprolactone,[201] poly(lactic 
acid) and polycaprolactone based blends,[202] Collagen,[196,203,204] Collagen-PEO blends[205]  
and elastin[202] poly(ethylene –co-vinyl alcohol).[195] 
 
 
 
2.3.2. Melt molding  
 
Melt moulding has been normally used in combination with porogen techniques or to 
produce a pre-shape of the final material, for example, to produce fibers that will be used 
in fiber bonding methods, as it was described above in the high pressure method that will 
be described further down in this section. 
One example of application of this method consists in the use of a mixture of fine PLGA 
powder and gelatine microspheres that are loaded in a PTFE mould and then heated 
above the glass-transition temperature of the polymer.[3,24,67,158] The PLGA-gelatine 
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composite is subsequently removed from the mould and gelatine microspheres are 
leached out by selective dissolution in distilled deionised water. In this way, porous PLGA 
scaffolds with geometry identical to the shape of the mould can be produced. Polymeric 
scaffolds of various shapes can be produced by simply changing the mould geometry. This 
method also offers independent control of porosity and pore size [3,24,67,158] by varying the 
amount and size of microspheres used, respectively. In addition, it is possible to 
incorporate bioactive molecules in either polymer or gelatine microspheres for controlled 
drug delivery because this process does not utilises organic solvents and is carried out at 
relatively low temperatures for amorphous PLGA scaffolds. Besides the choice of gelatine, 
other leachable components may be used. This manufacturing technique may also be 
applied to PLLA or PGA. However, higher temperatures are required (above the polymer 
melting temperatures) because these polymers are semi crystalline and this excludes the 
potential for protein incorporation into these systems[3,24,67,158]. 
Melt based techniques have also been extensively studied to produce starch based 
scaffolds [100,121,123]. For example, it was developed a method based on compression 
moulding combined with salt leaching. In this method a starch based polymer is blended 
with leachable particles of different sizes, in sufficient amounts to provide a continuous 
phase of a polymer and a dispersed phase of leachable particles in the blend. The mixture 
is then compression molded into a desired shape and afterwards immersed in water to 
remove the salt particles, leaving an interconnected pore structure with controlled porosity 
and pore sizes. Starch based scaffolds have also been produced using melt moulding as a 
single method based on traditional melting technologies, such as injection moulding and 
extrusion with blowing agents. In these processes, the polymers are mixed with blowing 
agents, which are previously selected according to their decomposition temperatures, 
toxicity, etc, and then processed in an extruder or in an injection moulding machine.  
These methods allow for the productions of highly reproducible scaffolds with very 
complex 3D structures,[7,100,121,123] since it is possible to obtain scaffolds with the precise 
shape of the mould designed for specific applications. This type of technologies also offers 
the possibility of using a wide range of currently available equipments that can be used to 
produce, for example, bi-material scaffolds, i.e., scaffolds that may combine two different 
polymers and/or two different structures.  
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3. IN VITRO CULTURING OF CELL-SCAFFOLD CONSTRUCTS 
 
 
3.1. Cell sources - bone marrow stromal cells 
 
A further important consideration for the most widely studied tissue engineering 
approaches, which are based on the seeding and extended in vitro culturing of cells within 
the scaffold prior to implantation, is the cell source and the ability to control cell 
proliferation and differentiation.  Primary cells derived from the patient’s own healthy 
tissues (i.e., autogenic cells) could be the first obvious choice, since this avoids many of 
the problems associated with immune rejection of foreign tissues.[59,63] However these cells 
are not, in most cases, readily available in sufficient quantities for immediate use. By in 
vitro culture their number may be increased, but to reach a cell population necessary for a 
specific application may take from days to weeks,[59,63] mainly depending on cell type. 
Furthermore, the procedure of harvesting a tissue sample from the patient to isolate the 
necessary cells is always associated with significant morbidity in the site.  Primary cells 
derived from normal donors of the same (i.e., allogeneic cells) or different species (i.e., 
xenogeneic cells) are, at least in concept, readily available in sufficient quantities due to 
the number of potential donors and to cryopreservation possibilities. However, in this case, 
rejection by the host’s immune system and the possibility of diseases transmission, are 
serious risks to be considerer.[59,63] The use of cell lines can overcome some of these 
limitations, but these immortalized cells exhibit some of the properties of neoplastically 
transformed cells.  Therefore, cells lines can be considered to be partially transformed 
cells with a predisposition to become fully neoplastic cells capable of forming tumors in the 
recipient. [59] 
 
The recent identification of human embryonic stem cells[87,206-209] – cells that can give rise 
to essentially all cell types in the body, depending on the culturing conditions – offers 
probably the most exciting alternative source of cells for tissue engineering. However, 
researchers are still far from being able to control the differentiation of embryonic stem 
cells in culture.[208]  In addition, the research on embryonic cells brings up a range ethical, 
political  and legislative problems[87,206,207,209-211] that differ from country to country. This has 
driven researchers to actively investigate alternative stem cell sources, such as the adult 
stem cells [172,207,208,211-214]. These are undifferentiated cells that occur in differentiated 
tissues in theoretically the adult body but in fact from birth. They can renew themselves in 
the body, making identical copies of themselves for the lifetime of the organism, or become 
specialized to yield the cell types of the tissue of origin. Thus they are presently considered 
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as multipotent stem cells.[207,211-222] They are considered rare, often difficult to identify and 
purify, and when grown in culture, are difficult to maintain in the undifferentiated state. 
However there is a constant and significant effort to circumvent these problems in order to 
explore (in an advantageous form) all the possibilities arising from the use of adult stem 
cells.  Sources of adult stem cells presently known include skin, brain, skeletal muscle, 
pancreas, fat, liver, the eye, dental pulp, the limit of the gastro-intestinal tract and maybe 
the most important, bone marrow and blood.[207,211-213,217,219,223-231] 
 
 
The bone marrow is comprised of hematopoietic cells and adherent stromal cells of non-
hematopoietic origin which together with the extracellular matrix provide a supportive 
scaffolding termed the bone microenvironment.[232,233] The cellular components of the 
marrow microenvironment include reticular endothelial cells, macrophages, adipocytes, 
fibroblasts and osteogenic precursor cells.[232,233] 
Friedenstein and his coworkers[234-242] were the first to utilize in vitro cultured and 
transplantation in laboratory animals to characterize cells that compose the physical 
stroma of bone marrow. Due to the low amounts of extracellular matrix that are found in 
marrow, gentle mechanical disruption (usually by pipetting and passage through syringue 
needles of decreasing sizes) can readily dissociate stroma and hematopoietic cell into 
single-cell suspension. When these cells are plated at low density, bone marrow stromal 
cells rapidaly adhere and can be easily separated from the nonadherent hematopoetic 
cells by repeated washing.[243] Friedenstein et al.[234-242] has demonstrated that these 
culture-adherent cells present in the marrow stroma are capable of differentiating into bone 
and cartilage when placed into an appropriate environment in vivo. These experiments 
have lead to the hypothesis that stroma contains a unique population of stem cells (the 
mesenchymal stem cells) which are capable of differentiating along multiple cell lineages, 
including osteoblasts, chondrocytes and adipocytes, when placed in appropriate in vitro 
and in vivo environments.[233,235,244,245] Techniques and conditions that select for these cells 
in culture have been established for several animal species, including human. However, to 
date, the isolation of “pure” population of multipotent marrow stromal stem cells remains 
elusive.[243] 
In humans, bone marrow can be harvested by aspiration from the superior iliac crest of the 
pelvis[214,244] and the associated morbidity is very low. Billions of marrow stromal cells can 
be generated from a limited amount of starting material, such as 1 ml of a bone marrow 
aspirate. Thus, these cells are rapidly adherent and capable of extended proliferation. 
From all the available sources  of  osteoblastic cells for bone tissue engineering, this is 
probably the only one that does not require an invasive surgical procedure or added time, 
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cost and risk for expand cells in vitro.[34] In addition, as cells can be harvested from the 
patient, the risk of disease transfer or immunological rejection is not an issue. The 
challenge lies in designing a microenvironment to provide the correct instructions to bring 
those cells to the desired functional state to create structurally organized tissues.[27,244,246]  
 
As stated before, bone marrow stromal cells are a promising component for engineered 
bone tissues, but in vitro formation of bone-like tissue requires conditions that direct these 
multipotent cells towards osteoblastic maturation.[246] Several studies[25,26,55,232,247-261] have 
reported the in vitro differentiation of these cells, both from animal and human origin, along 
the osteoblastic lineage, usually revealed by their capacity of expressing and/ or 
synthesize bone matrix proteins, alkaline phosphatase and ability to form mineralized 
nodules. These studies[25,26,55,232,247-261] demonstrated that several bioactive agents are able 
to induce the osteogenic character of bone marrow stromal cells, namely serum, ascorbic 
acid, β-glycerophosphate and dexamethasone.  Ascorbic acid (vitamin C) was found to be 
essential for collagen synthesis and secretion[255] while β-glycerophosphate provides an 
inorganic source of phosphate necessary for the occurrence of mineralization [255]. 
Dexamethasone has been extensively reported to stimulate osteogenic differentiation in 
bone marrow stromal cells form animal and human origin, demonstrated by morphological 
changes from an elongated to a more cuboidal cell shape and an increase in the 
expression and/or activity of alkaline phosphatase.[255] It has also been reported that this 
bioactive factor plays an essential role in the mineralization of marrow stromal cells.[255] 
Other studies have focused on the influence of mechanical stimulus on the proliferation 
and osteogenic differentiation of these cells.[43,246,249,262,263] 
 
 
3.2. In vitro culturing systems- bioreactors 
 
Several recent studies demonstrate the importance of mimicking certain critical aspects of 
the native environment for the engineering of functional bone tissue substitutes. Therefore, 
besides the selection of the scaffold material and  the cell source, it is necessary to 
develop more advanced procedures for culturing cells-scaffolds constructs in order to 
achieve microenvironments that encourage the cell and matrix organization to recapitulate 
the tissue´s natural structure and function, optimizing the in vitro culturing systems 
currently used. The most widely used culturing technique in tissue engineering studies is 
static culturing which is often characterized by non-homogenous cell distribution, confining 
the majority of the cells to the outer surfaces of the scaffold, which in turn results to an 
inhomogeneous distribution of the in vitro generated extracellular matrix.[58,264-266] In order 
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to overcome this limitation, several culturing systems which consist basically of growth 
chambers equipped with stirrers and sensors that regulate the appropriate amounts of 
nutrients, gases and waste products have been developed.[58,264-267] These systems, so-
called bioreactors, may have different designs attempting to achieve one or more of the 
following objectives: i) maintain an uniform distribution of cells into the 3D scaffolds, ii) 
provide adequate levels of oxygen, nutrients, cytokines and growth factors iii) expose the 
cultured cells to mechanical stimuli. Furthermore, it is important to realize that engineered 
constructs of cells and scaffolds will be subjected to a complex biomechanical 
environment, potentially consisting of time-varying changes in stresses, strains, fluid 
pressure, fluid flow and cellular deformation.[42] These various physical factors, as it was 
suggested in previous sections, have the capability to influence the biological activity of 
normal tissues and therefore, may play an important role in the eventual success or failure 
of engineered tissues. In this sense, it is very important to characterize the diverse array of 
physical signals that cell may experience in vivo, as well as their biological response to 
such potential stimuli.[42] Experiments involving in vitro bioreactor culturing can also be 
designed to obtain such type of information,  providing important insights into the long-term 
capability of engineered constructs to maintain the proper functionality.[264] 
 
Bioreactors are also one of the focus of the development of a manufacturing technology for 
tissue engineered products, because they represent a chemically and mechanically 
controlled environment in which a tissue-like construct can be grown in reproducible 
conditions.[268] When the main purpose is to obtain engineered tissue-like substitutes, the 
type and the specific functional design characteristics of a bioreactor are determined by 
the dimensional and functional requirements of the tissue to be substituted/regenerated as 
well as by the cell-scaffold system used. 
 
There are several types of bioreactors currently available, which can be grouped in three 
main types, namely the spinner flasks,[164,190,269] the rotating bioreactors[189,269-274] and the 
flow perfusion culture systems.[264,269,275-277] 
 
 
3.2.1. Spinner flask 
 
The spinner flask corresponds to one of the simplest biorreactor designs.[164,190,265,269,275] In 
these systems, the seeded scaffolds are attached to needles hanging from the cover of the 
flask and the mixing of the medium is maintained by a magnetic stir bar at the bottom of 
the flask. This mixing mechanism generates convective forces that enhance the nutrient 
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concentration gradients but only at the surface of the scaffolds. Nevertheless, these 
systems have shown to increase the cell number on cartilage constructs based on 
chondrocytes and fibrous polyglycolic acid scaffolds, while under static culture conditions 
cell growth rates are diffusionally limited due to increasing cell mass and decreasing 
effective construct porosity resulting from cartilage matrix regeneration.[188]  
In another study [264], three-dimensional porous 75:25 poly(D,L-lactic-co-glycolic acid) 
biodegradable scaffolds were seeded with rat bone marrow cells (RBMCs) and cultured for 
21 days under static conditions or in two model bioreactors (a spinner flask and a rotating 
wall vessel). The spinner flask culture demonstrated a 60% enhanced proliferation at the 
end of the first week when compared to static culture. Cell/polymer constructs cultured in 
the spinner flask had 2.4 times higher alkaline phosphatase (ALP) activity than constructs 
cultured under static conditions on day 14 and the total osteocalcin (OC) secretion in the 
spinner flask culture was 3.5 times higher than the static culture, with a peak OC secretion 
occurring on day 18. Furthermore, the spinner flask culture had the highest calcium 
content at day 14. On day 21, the calcium deposition in the spinner flask culture was 6.6 
times higher than the static cultured constructs and over 30 times higher than the rotating 
wall vessel culture. Histological sections showed concentration of cells and mineralization 
at the exterior of the scaffolds at day 21. The accelerated proliferation and osteogenic 
differentiation of marrow cells and the localization of the enhanced mineralization on the 
external surface of the scaffolds, may be explained by the better mixing provided in the 
spinner flask, external to the outer surface of the scaffolds. 
 
Spinner flasks can also be used as seeding systems, generating more homogenous and 
controlled cell distribution and density on the scaffolds. This was observed, for example in 
a study where, highly porous, fibrous polyglycolic acid scaffolds were seeded with bovine 
articular chondrocytes in spinner flasks. Essentially, all cells attached throughout the 
scaffold volume within 1 day. Mixing promoted the formation of 20-32-micron diameter cell 
aggregates that enhanced the kinetics of cell attachment without compromising the 
uniformity of cell distribution.[164]  
 
 
3.2.2. Rotating wall vessel (RWV)  
 
The rotating wall vessel (RWV) bioreactor was originally developed to protect delicate cell 
cultures from the high shear forces generated during the launch and landing of the space 
shuttle. Later on, when the device was tried for cell-line suspension cultures on the ground, 
cells were seen to aggregate and form larger structures resembling tissues. This 
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observation offered the exciting possibility that the bioreactor might be used to study the 
interactions of multiple cell types and their association with proliferation and cellular 
differentiation during the early steps of tissue formation.[270] 
Nowadays, the rotating wall vessel bioreactor can have several different designs and can 
be used with either microcarrier suspensions or scaffolds.[189]  
Basically, RWV bioreactors are horizontally rotated, fluid-filled culture vessels equipped 
with membrane diffusion gas exchange to optimize gas/oxygen supply. The initial 
rotational speed is adjusted so that the culture medium and the inoculum-individual cells, 
pre-aggregate cell constructs or tissue fragments-rotate synchronously with the vessel. As 
the cell aggregates grow in size, the rotational speed is increased to compensate for 
increased sedimentation rates. Under these conditions, at any given time, gravitational 
vectors are randomized and the shear stresses exerted by the fluid on the synchronously 
moving particles is minimized, thus establishing microgravity-like culturing conditions. 
 
Two of the most well-known rotating wall vessel bioreactors designs are the High Aspect 
Ratio Vessel (HARV) and the Slow Lateral Turning Vessels (STLV).[274] The HARV has a 
flat membrane oxygenator at the rear of the chamber and the SLVT consists of a 
cylindrical growth chamber containing an inner co-rotating cylindrical with a gas exchange 
membrane.[274] 
The oxygenation capacity of the HARV is higher than that of the SLTV and therefore, the 
HARV-type bioreactors are mostly used for cell types that require more oxygen per unit 
volume of culture medium while the SLTV-type bioreactors are suited for cells with low 
oxygen requirements. In a more advanced variant of the STLV, a fully automated computer 
controlled system continuously monitors flow through the rotating vessel, allowing for on-
line monitoring of important parameters for cell development, such as pH, oxygen and 
glucose levels.[274] 
 
The high aspect ratio vessel (HARV) systems have been used to investigate the formation 
of 3-D rat marrow stromal cell culture on microcarriers, specifically bioactive ceramic 
hollow microspheres, under conditions of simulated microgravity[271-273] these systems are 
aimed at applications as microcarriers for bone tissue engineering and as drug delivery 
systems. 
 
In one of these studies, hollow ceramic microspheres coated with synthesized 
hydroxylapatite (HA) and sintered were developed and then placed in a rotating-wall 
vessel (RWV) bioreactor. The trajectory analysis revealed that the hollow microsphere 
remained suspended in the RWV bioreactor, and experienced a low shear stress 
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(approximately 0.6 dyn/cm2). The cell culture studies performed using rat bone marrow 
stromal cells and osteosarcoma cells (ROS 17/2.8) showed that the cells attached to and 
formed 3-D aggregates with the hollow microspheres under the culture conditions provided 
by the RWV bioreactor. In additon, extracellular matrix was observed in the aggregates.[272] 
 
In another study,[272] it was investigated the formation of 3-D rat marrow stromal cell culture 
on microcarriers and the expression of bone-related biochemical markers under conditions 
of simulated microgravity, using a high aspect ratio vessel (HARV) system. In addition, it 
was calculated the shear stresses imparted on the surface of microcarriers of different 
densities by the medium fluid in a HARV. Again, the examination of cellular morphology by 
scanning electron microscopy revealed the presence of three-dimensional multicellular 
aggregates consisting of multiple cell-covered microcarriers bridged together. 
Mineralization was observed in the aggregates. The expressions of alkaline phosphatase 
activity, collagen type I, and osteopontin were shown via the use of histochemical staining, 
immunolabeling, and confocal scanning electron microscopy. Using a numerical approach, 
it was found that at a given rotational speed and for a given culture medium, a larger 
density difference between the microcarrier and the culture medium (e.g., a modified 
bioactive glass particle) imparted a higher maximum shear stress on the microcarrier.  
 
 
3.2.3. Flow perfusion bioreactor 
 
The flow perfusion bioreactor is a bioreactor design that improves mass transfer at the 
interior of scaffolds.[275] The flow perfusion bioreactor uses a pump to perfuse medium 
continuously through the interconnected porous network of the seeded scaffold. The fluid 
path must be confined, so as to ensure the flow path is through the scaffold, rather than 
around the edges. The bioreactors that employ the latter flow path, i.e., exchanging 
medium in the chamber around the scaffold do not guarantee the exchange of medium 
within the interior of the scaffold and are termed “perfusion chambers”.[269] The perfusion 
bioreactor enhances the transport of nutrients because it allows the transport of medium 
through the interconnected pores of the scaffold. In addition, it offers a convenient way of 
providing mechanical stimulation to cells by means of fluid shear stress, which is 
particularly important in bone tissue engineering since bone cells are known to be 
stimulated by mechanical signals.[38,276] Furthermore, the magnitude of the shear stresses 
experienced by the cells can be varied by adjusting the flow rates through the systems. 
However, the local shear stresses experienced by individual cells are also dependent on 
the scaffold microarchitecture.[275]  
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Due to its characteristics, the flow perfusion bioreactor may facilitate the in-vitro 
development of tissue-like constructs for the regeneration of larger tissue defects. In 
addition, this culturing system also provides a valuable tool for in vitro investigation on 
biological mechanisms associated to bone growth and regeneration. In fact, the true 
biological environment of a bone cell derives from a dynamic interaction between 
responsively active cells experiencing mechanical forces and a continuously changing 3D 
matrix architecture, which can be simulated, obviously to a limited extent, in this type of 
bioreactor. 
 
Several studies[276-278] have been carried out aiming at studying the differentiation and 
proliferation patterns of marrow stromal cells cultured in 3D titanium meshes under flow 
perfusion conditions. These studies demonstrated that under flow conditions (at different 
flow rates), mineralized matrix production was dramatically increased over statically 
cultured constructs with the total calcium content of the cultured scaffolds increasing with 
increasing flow rate. Flow perfusion induced de novo tissue modelling with the formation of 
pore-like structures in the scaffolds and enhanced the distribution of cells and matrix 
throughout the scaffolds. These results report on the long-term effects of fluid flow on 
primary differentiating osteoblasts and indicate that fluid flow has far-reaching effects on 
osteoblasts differentiation and phenotypic expression in vitro.[276] Further studies, using the 
same type of bioreactor, investigated the direct involvement of fluid shear stresses on the 
osteoblastic differentiation of marrow stromal cells. For this purpose, rat bone marrow 
stromal cells were seeded in 3D porous titanium fiber mesh scaffolds and cultured for 16 
days in a flow perfusion bioreactor with perfusing culture media of different viscosities 
while maintaining the fluid flow rate constant. This methodology allowed exposure of the 
cultured cells to increasing levels of mechanical stimulation, in the form of fluid shear 
stress, whereas chemotransport conditions for nutrient delivery and waste removal 
remained essentially constant. Under similar chemotransport for the cultured cells in the 
3D porous scaffolds, increasing fluid shear forces led to increased mineral deposition, 
suggesting that the mechanical stimulation provided by fluid shear forces in 3D flow 
perfusion culture can indeed enhance the expression of the osteoblastic phenotype. 
Increased fluid shear forces also resulted in the generation of a better spatially distributed 
extracellular matrix inside the porosity of the 3D titanium fiber mesh scaffolds. The 
combined effect of fluid shear forces on the mineralized extracellular matrix production and 
distribution emphasizes the importance of mechanosensation on osteoblastic cell function 
in a 3D environment.[278]  
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Chapter II  
 
MATERIALS & METHODS 
 
 
1 - SCAFFOLDS DEVELOPMENT 
 
1.1. Biodegradable polymers 
 
The developed scaffolds were based in several biodegradable blends of corn starch with 
different synthetic polymers, namely: 
 
• a blend of starch with ethylene vinyl alchool (50/50 wt %) - SEVA-C 
• a blend of starch with poly(ε-caprolactone) (30/70 wt%) - SPCL 
• a blend of starch with cellulose acetate (50/50 wt %) -  SCA 
• a blend of starch with polylatic acid (50/50 wt %) - SPLA 
 
All these blends were obtained from Novamont, Novara, Italy. 
 
1.2. Scaffolds obtained by extrusion and injection moulding with blowing agents 
 
The polymeric materials were mixed in a rotating drum with one of the blowing agents 
described bellow, in amounts from 1% to 15% prior to processing by injection moulding or 
extrusion. In the injection moulding process it was used a Krauss Maffei KM60-120A 
injection moulding machine with a mould which was particularly designed for this 
application (developed at the Dept of Polymers Engineering, Univ. Minho) in order to allow 
maximal expansion and therefore enhance the formation of pores within the polymer melt.  
In the extrusion process, it was used a Carvex twin-screw extruder with a die diameter of 
12 mm.  
 
1.2.1. Blowing agents 
 
The blowing agents have been carefully selected,[1-3] considering its decomposition 
temperatures and the melting temperatures of the polymer, but also considering the final 
application of the materials being developed since there has to a be special attention 
regarding to its composition and to the products released upon its decomposition, which 
can not be toxic.  
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This blowing agents used are mainly composed of carboxylic acids which react by heating, 
releasing CO2 and water, forming the pores within the polymer melt. 
 
The selection of suitable blowing agents as well as optimization of the processing 
conditions and cytotoxicity studies, has been a subject of previous studies.[1-3]   
The blowing agents (BA) that were used to obtain the scaffolds studied in this thesis were: 
• Hostatron, System P9947, Hoechst, Germany 
• Hydrocerol BIH 70 and Hydrocerol BIH 40, Clariant, Germany.  
• Celogen 780, Uniroyal Chemical, Germany 
 
1.2.2. Processing conditions 
The tables II.1 to II.4 present the optimised extrusion and injection moulding processing 
conditions that were used to obtain the scaffolds which were studied in this thesis. 
 
Table II.1. Processing conditions used to obtain scaffolds based on SCA by extrusion with different 
blowing agents. 
 
Blowing agent 
 
Processing Parameters 
Type Amount 
(wt %) 
Temperature 
profile: 
Die Temperature 
(ºC) 
Screw speed 
(rpm) 
10%  
Hostatron 9947  
15% 
Hostatron 9947 + 1% 
glycerol 
10% 
 
 
160 - 165 - 170ºC 
 
 
175 
 
 
25 
2%  
BIH 40 
 3% 
BIH 70 2.5 
 
 
150 - 155 - 160ºC  
 
165 
 
 
17-18 
 
 
 
Table II.2. Processing conditions used to obtain scaffolds based on SEVA-C by extrusion with a 
blowing agent 
 
Blowing agent 
 
Processing Parameters 
Type Amount 
(wt %) 
Temperature 
profile: 
Die Temperature 
(ºC) 
Screw speed 
(rpm) 
1% 
 
145 - 150 - 155ºC 160 24 
2% 155 -160 - 165 ºC 165 17 
 
BIH 40 
 
3% 160 - 165 - 170ºC 170 17 
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Table II.3. Processing conditions used to obtain scaffolds based on SPLA by extrusion with a 
blowing agent 
 
Blowing agent 
 
Processing Parameters 
Type Amount 
(wt %) 
Temperature 
profile: 
Die Temperature 
(ºC) 
Screw speed 
(rpm) 
 
BIH 40 
 
 
1% 
 
185 - 190 - 195ºC 
 
200 
 
20 
 
 
Table II.4. Processing conditions used to obtain the scaffolds based on SCA by injection moulding 
with a blowing agent.  
 
Processing Parameters  
Material Temperature profile: 140-160-175-180ºC 
Polymeric 
blend 
 
Blowing agent Injection 
Pressure 
(MPa) 
Holding 
Pressure 
(MPa) 
Cooling Time 
(s) 
Mold Temp. 
(ºC) 
 
SCA 
 
 
1,5% CELOGEN 
780 
 
12,5 
 
8 
 
 
 
15 
 
30 
 
 
 
 
1.3. Compression moulding - particle leaching 
 
The compression moulding and particle leaching was thought to overcome one of the main 
limitations of the methods based in the injection moulding and extrusion with blowing 
agents that is the difficulty of  controlling the pore size and the porosity of the scaffolds.  
The compression moulding and particle leaching enables to control the percentage of 
porosity and the pore size by simply selecting the appropriate amount and size of the 
leachable particles used. 
The compression moulding and particle leaching method was based on blending together 
a starch based polymer (in the powder form) and leachable particles (in this case, sodium 
chloride particles - NaCl, Merck) of different sizes (from 150 to 300µm), in sufficient 
amounts to provide a continuous phase of a polymer and a dispersed phase of leachable 
particles in the blend. The mixture of the polymer and leachable particles was then 
compression moulded in a press Moore, using a mould specially designed for this purpose. 
This mould produced discs with 6 cm of diameter and approximately 1 cm of height, which 
were subsequently cut into smaller samples according to the experience to be performed. 
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The resultant samples were then immersed in distilled water (to remove the leachable   
particles), for about 5 days, changing the water daily.  Table III.5 presents the optimised 
conditions used to obtain scaffolds by the compression moulding-particle leaching method, 
based on SCA with 50 and 65% (wt%) of leachable particles . 
 
Table III.5.  Processing conditions used in the compression moulding of SCA and SPLA with 
different amounts of salt particles. 
 
 
Material 
 
 
Temperature (ºC)
 
Holding Time 
(min) 
 
SCA + 50% salt 
 
 
SCA + 65% salt 
 
 
 
170 
 
 
10-15 
 
SPLA + 65% salt 
 
 
200 
 
12-15 
 
 
 
1.4. Solvent-casting/particulate-leaching 
 
The solvent casting and particle leaching method has been widely used for producing 
scaffolds for tissue engineering. The procedure studied in this work was therefore based 
on those found in the literature[4-13]. However, there was a significant effort to overcome the 
disadvantages presented by the use of this technique as reported in the literature.[4-13] For 
example, in most cases, highly toxic solvents are used, which may leave residues in the 
final samples. Furthermore, in many cases, using this method, it was only possible to 
produce thin membranes, and/or materials with rather low mechanical properties.  
The starch based polymers used to obtain scaffolds by solvent casting, in this case SCA 
and SEVA-C, were grounded in a high-speed milling (RETSCH) and then dissolved in 
acetic acid (Merck, Germany) (SCA) and dimethylsulfoxide (Aldrich, Germany), 
respectively. It was obtained a very viscous solution by mixing approximately 12 g of the 
polymer powder with 20 mL of the solvent and then it was added the leachable particles 
(NaCl). Usually, after preparing the polymeric solution it is necessary to allow the 
evaporation of the excess solvent (for about 1 day) before adding the salt particles, in 
order to obtain a better dispersion of the particles within the polymeric solution. The 
amount and size of the used salt particles determined the amount and size of the pores in 
final sample. In general, it was added a salt weight fraction of 60 to 70% (based on the 
total mass of polymer and salt). The size of the particles used ranged from 50 to 1000µm. 
The mixture of the polymeric solution with the salt particles was then poured into a mould 
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(a glass petri-dish of 3cm diameter) and placed in an oven at 37ºC in order to allow a 
progressive evaporation of the solvent, for about 4 to 5 days. Finally, when the samples 
were completely solidified, they were cut into smaller samples (according to the tests to be 
performed) and immersed in distilled water during several days (about one week), for 
leaching of the salt particles, being afterwards dried. 
 
 
1.5. In-situ polymerization 
 
This innovative so-called in situ polymerization process was based on a polymerization 
process developed in our group in order to obtain materials to be used as bone cements or 
hydrogels[14-16]. The innovation introduced by this method of obtaining scaffolds for tissue 
engineering lies in the fact that it is possible to produce the scaffold in-situ, i.e., it might be 
possible to inject the scaffold directly into the defect to treat , which can, therefore, take 
immediately the shape of the defect.  
Materials produced by this method are not totally degradable, but they might be very useful 
in situations where it is necessary high mechanical properties and/or in situations where 
the defect or trauma that is necessary to treat is of difficult access, avoiding highly invasive 
surgery techniques.  
These materials were prepared by adding the liquid phase, constituted by the acrylic 
monomers (from acrylic acid, Merck), and 1% (w/w) of DMOH, to the solid phase, which 
consisted of SEVA-C powder and 2% (wt/wt) of BPO. N-dimethylaminobenzyl alcohol  
(DMOH), was used as the activator of the initiation process, after being synthesised by 
selective reduction of 4-dimethylaminobenzaldehyde with sodium borohydride in alkaline 
medium[17]. Benzoic peroxide (BPO, Merck), was used as the radical initiator, after 
purification by fractional recrystallization from ethanol and subsequently vacuum dried 
(m.p. 104 ºC). 
The leachable NaCl particles (sized between 150 to 300 µm) were added to the liquid or to 
the solid phase. The solid and the liquid phases are then mixed together with a 10% of 
water with respect to the total weight and poured in a dough state in poly 
(tetrafluoroethylene) (PTFE) moulds until complete polymerisation take place. A total 
amount of 4g were used to prepare each sample of 4 cm of diameter. 
After curing time, about 5 minutes, moulds are placed into the oven at 60ºC overnight to 
ensure a complete polymerization and then vacuum dried until constant weight was 
attained. Finally the samples were immersed in water to leach out the salt particles. 
 
 
Chapter II: Materials & Methods 
 
- 66 - 
 
1.6. Scaffolds obtained by fiber bonding processes 
 
Scaffolds based on SPCL (a 30/70 wt% blend of starch with poly(ε-caprolactone)) were 
prepared by a fiber bonding process consisting of cutting and sintering  fibers with a 
diameter of about 180µm, obtained by melt-spinning. The fibers used were previouslly 
produced by melt spinning by Novamont (Novara, Italy). The typical processing conditions 
for the extrusion of SPCL fiber are presented in table III.6. 
 
 
Table III.6.  Processing conditions used to obtain SPCL fibers by extrusion 
 
Polymer 
 
 
Processing Parameters 
Temperature profile Die Temperature  Geometry of the die 
 
 
 
SPCL 
 
100-130-140ºC 
 
150 ºC 
 
D=0.5-0.7, L/D=2-3 
 
 
 
The procedure for obtaining the fiber meshes is based on a method developed by 
Novamont, Italy: The SPCL fiber meshes were cut into 1-3 cm pieces and then washed 
with distilled water to remove plasticizers. A selected amount of fibers was placed in a 10 
ml glass beaker; for the studies described in this thesis, we have prepared scaffolds with 
two different porosities, namely 50 and 75%; the different porosity of the fiber meshes was 
obtained using different amounts of fibers.  
A glass cylinder (which runs within the beaker), is let drop (by gravity) several times to 
compact the fibres. The cylinder is then removed and the beaker is placed in an oven at 
150ºC during 5 minutes. Immediately after removing the beaker from the oven, the glass 
cylinder is dropped once to compress the heated fibers. The beaker with the fibers is then 
transferred to a freezer at –15ºC for about 10 minutes.  
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2. CHARACTERIZATION OF THE POROUS STRUCTURES 
 
2.1. Morphological characterization 
 
The porous structure of the materials developed was characterised by scanning electron 
microscopy (SEM), in a Leica Cambridge S360. All the samples were previously gold 
coated in a Sputter Jeol JFC 1100 equipment. 
The SEM analysis allowed to evaluate the morphology of the pores, their size and 
distribution and also the interconnectivity between these pores.  
 
The porosity of the scaffolds was determined by microcomputerized tomography (µCT) 
(ScanCo Medical µCT 80, Bassersdorf, Switzerland) at a resolution of 10 µm, and using at 
least 3 samples per group (of different porosity). 
 
Estimations of the porosity of the scaffolds were also obtained from calculations of the 
apparent density of scaffolds based on SEVA-C and SCA, using the equations II.3 and II.4: 
 
 ρ* = m/V   ρ*= apparent density     (Equation II.1) 
    m = weight of the sample 
    V= volume of the sample 
 
 
 ε = 1 - ρ*  x 100%  ε = porosity                  (Equation II.2)  
         ρ    ρ = density of the polymer  
(for SEVA-C, ρ=1.26; for SCA, ρ=1.28) 
 
 
 
2.2. Degradation behaviour 
 
The degradation behaviour was assessed after several pre-fixed ageing periods (0,3, 7, 
14, 30, 60 and 90 days), in an isotonic saline solution (NaCl 0.154 M).  At the end of each 
degradation period, the samples (n=4) were removed from the solution, rinsed with distilled 
water and weighted, to determine the water uptake, according to the equation II.1 shown 
bellow; one batch of samples was then dried up to exhaustion (6 days at 60ºC) in order to 
determine the dry weight loss, using equation II.2 described bellow; the other batch of 
samples was dried in a controlled environment of 23ºC and 55% RH, to be tensile tested in 
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order to evaluate the changes in the mechanical properties as a function of the 
degradation time. 
 
 
% water uptake =  final wet weight - initial weight  x 100%   (Equation II.3) 
initial weight 
 
 
 
% weight loss=  initial weight - final dry weight  x 100%     (Equation II.4) 
initial weight 
 
 
2.3. Mechanical properties - compression tests 
 
The developed materials were mechanically tested on compression experiments in an 
Instron 4505 universal mechanical testing machine, using a load cell of 50 kN. 
Compression testing was carried out at a crosshead speed of 2 mm/min (4.7 x 10-5 m/s), 
until fracture or until obtaining a maximum reduction in samples height of 60%. At least six 
samples of each type were tested. As the different processing methods produced scaffolds 
of different geometries, the samples tested have also different geometries and dimensions, 
as shown in Table II.7.  
 
 
Table II.7. Typical geometry (and dimensions) of the several scaffold samples (obtained by different 
processing methodologies) tested on compression. 
 
Processing method 
 
 
Geometry of sample 
 
Dimensions 
 
Extrusion with blowing agent 
 
Cylindrical 
 
   Height: 15 mm 
   Diameter: 12mm 
 
 
Injection moulding with 
blowing agent 
 
Rectangular 
 
     
    Height: 9.5 mm 
    Length: 16mm 
    Width:16 mm 
 
Compression moulding + 
particle leaching 
 
Rectangular 
 
     
    Height: 8.5 mm 
    Length: 24mm 
    Width:18mm 
 
Solvent casting + particle 
leaching 
 
Rectangular 
    
    Height: 8.5 mm 
    Length: 16 mm 
    Width: 14 mm 
Chapter II: Materials & Methods 
 
- 69 - 
 
3. CULTURING OF CELLS-SCAFFOLDS CONSTRUCTS 
 
3.1. Samples preparation 
 
Several starch-based scaffolds were developed, using different starch based blends and 
distinct processing methodologies. For the cell culturing experiments, two types of 
scaffolds were selected, namely the scaffolds obtained by extrusion of SEVA-C with a 
blowing agent and fiber-mesh scaffolds based on SPCL. 
Several studies[18-22] refs indicated that fiber-mesh scaffolds might have more adequate 
structures for use in tissue engineering strategies that use bioreactor cultures, probably 
because they provide highly interconnected porosity. On the contrary, most of the porous 
obtained with other methodologies exhibit lower interconnectivity which is very likely to 
generate complex fluid flow pathways thought the scaffolds. Nevertheless, SEVA-C 
scaffolds was thought to provide evidence of the influence of scaffold architecture, namely 
of their porosity and pore interconnectivity, on the development of functional bone tissue 
engineered constructs. 
. 
All samples used in cell culture experiments were previously cut into discs of 
approximately 8 mm diameter and 1.5-2 mm high and EtO sterilized at Pronefro (Maia, 
Portugal) or at the Dept of Bioengineering (Rice Univ., Houston, USA). Typical conditions 
include a working temperature of 45ºC, a moisture level of 50%, a cycle time of 14 hours 
and a chamber pressure of 50kPa. 
 
 
3.2. Isolation and expansion of rat bone marrow cells 
 
Rat bone marrow (RBM) cells were isolated and cultured using the method described by 
Maniatopoulos8. The animals, (Wistar rats from Harlan, USA) were euthanized using CO2, 
under isofluorane anaesthesia. The femurs and tibias were removed and briefly Immersed 
in ethanol (70%) and then in culture medium (without osteogenic supplements) containing 
a higher percentage of antibiotics. The epiphyses are cut off and the diaphyses flushed 
with 5 ml of complete medium, removing the bone marrow to 50 ml tubes. The mixture 
(bone marrow + medium) was ressuspended with a plastic Pasteur pipette (see Figure II.1) 
and then transferred (5 mL) to 75cm2 culture flask previously filled with 10mL of complete 
culture medium. After 24 hours, the medium was replaced very carefully, avoiding 
movement as much as possible and then changed each 2 days until day 6. The 
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hematopoetic cells present in the marrow cell preparations usually do not attach to culture 
flasks and are removed during feeding in the primary cultures[23,24] . This way they are 
easily separated from the bone marrow stromal cells  that rapidly adhere to culture flasks. 
 
The medium used in all experiment was α-MEM (Minimal Essential Medium Eagle; MEM 
alpha modification-M0644, Sigma, USA), supplemented with 10 % FCS (foetal calf serum, 
Gemini, USA), 50 µg/ml ascorbic acid (Sigma, Chemical Co., St.Louis, MO, USA), 50 
µg/ml gentamycin, 100µg/ml ampicillin, 3 µg/ml fungizone, 10 mM Na β-gycerophosphate 
(Sigma) and 10–8 M dexamethasone (Sigma). Several studies[23,25-42] have demonstrated 
the ability of culture medium supplemented with these osteogenic supplents, namely 
ascorbic acid, β-glycerophosphate and dexamethasone, to induce the osteogenic 
character of bone marrow stromal cells.  Ascorbic acid (vitamin C) was found to be 
essential for collagen synthesis and secretion[35] while β-glycerophosphate provides an 
inorganic source of phosphate necessary for the occurrence of mineralization[35]. 
Dexamethasone has been reported[35] to stimulate osteogenic differentiation in bone 
marrow stromal cells form animal and human origin, demonstrated by morphological 
changes from an elongated to a more cuboidal cell shape and an increase in the 
expression and/or activity of alkaline phosphatase. It has also been reported that this 
bioactive factor plays an essential role in the mineralization of marrow stromal cells[35]. 
Cells were cultured in a humidified atmosphere of 5 % CO2 at 37°C during 6 days. 
 
 
a)    b)   c)    
Figure II.1. Some sequential steps of the procedure for isolation of rat bone marrow cells: 
a) Cutting off the epiphyses of the rat femur b) flushing the bone marrow with 5 ml of culture 
medium and transfer to 50 ml tubes. b) ressuspending the bone marrow. 
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3.3. Cell seeding on starch based scaffolds  
 
3.3.1. Pre-wetting of the samples 
The samples were immersed in 30 ml of serum free medium in 50 ml tubes and the air 
removed by means of a 30 ml syringue with a 18 g needle. The scaffolds were left in the 
serum free medium overnight to allow swelling. 
 
3.3.2. Seeding 
After 6 days of primary culture, cells were detached using trypsin/ EDTA (0.25% w/v 
trypsin / 0.02% EDTA, Sigma). The cells were concentrated by centrifugation at 1500 rpm 
for 5 min and resuspended in media. Subsequently, the scaffolds (n=6 for flow and n=6 for 
static culture, for each culture period), were inserted into the cassettes (see figure II.1) 
which were placed in a 6-well plates and seeded with 300µl of a cells suspension 
containing 5x105 cells.  After 2 hrs of attachment, 10 ml of complete medium was added to 
the each well.  Seeded scaffolds were incubated for further attachment overnight. The 
following day seeded scaffolds were placed into fresh 6-well plates for static conditions or 
into the flow perfusion system for culturing during the selected time periods. 
 
 
      a)     b) 
 
Figure II.2. Schematic representation of the cassette, containing the scaffold,  
a) side and b) top view). 
 
 
3.4. Cell culturing: the flow perfusion culture system 
 
The Flow Perfusion Culture System that was used in this thesis was developed in the 
Department of Bioengineering of Rice University[43]. This type of bioreactors uses a 
peristaltic pump to perfuse medium continuously through the interconnected porous 
network of the seeded scaffold. The fluid path is confined to ensure the flow path is 
through the scaffold and not around the edges. In this manner, medium is delivered 
throughout each scaffold, enhancing delivery of nutrients and providing mechanical 
18mm 
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stimulation to the seeded cells by way of fluid shear stresses.  
This flow perfusion bioreactor was machined from Plexiglas and is mainly composed of a 
main part with of flow chambers, a peristaltic pump and two medium reservoirs. Each flow 
chamber contains a cassette in which the scaffold is press-fit.  Each cassette is then 
sealed with two o-rings to ensure the flow path goes only through the scaffold.  Silicon 
tubing then connects each flow chamber with a multichannel peristaltic pump and a 
medium reservoir. Each chamber is on its own independent pumping circuit, but all pumps 
draw media from a common reservoir.  For these experiments, culture media was pumped 
continuously at a flow rate of 0.3ml/min or 1 ml/min through the cell/scaffold construct 
cassette/housing unit and recirculated back to the reservoir. These flow rates were 
selected with basis on previous experiments performed using titanium fiber-meshes[19]. In 
fact, these are several reports[19,21] on studies using these non-degradable scaffolds and 
this flow perfusion bioreactor, but this thesis reports on the first studies using 
biodegradable scaffolds, as part of a tissue engineering therapy which aims at substituting 
temporary bone defects while the tissue is being regenerated.  
 
The total volume of culture medium in the flow system was 210mL and in static cultures 
was 10mL per well. In both cases, the whole volume of medium was changed every 3 
days. The entire culture system was sterilized by ethylene oxide sterilization and 
maintained at 37°C with a 5% CO2 environment. The silicon tubing was replaced in every 
new experiment. 
 
 
Table II.8. Experimental conditions used in bioreactor cultures. 
 
Constant conditions Variable conditions 
Total Volume of medium: 210 ml Flow rate: 0.3 ml/mim 
1ml/mim 
Frequency of medium 
change (total volume 
change): 
 
 
Each 3 days 
Culture periods: 3 days 
7 days 
10 days 
15 days 
Total number of samples in 
the bioreactor: 
 
6 samples 
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Figure II.3. Schematic representation of the flow circuit diagram of the flow perfusion system of only 
one of the six chambers. Adapted from Brancroft et al.[43] 
 
 
 
Figure II.4. Representation of one flow chamber in the main part of the flow perfusion bioreactor: 
the cassette (1) with the scaffold (2) is inserted in the flow chamber (3). The O-rings (4) placed 
above and bellow the cassette prevent linkage and ensure the flow path (indicated by the arrows) 
goes only through the seeded scaffold. A screw top (6) closes the flow chamber.  
Adapted from Brancroft et al.[43] 
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4. CHARACTERIZATION OF THE CULTURED CELL-SCAFFOLDS CONSTRUCTS  
 
4.1. Biochemical analysis 
 
For DNA, Calcium and ALP analysis. at the end of each culturing period selected, the 
cultured cell-scaffold constructs were rinsed with PBS and stored at -70°C in 10ml tubes 
containing 1.4 ml of milliQ water. 
 
 
4.1.1. Determination of cellularity of scaffolds 
The DNA content of each scaffold was measured in order to evaluate the cell proliferation 
using the PicoGreen dye and buffers contained in the Molecular Probes PicoGreen dsDNA 
Quantification Kit (P-7589).  This assay measures the fluorescence produced when 
PicoGreen dye is excited by UV light while bound to dsDNA.  The protocol used is 
described below.  First the homogenates stored at –70ºC were allowed to thaw at room 
temperature and sonicated for about 15 minutes.  Aliquots of 43 µl of each sample were 
then placed into individual wells of a 96-well plate.  Standards ranging from 0 – 6 µg/ml 
were made from dilutions of a standard solution of calf thymus DNA (100µg/ml).  Aliquots 
of 43 µl of these standards were placed into other wells.  Tris-EDTA buffer was prepared 
according to the manufacturer’s instructions using reagents provided in the kit and 107 µl 
added to each of the sample and standard wells.  The PicoGreen dye solution was also 
prepared according to the manufacturer’s instructions using reagents provided in the kit 
and 150 µL added to each of the sample and standard wells.  The 96-wells plate was  then  
incubated in the dark for 10 minutes at room temperature and the fluorescence then 
measured on a fluorometer using an emission wavelength of 490 nm and an absorbance 
wavelength of 520 nm.  From these dsDNA determinations the cellularity of each scaffold 
was estimated using a previously determined[19]  conversion factor of 2.7 pg dsDNA/cell 
and the results presented as number of cells per scaffold. 
 
 
4.1.2. Determination of alkaline phosphatase activity of cells on scaffolds 
The alkaline phosphatase activity of each scaffold was assayed as a measure of the 
osteoblastic expression of the cells present.  The alkaline phosphatase activity was 
measured using Sigma Diagnostic Kit #104.  This columetric endpoint assay measures the 
conversion of the colorless substrate p-Nitrophenol phosphate by the enzyme Alkaline 
Phosphatase to the yellow product p-Nitrophenol. The method is described in detail in the 
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instructions provided with the kit.  Briefly, the scaffolds were rinsed twice with calcium-free 
phosphate buffered saline and then homogenized in 1.4 ml of filtered ddH20.  The 
homogenates (frozen overnight at -70°C) were allowed to thaw at room temperature and 
then sonicated for about 15 minutes. Aliquots of 80 µl were then taken from each sample 
and placed into microplate wells on a 96-well plate. Standards in concentrations ranging 
from 0 – 250 µM were prepared from dilutions of a standard solution of p-Nitrophenol 
(10µmol/ml) provided in the kit.  Aliquots of 80 µl of these standards were added to the 
same 96-well plate.  The Working Alkaline Buffer Solution was prepared according to the 
manufacturer’s instructions using reagents provided in the kit and 20 µl of this buffer was 
added to each of the sample and standard wells.  The Substrate Solution was also 
prepared according to the manufacturer’s directions using reagents provided in the kit and 
100 µl of this solution will be added to each of the sample and standard wells.  The 
microplate was then incubated for 1 hour at 37°C in a cell culture incubator.  After this, 
aliquots of 100 µl from a Stop Solution consisting of 0.3 M NaOH in ddH20 were added 
each of the sample and standard wells. Finally, the absorbance of each well at 405 nm 
was measured on a plate reader. The results obtained were normalized to the number of 
cells in each scaffold and presented as pmol per hour per scaffold. 
 
 
4.1.3. Determination of calcium content of scaffolds 
The calcium content of each scaffold was assayed in order to quantify the amount of 
mineralized matrix present.  The scaffolds were incubated overnight in 1N acetic acid to 
dissolve the calcium in the scaffolds. The calcium content was then measured using Sigma 
Diagnostic Kit #587.  This columetric endpoint assay measures the amount of purple-
colored calcium-cresolphthalein complexone complex formed when cresolphthalein 
complexone binds to free calcium in an alkaline solution.  The method is described in detail 
in the instructions provided with the kit.  Briefly, aliquots of 10 µl were taken from each 
sample and placed into microplate wells on a 96-well plate.  A stock solution of 1 mg/ml 
CaCl2 was prepared and standards in concentrations ranging from 0-300 µg/ml were 
prepared from dilutions of this stock solution.  Aliquots of 10 µl of these standards were 
added to the same 96-well plate.  The Assay Working Solution was prepared by mixing 
equal parts of the Calcium Binding Reagent and Calcium Buffer Reagent provided in the 
kit.  Aliquots of 300 µL of the Assay Working Solution were added to each well containing 
sample or standard aliquots in the 96-well plate.  The 96-well plate was then incubated for 
10 minutes at room temperature and then the absorbance of each well at 575 nm 
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measured on a plate reader. The results were expressed as mg of Ca2+ equivalents per 
scaffold. 
 
4.1.4. Statistics 
Several samples were used for each measurement (n=3 to 5) and all the values are 
presented as averages ± the respective standard deviations. Multiple pairwise 
comparisons have been performed using the Turkey-Kramer method with a significance 
level of 95%. 
 
 
4.2. Histology and imaging of tetracycline fluorescence 
 
The cultured samples were rinsed with PBS, fixed in formalin for 1 week at 4ºC, rinsed with 
water and embedded in frozen tissue embedding media (HistoPrepTM, FisherDiagnostic).   
Sections of about 30 µm were obtained using a cryotome (Microm 505) and stained with 
hematoxylin and eosin for general histological evaluation. For visualization of mineralized 
tissue, additional sections were exposed to a 5% silver nitrate solution under UV light for 
25 minutes and counter stained with a safranin-O solution (0.5%). Mineral deposition was 
also observed after adding tetracycline-HCl (10µg/ml) to the culture media. Tetracycline is 
known as a fluorochrome-labeling agent for bone tissue as it accumulates at bone forming 
sites and fluoresces when activated with fluorescent light. All the histological sections were 
observed in a light microscope Nixon E600 equipped with a Sony DXC-950P CCD camera 
and with a fluorescence lamp (for imaging of tetracycline fluoroscesce). 
 
 
 
4.3. Immunohistochemistry analysis 
 
4.3.1. Samples processing 
At the end of each culturing period, the cell-mesh constructs were removed from the 
bioreactors, rinsed with a phosphate buffer saline solution (PBS, 0.01M, pH 7.4) and fixed 
in a 10% formalin solution (Sigma). The constructs were then rinsed with PBS, cut in 
halves, embedded in optimal freezing temperature (O.C.T.) compound (Tissue-Tek, USA) 
and frozen on dry ice. Serial sections (10 µm in thickness) were prepared and stored at –
80ºC until staining. 
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4.3.2. Immunostaining procedure 
The sections were immunostained using previously established protocols[44] using the 
avidin-biotin immunoperoxidase staining technique which is based on the ability of egg-
white glycoprotein avidin to non-immunologically bind four molecules of the vitamin biotin 
[45]. This technique uses 3 main reagents: the first is a primary antibody specific for the 
antigen to be localized; the second is antimouse/antigoat polyclonal antibody (secondary) 
which is covalently linked to a molecule of biotin and the third is a complex of peroxidase 
conjugated with biotin and avidin. The free sites on the avidin molecule allow binding to the 
biotin on the second antibody. The peroxidase enzyme, and therefore the original antigen, 
is identified with an appropriate chromogen [45]. 
 
The experimental staining procedure can be briefly described as follows: the sections were 
first incubated with a hydrogen peroxide solution to block against endogenous peroxidase 
activity and then incubated with normal serum to block against random secondary antibody 
binding. Afterwards, the sections were incubated with primary antibody for the antigen of 
interest and then incubated with the avidin-biotin secondary antibody system and with 3,3’-
diaminobenzidin developing reagent (DAB, Vector Laboratories). As a last step, the 
sections were counterstained with hematoxylin and mounted. The negative staining 
controls consisted of sections incubated with 0.01M PBS instead of the primary antibody. 
A group of samples received conventional hematoxilin and eosin staining. 
 
 
4.3.3. Primary antibodies 
For this study, the following antibodies were selected: anti-transforming growth factor-β1 
(anti-TGF-β1, goat polyclonal antibody, sc-146-G), anti-platelet derived growth factor-A 
(anti-PDGF-A, mouse monoclonal antibody, sc-9974), anti-fibroblast growth factor-2 (anti-
FGF-2, goat polyclonal antibody, sc-79-G), anti-vascular endothelial growth factor (anti-
VEGF, mouse monoclonal antibody, sc-7269) and anti-bone morphogenetic protein-2 
(anti-BMP-2, goat polyclonal antibody, sc-6895). All the antibodies were purchased from 
Santa Cruz Biotechnology (California, USA) and used at a concentration of 2µg per ml of 
0.1 PBS. The diluted antibody solutions were used in the same day they were prepared. 
The mouse monoclonal antibodies were used in conjunction with an anti-mouse avidin-
biotin complex ABC kit and the goat polyclonal antibodies were used in conjunction with an 
anti-goat ABC kit (both Vectastain Elite® ABC kit, Vector Laboratories).  
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4.4. Microscopy analysis 
 
For analysis under scanning electron microscope and confocal microscope, the samples 
were fixed in a solution of 2.5% glutaraldehyde and for histology and histochemical 
analysis the samples were fixed in a 10% formalin solution. 
 
4.4.1. Scanning electron microscopy  
For SEM analysis the samples were fixed in a solution of 2.5% glutaraldehyde (in PBS), 
dehydrated in a gradient series of ethanol (35, 50, 70, 80, 90, 95 and 100%), dried with 
tetramethylsilane and sputter coated with gold. Samples were then observed in a Leica 
Cambridge S360 scanning electron microscope. 
 
 
4.4.2. Confocal microscopy 
In order to visualize cell distribuition within the scaffolds, the scaffolds cutured for 15 days 
(previously fixed with glutaraldyede) were cut in half (in order to visualize the interior cross 
section of the samples), rinsed with PBS and incubated with a picogreen dye (0.1%) for at 
least 15 minutes and then observed under a confocal microscope (Zeiss LSM Axiovert, 
Carl Zeiss, Germany).  
Depth projections of the surface (up to 300µm) were also obtained and the images were 
pseudo-coloured to show depth as a function of colour. 
 
4.4.3. Light Microscopy 
All the histological sections were observed with an Eclipse E600 light microscope (Nikon, 
Melville, NY, USA) equipped with a CCD camera (Sony DXC-950P, NY, USA) and with a 
fluorescence lamp (for imaging of tetracycline fluoroscesce). 
In the case of the sections immunohistochemically stained, the Image acquisition was 
performed as follows: for each stained section, 3 digital images were taken, corresponding 
to the opposite ends and center of the sample (see figure VII.1, chapter VII), at a 
magnification of x4. 
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4.5. Spectroscopy and diffraction  
 
Diffraction or spectroscopy methods were used to analyse the mineral deposition on cell-
scaffolds constructs cultured for 15 days under flow perfusion conditions. The use of these 
techniques aimed at complement the analysis by the biochemical assay (calcium 
deposition) and histological staining (Von Kossa) because the results arising from these 
analyses can be misinterpreted, as the matrix is known to uptake calcium independently of 
mineral deposition.[46] 
 
4.5.1. Fourier transformed infrared spectroscopy with attenuated total reflectance (FTIR-
ATR) 
The composition of the cell-scaffolds constructs cultured for 15 days in the perfusion 
bioreactor was analyzed by Fourier Transformed Infrared Spectroscopy with Attenuated 
Total Reflectance (FTIR-ATR). The samples were fixed in a solution of 2.5% 
gluteraldehyde and dried at room temperature. All spectra were recorded using at least 64 
scans and 2cm-1 resolution in a FTIR spectrophotometer (Perkin-Elmer 1600 Series, USA) 
with a single reflection ATR system (MKII Golden GateTM, Specac, UK). Results were 
compared to cell-free scaffolds, which were kept under the same conditions as the static 
cultures and received the same treatment before performing the analysis, in order to 
exclude the contributions from the culture medium. 
 
 
4.5.2. Thin-film X-ray diffraction (TF-XRD) 
Thin-film X-ray diffraction (TF-XRD, Philips X'Pert MPD, The Netherlands) was used to 
identify any mineral phase present in cell-scaffolds constructs cultured in the perfusion 
bioreactor for 15 days. As for the FTIR-ATR analysis, the samples were dried at room 
temperature after being fixed in a solution of 2.5% gluteraldehyde. The data collection was 
performed by the 2θ scan method with 1º as incident beam angle using CuKα X-ray line 
and a scan speed of 0.05º/min in 2θ. Again, the results were compared to cell-free 
scaffolds, which were kept in the same conditions and submitted to same treatment as 
samples resulting from static cultures. 
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Chapter III 
 
Alternative Tissue Engineering Scaffolds Based on Starch: Processing 
Methodologies, Morphology, Degradation and Mechanical Properties* 
 
 
 
 
 
Abstract 
 
An ideal tissue engineering scaffold must be designed from a polymer with an adequate 
degradation rate. The processing technique must allow for the preparation of 3-D scaffolds 
with controlled porosity and adequate pore sizes, as well as tissue matching mechanical 
properties and an appropriate biological response. 
This communication revises recent work that has been developed in our laboratories with 
the aim of producing 3-D polymeric structures (from starch based blends) with adequate 
properties to be used as scaffolds for bone tissue engineering applications. Several 
processing methodologies were originally developed and optimized. Some of these 
methodologies were based in conventional melt based processing routes, such as 
extrusion using blowing agents and compression moulding (combined with particulate 
leaching). Other developed technologies included solvent casting and particle leaching and 
an innovative in-situ polymerisation method.  
By means of using the described methodologies it is possible to tailor the properties of the 
different scaffolds, namely their degradation, morphology and mechanical properties, for 
several applications in tissue engineering. Furthermore the processing methodologies 
(including the blowing agents used in the melt based technologies) described above do not 
affect the biocompatible behaviour of starch-based polymers. Therefore scaffolds obtained 
from these materials, by means of using one of the described methodologies may 
constitute an important alternative to the materials currently used in tissue engineering.  
 
 
 
 
 
* This chapter is based on the following publication: 
ME Gomes, JS Godinho, RL Reis, AM Cunha. Alternative Tissue Engineering Scaffolds based on Starch: 
Processing Methodologies, Morphology, Degradation Behaviour and Mechanical Properties. Materials 
Science and Engineering: C Biomimetic and Supramolecular Systems  (2002) 20:19-26 
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1. INTRODUCTION 
 
The advent of tissue engineering has been motivated by the challenge of producing tissue 
substitutes that can restore the structural features and physiological functions of natural 
tissues in-vivo [1,2], circumventing the limitations of current therapies for tissue mal-
functioning or tissue loss. Tissue engineering is an interdisciplinary science that combines 
the knowledge of distinct fields, from biology to materials science and engineering, to 
obtain hybrid materials to use in substitution medicine. In most cases, biocompatible, 
degradable polymers are utilised to induce surrounding tissue ingrowth or to serve as 
temporary scaffolds for transplanted cells to attach, grow and maintain differentiated 
functions[2-7], which then degrade, as the new tissue is formed. 
These materials must comply with a large number of requirements. Besides the obvious 
demand of biocompatibility and biodegradability, they should have other properties such as 
the appropriate mechanical properties, to provide the correct stress environment for the 
neo tissue[1,5,8-14], the adequate degradation rate that assures that the strength of the 
scaffolds is retained until the newly grown tissue takes over the synthetic support[2,5,10,12-15], 
the adequate porosity and permeability in order to allow the ingress of cells and 
nutrients,[2,5,8,12-15] and the appropriate surface chemistry for enhanced cell attachment and 
proliferation[3,5,12,13,16-18] Until now, several natural and synthetic polymers have been 
investigated to be used as scaffold materials, but only a very small number is being 
clinically used in a limited range of tissue engineering applications. 
 
The first stage of tissue engineering, and one of the most important ones, is the design 
and processing of a porous 3-D scaffold with an interconnected structure of well-distributed 
pores with appropriate sizes for cell seeding.[19] The methods of manufacturing such 
scaffolds in a reproducible manner are crucial to their success, and should allow for the 
necessary scale-up of the developed tissue engineering technology.[4,8] The technique 
used to manufacture scaffolds for tissue engineering must allow the preparation of 
scaffolds with complex three-dimensional geometries and adequate porous structure, 
without affecting the biocompatibility of the material.[3,20] 
In this work, several methods based on conventional processing techniques and combined 
techniques, such as solvent casting and compression with salt leaching, were developed in 
order to obtain porous structures from starch based polymers, that are suitable for bone 
tissue engineering applications. The scaffolds obtained by the different methods exhibit 
different structure/properties combinations that may constitute a promising alternative to 
currently used biodegradable scaffolds. 
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2. MATERIALS & METHODS 
 
In this study, two different polymeric blends of corn starch with: i) ethylene vinyl alcohol 
blends (SEVA-C) and ii) cellulose acetate (SCA), both obtained from Novamont, Italy, were 
used. 
Several blowing agents (BA) were selected for the present study. The first blowing agent 
selected was Hostatron System P9947, from Hoechst, Germany, which will be designated 
as blowing agent 1 (BA1). This blowing agent of commercial origin is mainly composed of 
carboxylic acid that reacts by heating, releasing CO2 and water at about 200ºC. Two other 
blowing agents were selected, namely Hydrocerol BIH 70 and Hydrocerol BIH 40, which 
will be designated by blowing agent 2 (BA2) and blowing agent 3 (BA3), respectively; both 
were obtained from Clariant, Germany. These blowing agents are based on citric acid and 
they also release CO2 and water upon decomposition, which happens around 170ºC. The 
cytotoxicity of these materials has been tested[21] and the results show a non-cytotoxic 
behaviour. 
 
 
2.1. Extrusion with blowing agents 
In the extrusion process, the polymers were previously mixed with the blowing agents in a 
bi-axial rotating drum prior to processing in a twin-screw extruder Carvex, with a die of 12 
mm of diameter. This process was optimised for mixtures of the polymer with 10% and 
15% (w/w) of blowing agent 1. The weight fraction of blowing agent 2 and 3 necessary to 
produce the same percentage of porosity was much smaller than the one used with BA1 
(between 1 to 2,5%).  
 
 
2.2. Compression moulding - particle leaching 
The compression moulding and particle leaching method was based on blending together 
a starch based polymer (in the powder form) and leachable particles (in this case, salt 
particles) of different sizes, from 50µm to 1000µm, in sufficient amounts to provide a 
continuous phase of a polymer and a dispersed phase of leachable particles in the blend. 
The blend was then compression moulded into a desired shape.  The mould used was 
specially designed for this purpose, and allowed to obtain discs of 6 cm of diameter and 
approximately 1 cm of height. The resultant samples were then immersed in distilled water 
to remove the leachable particles. In all the methods combined with salt leaching 
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described in this manuscript, the leaching procedure was optimised for “excess leaching” 
of the salt. 
 
2.3. Solvent-casting/particle-leaching 
For the development of the solvent casting and particle leaching method it was necessary 
to find a solvent capable of dissolving properly the starch based polymers, once that it was 
found that due to its complex structure (and high molecular weight of the starch) these 
materials were not soluble, without degradation, in the traditional organic solvents. After 
performing an all range of solubility tests using several solvents, it was found that at least 
four solvents were able to dissolve these polymers, namely, acetic acid, 
dimethylformamide and dimethylsulfoxide. The results shown in this manuscript are 
referred to SCA (starch with cellulose acetate) dissolved in acetic acid, from Merck, 
Germany. With this method, the polymers were first dissolved in an appropriate organic 
solvent and  mixed with salt particles of different sizes. In general, it was added a salt 
weight fraction of 60 to 70% (based on the total mass of polymer and salt). The size of the 
particles used ranged from 50 to 1000µm. The mixture of the polymeric solution with the 
salt particles was then poured into a mould (a glass petri-dish of 3cm diameter) and placed 
in an oven at 37ºC in order to allow a progressive evaporation of the solvent. Finally, when 
the samples were completely solidified, they were immersed in distilled water, for leaching 
of the salt particles, and afterwards dried. 
 
 
2.4. In-situ polymerisation 
This innovative so-called in-situ polymerization process was based on a polymerization 
process developed in our group in order to obtain materials to be used as bone cements or 
hydrogels[22].  
These materials were prepared by adding the liquid phase, constituted by the acrylic 
monomers ((AA), from Merck), and 1% (w/w) of N-dimethylaminobenzyl alcohol  (DMOH), 
which was used as the activator of the initiation process, to the solid phase, which 
consisted of SEVA-C powder and 2%(wt/wt) of benzoic peroxide ((BPO), from Merck), 
which was used as the radical initiator, after purification by fractional recrystallization from 
ethanol, mp 104 ºC BPO. The leachable NaCl particles were added to the liquid or to the 
solid phase in order o provide the porosity of the structure. The solid and the liquid phases 
are then mixed together with a 10% of water with respect to the total weight and poured in 
a dough state in poly (tetrafluoroethylene) (PTFE) moulds until complete polymerisation 
take place.  
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After curing time, about 5 minutes, moulds are placed into the oven at 60ºC overnight to 
ensure a complete polymerization and then vacuum dried until constant weight was 
attained. Finally the samples were immersed in water to leach out the salt particles, in 
order to better simulate the in-vivo application of these materials. 
 
 
2.5. Materials Characterization 
The porous structure of the materials developed, namely the morphology of the pores, 
their size and distribution and also the interconnectivity between these pores, was 
characterised by scanning electron microscopy (SEM), in a Leica Cambridge S360. All the 
samples were previously gold coated in a Sputter Jeol JFC 1100 equipment. The porosity 
measurements were obtained from the photographs acquired by SEM that were processed 
using an image analysis software. 
The mechanical properties of the developed materials were assessed on compressive 
experiments in an Instron 4505 universal mechanical testing machine, using a load cell of 
50 kN. The compression tests were carried out at a crosshead speed of 2 mm/min (4.7 x 
10-5 m/s), until obtaining a maximum reduction in samples height of 60%. A minimum of six 
samples of each type was tested.   
The degradation behaviour was assessed after several pre-fixed ageing periods (0,3, 7, 
14, 30, 60 and 90 days), in an isotonic saline solution (NaCl 0.154 M).  At the end of each 
degradation period, the samples were removed from the solution, rinsed with distilled 
water and weighted, to determine the water uptake; one batch of samples was then dried 
up to exhaustion (6 days at 60ºC) in order to determine the dry weight loss. 
 
 
 
3. RESULTS AND DISCUSSION 
 
3.1. Morphology of the porous structures 
 
3.1.1. Extrusion with blowing agents 
The porous structure of the samples obtained by extrusion of the polymers combined with 
blowing agents results from the gases released by decomposition of the BA during 
processing. Therefore, it is difficult to control the pore size and the interconnectivity 
between the pores. However, a thin layer of solid material (less than 1 mm in 12 mm thick 
samples) surrounds the porous structure of the material.  
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Figure III.1. Scaffold obtained by of SCA extrusion of SCA with 10% of  
blowing agent 1 (Hostatron 9947) 
 
 
The extrusion process using blowing agent 1 (figure III.1), produces samples with pore 
sizes roughly between 50 to 300 µm, but the interconnectivity of the porous structure 
obtained is still very poor, even with the use of the surfactant agents. 
 
 
 
 
Figure III.2. SCA scaffold obtained by extrusion of SCA with 2.5 % of  
blowing agent 2 (Hydrocerol BIH 70) 
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Figure III.3. Scaffold obtained by extrusion of SCA with 2% of blowing agent 3 (Hydrocerol BIH40) 
 
In figures III.2 and III.3 it can be see that by means of using blowing agent 2 and 3 (in both 
cases hydrocerols), it was possible to obtain higher porosity and significant improvements 
with respect to the interconnectivity of the porous structures. This becomes much more 
evident in figure III.3 that corresponds to the materials obtained using the blowing agent 3. 
Furthermore, such increase in the porosity was obtained using much lower amounts of 
blowing agent (about 2 wt%). In this case, the pore sizes are in the range of 100 to 500 
µm, a range that includes the values that are believed to give the best results in terms of 
bone cell culture and bone tissue ingrowth by several researchers[17,23,24].  The density of 
the samples obtained by this process is approximately 0.7-0.8 g/cm3 (depending mainly on 
the blowing agent used), leading to a porosity of about 40-50%. 
 
3.1.2. Compression moulding and particle leaching 
 
 
Figure III.4. Scaffold obtained by compression moulding-particle leaching of SCA with 65% of salt. 
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The compression moulding – particle leaching technique gives rise to structures consisting 
in an open network of pores throughout the sample (see figure III.4), with sizes ranging 
from 10 to 500µm. The pores showed a large degree of interconnection, which is very 
important for cell seeding and growth. These scaffolds present a density of about 
0.7g/cm3, leading to a porosity of about 50%.  With this technique it is possible to control 
the percentage of porosity and the pore size by simply varying the amount and size of the 
leachable particles. 
 
3.1.3. Solvent casting and particle leaching 
The solvent-casting and particle leaching method allowed to obtain an open-porous 
structure with a good interconnectivity between the pores throughout the entire structure 
(figure 6). In fact, these scaffolds presented the best interconnectivity achieved so far, with 
respect to the other processing methods. Furthermore, this method allows for the accurate 
control of the pore size, distribution of pore sizes and porosity (volume of voids). These 
parameters of the porous structure can be tailored by varying the size, shape and 
distribution of the particles and the chosen volume ratio of polymer/particles. The control of 
scaffold porosity is critical for controlling cellular colonization and organization within an 
engineered tissue.  
 
 
Figure III.5. Scaffold obtained by the solvent casting-particle leaching method 
 
The sample exhibited in figure III.5, present a pore size between 50-300µm. In this cases 
the samples present a density of about 0.6g/cm3, which leads to a porosity around 60%. 
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3.1.4. In situ polymerisation 
The innovation introduced by the in-situ polymerisation method of obtaining scaffolds for 
tissue engineering lies in the fact that it is possible to produce the scaffold in-situ, i.e., it 
might be possible to inject the scaffold directly into the defect to treat, which can, therefore, 
take immediately the shape of the defect.  
These moldable polymer scaffolds fitting to the three dimensional geometry of specific 
tissue defects are highly in demand for clinical applications due to the invasiveness of the 
surgical implantation procedure[25-27] SEM analysis of this scaffolds showed pores ranging 
in size roughly from 10 to 100µm in diameter (figure 6), but once again, the pore size 
depends on the salt particles used. 
 
 
 
Figure III.6. Scaffold based on SEVA-C obtained by a method based on in situ polymerization 
 
 
 
3.2. Degradation behaviour 
 
Figures III.7 and III.8 show the water uptake and the weight loss as a function of the 
degradation period for the scaffolds obtained by the different processing methodologies 
developed.  
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Figure III.7. Water uptake vs. degradation period for SCA based scaffolds obtained 
by the different processing technologies developed. 
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Figure III.8. Weight loss vs. degradation period for SCA based scaffolds obtained 
 by the different processing technologies developed. 
 
 
As expected, the scaffolds obtained from the different methods presented similar water 
uptake and degradation profiles although they exhibited different degradation rates and 
different water uptake ability, according to the processing method and conditions. As 
expected, the samples obtained using higher blowing agents fraction/ higher salt particles 
fractions, exhibit higher porosity. The different scaffolds porosity attained by the different 
method and also to the thickness of the outer solid layer, will have direct influence in the 
easy of retention and access of the degradation solution in the bulk of the material, 
respectively, which will therefore influence their degradation behaviour. 
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The scaffolds obtained by the combination of compression moulding with particle leaching 
exhibit significantly higher water uptakes, compared to samples obtained by extrusion with 
blowing agents, which demonstrates the higher porosity and interconnectivity achieved 
with this method. However, the weight loss of these scaffolds is lower than for the scaffolds 
obtained by extrusion, which is most probably due to thermo-mechanical degradation 
undergone by the materials processed by extrusion, which leads to an easier breakdown 
of the material (associated to leaching of low molecular weight chains).  
The scaffolds obtained by the solvent casting and particle leaching exhibit very high water 
uptakes (more than 100% after only days of immersion in the degradation medium), as 
compared to samples obtained by all the other processes. This is probably due to the high 
porosity and interconnectivity achieved with this method. 
The scaffolds obtained by the in-situ polymerisation method present the highest water 
uptake ability, since they have water uptake properties of hydrogels. Their degradation 
rates are obviously lower than those presented for the above scaffolds, since this final 
material is composed of a blend of the starch based polymer with acrylic acid. The 
materials produced by this method are, in fact, not totally degradable, but they might be 
very useful in situations where it is necessary high mechanical properties and/or in 
situations where the defect or trauma that is necessary to treat is of difficult access, 
avoiding highly invasive surgery techniques.  
Furthermore, it is also possible to easily incorporate HA in the materials formulation, 
improving, at the same time, their mechanical properties and biological behaviour. This will 
be reported in a future paper. 
 
 
3.3. Mechanical properties 
 
The scaffolds obtained by extrusion with blowing agent 1, present the best compression 
properties, with a modulus varying from 205 to 230 MPa.  
The blowing agents 2 and 3 gave rise to lower mechanical properties, probably due to the 
higher porosity and interconnection between pores that was achieved with these blowing 
agents, although these porous structures are more adequate for the final application of the 
scaffolds. Nevertheless, these scaffolds present very promising mechanical properties 
when compared to other scaffolds, obtained from other biodegradable polymers, and 
proposed for use in tissue engineering of bone. For example, PLLA/ hydroxyapatite 
composite foams, prepared by a process based on phase separation, presented a 
compression modulus bellow 12 MPa.[5] The results presented on table III.1 might be 
further improved by reinforcing the scaffolds with hydroxyapatite. 
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Table III.1. Mechanical properties of the scaffolds obtained by the different processing 
methodologies developed.  
 
 
Processing 
 method 
 
Type and percentage of 
blowing agent or porogen 
used 
 
 
Porosity of the 
scaffolds 
(%) 
 
Compressive 
modulus (MPa) 
 
Compressive 
strenght 
(MPa) 
 
10% Hostatron 9947 (BA1) 
  
205.0 ± 9.5 
 
 
12.0 ± 1.4 
 
 
15% Hostatron 9947 (BA1) 
  
217.8 ± 25.8 
 
 
17.6 ± 0.9 
 
 
10% Hostatron 9947 (BA1) 
+ 1% glycerol 
 
40-50 
 
230.8  ± 71.0 
 
12.2 ± 2.5 
 
2% Hydrocerol BIH 70 
(BA2) 
  
172.4 ± 35.5 
 
8.7 ± 0.5 
 
 
 
 
 
 
Extrusion with 
blowing agents 
 
2 % Hydrocerol BIH 40 
(BA3) 
  
124.6 ± 27.2 
 
8.0 ± 0.9 
 
50 % of NaCl particles 
 
 
  50-60 
 
341.6 ± 34.3 
 
67.69 ± 6.2 
 
 
Compression molding  
and 
 particle leaching. 65 % of NaCl particles 
 
 133.7 ± 20.6 20.56 ± 6.2 
 
 
Solvent casting and 
particle leaching. 
 
 
60-70% of NaCl particles 
 
60-70 
 
170.5 ± 16.09 
 
21.73 ± 1.1 
 
 
 
The compressive properties of the scaffolds obtained by compression moulding and 
particle leaching are also very dependent on the porosity obtained, being in some cases, 
superior to those obtained by the extrusion process. 
 
As should be expected, the mechanical properties of the scaffolds obtained by the solvent 
casting and particle leaching method are lower when compared to the properties of the 
samples obtained by melt-based technologies. However, these properties may be 
considered very good when compared to scaffolds obtained from other materials by 
identical processing methods and proposed for the same type of applications. For 
example, a PLGA scaffold obtained by the solvent casting and particle leaching method, 
exhibits a modulus of 1.09 MPa [28] 
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4. CONCLUSIONS 
 
It was possible to develop a wide range of processing methods to obtain starch based 
tissue engineering scaffolds. These scaffolds present adequate porous structure, that can 
be tailored according to the intended application, with pore sizes in the range of those 
which are believed to be the most appropriate for bone cell culturing and/or bone tissue 
ingrowth. The interconnectivity obtained is dependent on the processing method. In 
general, the methods based on compression or solvent casting associated with particle 
leaching, allowed to obtain the best interconnectivity between pores. 
With respect to the degradation behaviour, although the profile is similar to all types of 
samples, the degradation rates can be significantly different, depending on the processing 
method and on the final porosity obtained. 
The mechanical properties of the scaffolds obtained by melt based methods are the 
highest ones, as compared to the scaffolds obtained by the other methods, but in general 
all the starch based scaffolds present better mechanical properties than those reported in 
the literature for scaffolds obtained from other biodegradable polymers and proposed for 
bone tissue engineering applications. 
 
The methods detailed herein allow for the optimisation of the porous structure, degradation 
kinetics and mechanical behaviour of starch based scaffolds for a given application within 
the bone tissue engineering field. Therefore scaffolds obtained from these materials using 
one of the described methodologies may constitute an important alternative to the 
materials currently used in tissue engineering.  
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Abstract 
 
The design and processing of appropriate porous 3-D scaffolds is one of the most 
important steps towards the regeneration of damaged tissues/organs using a tissue 
engineering approach, since most of the cell types require an adequate support in order to 
form the intended new tissue. 
This work reports the development of several processing techniques have been 
specifically designed for producing biodegradable scaffolds from a range of starch based 
polymers. The developed methods include melt based processing technologies (based on 
injection moulding and extrusion using blowing agents), combined techniques based on 
solvent casting and on compression moulding associated to particle leaching. It has been 
possible to produce scaffolds that combine an appropriate degradation rate, with controlled 
porosity and adequate pore sizes, as well as tissue matching mechanical properties. 
Furthermore, the developed methods have no negative effect on the biocompatible 
behaviour of the starch based polymers.  
 
 
 
 
 
 
 
 
 
* This chapter is based on the following publication: 
M.E. Gomes, J.S. Godinho, R.L. Reis, A.M. Cunha, “Design and Processing of Starch Based Scaffolds for 
Hard Tissue Engineering”, Journal of Applied Medical Polymers, 2002, 6: 75-80 
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1. INTRODUCTION 
 
Tissue loss or end-stage organ failure resulting from an injury or disease is a major health 
problem, since the transplantation of tissues or organs in these patients is severely limited 
by donor scarcity and by the risk of rejection and disease transfer.[1-4] 
Tissue engineering has emerged as a promising alternative approach to circumvent the 
limitations of the existing therapies for the treatment of malfunctioning or lost organs.[1-6] 
In this approach, a porous material acts as a temporary scaffold, serving as an adhesive 
substrate for the implanted cells and simultaneously supporting the formation of the new 
tissues/organs. Transplanted cells adhere to the scaffold, proliferate, secrete their own 
extracellular matrices (ECM), and stimulate new tissue formation. During this process, the 
scaffold gradually degrades and is eventually eliminated.[3,4] 
In tissue engineering of bone, the scaffold matrix must serve an additional function:[7-9] it 
must provide sufficient temporary mechanical support to withstand in vivo stresses and 
loading. In this case the material must be designed with a degradation rate that ensures 
that the strength of the scaffold is retained until the tissue engineered transplant is fully 
remodelled by the host tissue and can assume its structural role.[7-9]  
As a consequence, the search for improved biodegradable polymers and for processing 
techniques to produce scaffolds for hard tissue regeneration, so that physical and chemical 
properties can be simultaneously optimised, is still an important and very demanding issue 
in hard tissue engineering research.[10,11]  
 
 
2. MATERIALS & METHODS 
 
Usually, polymer scaffold processing is divided in two general groups of techniques: melt 
processing and solvent processing. Melt processing involves heating the polymer above 
the glass transition temperature (Tg) or the melting temperature (Tm) and depends on melt 
viscosity. Solvent processing depends on the polymer solubility in various organic solvents 
and on the solvent volatility.  
This section describes several processing methods for producing the scaffolds based on 
starch based blends with distinct synthetic polymers, namely with cellulose acetate (SCA), 
ethylene viny alchool (SEVA-C) and polylactic acid (SPLA), all provided by Novamont, 
Italy. Several blowing agents (BA) were selected for the study, however in this manuscript 
we only report results obtained with the blowing agents that produced the scaffolds with 
higher porosities and/or best interconnectivity, namely: Hydrocerol BIH 40 (BA1), from 
Clariant, Germany and Celogen 780 (BA2) from Uniroyal Chemical. 
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2.1. Extrusion and Injection Moulding with Blowing Agents 
The polymeric materials were mixed in a rotating drum with one of the blowing agents 
described above, in amounts from 1% to 15% prior to processing by injection moulding or 
extrusion. In the injection moulding process it was used a Krauss Maffei KM60-120A) 
injection moulding machine with a mould which was particularly designed for this 
application in order to allow maximal expansion and therefore enhance the formation of 
pores within the polymer melt.  In the extrusion process, it was used a Carvex  twin-screw 
extruder with a  die diameter of 12 mm.  
 
2.2. Compression moulding - particle leaching 
The starch based polymers and the leachable salt particles of different sizes, were blended 
and then compression moulded into a desired shape. The resultant sample was then 
immersed in water to dissolve the salt particles, creating a porous structure. The leaching 
procedure was optimised for “excess leaching” of the salt particles, which corresponded to 
the immersion of each sample in distilled water during 5 days, changing the water daily. 
 
2.3. Solvent-Casting/Particle-Leaching 
 The polymers were dissolved in an appropriate organic solvent and then mixed with salt 
particles of different sizes. When the mixture had solidified, by evaporation of the solvent, 
the samples were immersed in water to leach out the salt particles. 
 
2.4. Materials Characterization 
The porous structure of the materials developed was characterised by scanning electron 
microscopy (SEM), in a Leica Cambridge S360. All the samples were previously gold 
coated in a Jeol JFC 1100 sputter coater. The SEM analysis allowed to evaluate the 
morphology of the pores, their size and distribution and also the interconnectivity between 
these pores. 
The materials were mechanically tested on compression experiments in an Instron 4505 
universal mechanical testing machine, using a load cell of 50 kN. Compression testing was 
carried out at a crosshead speed of 2 mm/min (4.7 x 10-5 m/s), until obtaining a maximum 
reduction in samples height of 60%. A minimum of six samples of each type was tested.  
The degradation behaviour was assessed after several pre-fixed ageing periods (0,3, 7, 14 
and 30 days), in an isotonic saline solution (NaCl 0.154 M), at 37ºC.  At the end of each 
degradation period, the samples were removed from the solution, rinsed with distilled 
water and weighted, to determine the water uptake. Finally 5 of these samples were dried 
to constant weight (6 days at 60ºC) in order to determine the final dry weight loss and 
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other 5 samples were dried at room temperature and then mechanical tested (as described 
above) in order to evaluate the changes in mechanical properties after degradation. 
 
 
 
 
3. RESULTS & DISCUSSION 
 
3.1. Extrusion and Injection Moulding with Blowing Agents:  
The porosity of the samples obtained by these processes results from the gases (mainly 
CO2) released by decomposition of the blowing agents during processing. Therefore, it is 
difficult to accurately control the porosity and the pore size obtained. However, the 
consecutive optimisation of the processing conditions as well as progressive better 
selection of the blowing agent and mould design, allowed to obtain significant 
improvements in the percentage of porosity and interconnectivity of the porous structures. 
This is shown for example, in figure IV.1 that displays a representative SEM 
microphotograph of  the structure of a scaffold obtained by injection moulding of SCA with 
only 1.5% of the BA2 (Celogen 780). The estimated porosity in this case is about 40-50%, 
depending mainly on the type and amount of blowing agent used.  In addition, the injection 
mouding and the extrusion processes produce a uniform microporosity throughout the pore 
walls of the scaffolds (see figure IV.2) which can perform an important role in the transport 
of nutrients during cell culturing, enabling the proliferation of cells also within the scaffolds 
and not only on the surface. 
The mechanical properties of these scaffolds are mainly affected by the synthetic 
component of the starch based blend used and obviously on the percentage of porosity of 
the scaffold (see table IV.1). 
 
 
 
Chapter IV: Design and Processing of Starch Based Scaffolds  
- 103 - 
 
Figure IV.1. Scaffold obtained by injection moulding of SCA with 1.5% of 
blowing agent 2 (Celogen 780)  
 
 
 
Figure IV.2. Scaffold obtained by injection moulding of SCA with 1.5% of blowing agent 2 
 (Celogen 780) showing the uniform microporosity of the structure. 
 
 
3.2. Compression Moulding –Particle Leaching: 
The compression moulding and particle leaching technique gives rise to structures on 
which the porosity and pore size are mainly dictated by the amount and sizes of the 
leachable particles used and usually with good interconnectivity between pores. Figure 
IV.3 shows the structure of a scaffold based on SCA obtained by compression moulding 
with 65% of salt particles. In this case, it was obtained about 65% porosity and the pore 
sizes were between 10 to 500µ.  The compressive strength of these scaffolds are also 
deeply dependent on the porosity obtained, as shown in table IV.1. 
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Figure IV.3. Scaffold based on SCA obtained by the solvent casting and particle leaching  
 method using 65% of salt particles. 
 
 
 
3.3. Solvent Casting-Particulate Leaching: 
The solvent casting and particle leaching method as in the compression moulding with 
particle leaching, allows for the accurate control of the pore size, distribution of pore sizes 
and porosity (volume of voids) as these parameters can be tailored by varying the size, 
shape and distribution of the particles and the chosen volume ratio of polymer/particles. 
Furthermore, a good interconnectivity between the pores throughout the all structure can 
be achieved. However, and as expected, the mechanical properties are lower when 
compared to the properties of the samples obtained by melt-based technologies (see table 
IV.1). 
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Table IV.1. Mechanical properties of the SCA (and SEVA-C) based scaffolds obtained by the 
different methodologies.  
 
Processing 
 Method 
 
Type and percentage of 
blowing agent or porogen used 
 
 
Compressive 
modulus (MPa) 
 
Compressive 
strength (MPa) 
 
1% Hydrocerol BIH 40 (BA1) 
 
240.1 ±  62.8* 
 
 
17.28 ± 1.7* 
 
 
2% Hydrocerol BIH 40 (BA1) 
 
248.9 ±  39.1* 
 
 
17.5 ±  1.9* 
 
 
3% Hydrocerol BIH 40 (BA1) 
 
249.1  ± 85.1* 
 
18.9 ±  1.1* 
 
 
 
 
 
 
Extrusion  
 
2 % Hydrocerol BIH 40 (BA1) 
 
124.6 ± 27.2 
 
8.0 ± 0.9 
 
Injection moulding 
 
Celogen 780 (BA2) 
 
134.5 ±  39.5 
 
18.4 ± 2.8 
 
50 % of NaCl particles 
 
341.6 ± 34.3 
 
67.69 ± 6.2 
 
 
Compression 
molding  
65 % of NaCl particles 133.7 ± 20.6 20.56 ± 6.2 
 
 
Solvent casting  
 
 
60-70% of NaCl particles 
 
170.5 ± 16.09 
 
21.73 ± 1.1 
 
* These values refer to SEVA-C based scaffolds; all the other values presented in this table refer to SCA based 
scaffolds. 
 
 
 
 
4. GENERAL REMARKS 
 
In figures IV.4 and IV.5, the water uptake and degradation behaviour of the scaffolds 
obtained by the different processing methods described in this study may be compared. 
The scaffolds obtained from the above described methods presented similar degradation 
profile.  However, they exhibited different degradation rates, according to processing 
method and processing conditions, especially those that have direct influence in the 
percentage of porosity, such as the amount of blowing agent and or amount of leachable 
particles. In general, the methods that give rise to scaffolds with higher porosity and 
interconnectivity exhibit higher water uptake. However, the degradation rate is not only 
influenced by the porosity of the structure but also by other aspects related to the 
processing method. For example, the scaffolds obtained by compression moulding and 
particle leaching exhibit higher water uptake than those obtained by extrusion and injection 
moulding with blowing agents, but their weight loss is lower. This is most problably due to 
the thermo-mechanical degradation undergone by the materials processed by injection 
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moulding and extrusion, which leads to an easier breakdown of the polymeric chains. In 
addition to this, the lower porosity and poor interconnectivity of the samples obtained by 
these processes, but particularly with the injection moulding, may contribute to faster 
degradation rates due to enhanced sutocatalysis in those scaffolds, which are unable to 
evacuate acidic degradation by-products. 
The mechanical properties of the scaffolds do not exhibit signifficant decreases after in 
vitro degradation during the first 30 days as shown, for example, for SPLA based scaffolds 
obtained by extrusion and compression moulding (see figure IV.5). The mechanical 
properties of these scaffolds, namely the compressive modulus, are in the range of those 
reported  for human trabecular bone, and the fact that it is decreased less than 30% in the 
first 30 days of  in-vitro degradation is determinant for their application as bone tissue 
engineering scaffolds. 
 
 
0
20
40
60
80
100
120
140
160
0 10 20 30 40 50 60
Degradation period (days)
W
at
er
 u
pt
ak
e 
(%
)
Solvent casting Compression
Extrusion Injection 
 
 
Figure IV.4. Water uptake vs. degradation period for SCA based scaffolds obtained by the different 
processing technologies developed. Standard deviations are between 3.1 to 5.36% (not shown for 
easier visualization of the displayed results). 
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Figure IV.5. Weight loss vs. degradation period for SCA based scaffolds obtained by the different 
processing technologies developed. Standard deviations are between 0.38 to 1.18% (not shown for 
easier visualization of the displayed results). 
 
 
 
 
Figure IV.6. Compressive modulus of SPLA based scaffolds obtained by two different processing 
technologies after several degradation periods in a saline solution. 
 
The biological behaviour of starch based polymers has been the subject of several 
different in vitro and in vivo studies [12-14]. All these studies have shown that these polymers 
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exhibit a biocompatible behaviour, which is not affected under controlled processing 
conditions. More recently, preliminary cell culture studies have demonstrated that the 
starch based scaffolds produced by the methodologies described herein allow for the 
proliferation and growth of human osteoblasts[15]. Although it is necessary to further test 
these materials with respect to their ability to act as a support for the growth and 
differentiation of cells, these preliminary results indicates the potential of the developed 
porous materials for use as bone tissue engineering scaffolds. 
 
 
 
 
5. CONCLUSIONS: 
 
Several processing methods to obtain starch based scaffolds were developed. These 
methodologies allow to tailor, to an extended degree, the pore sizes and pore structure of 
the scaffolds as well as their degradation rates since it was shown that the degradation 
rates can be significantly different, depending on the processing method and on the final 
porosity obtained. 
Furthermore, although only few data on mechanical properties of scaffolds for tissue 
engineering is found in the literature, it is possible to conclude that mechanical properties 
of all the tested scaffolds are very promising, when compared to scaffolds obtained from 
other biodegradable polymers. In addition, these properties are not significantly affected in 
the first 30 days of in vitro degradation, which suggests that the scaffold will be able to 
provide the necessary structural support in the first period of implantation. 
In conclusion, all these results, both from a materials science and a biological perspective, 
are very promising for the future application of starch based biodegradable polymers as 
tissue engineering scaffolds.  
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Chapter V 
 
Effect of Flow Perfusion on the Osteogenic Differentiation of Bone Marrow Stromal 
Cells Cultured on Starch Based Three-Dimensional Scaffold 
 
 
 
Abstract 
 
This study aims to investigate the effect of culturing conditions (static and flow perfusion) 
on the proliferation and osteogenic differentiation of rat bone marrow stromal cells seeded 
on two novel scaffolds exhibiting distinct porous structures. Specifically, scaffolds based on 
SEVA-C (a blend of starch with ethylene vinyl alcohol) and SPCL (a blend of starch with 
polycaprolactone) were examined in static and flow perfusion culture. SEVA-C scaffolds 
were formed using an extrusion process, while SPCL scaffolds were obtained by a fiber 
bonding process. For this purpose, these scaffolds were seeded with marrow stromal cells 
harvested from femoras and tibias of Wistar rats and cultured in a flow perfusion bioreactor 
and in 6-well plates for 3, 7 and 15 days. The proliferation and alkaline phosphatase 
activity patterns were similar for both types of scaffolds and for both culture conditions. 
However, calcium content analysis revealed a significant enhancement of calcium 
deposition on both scaffold types cultured under flow perfusion. This observation was 
confirmed by Von Kossa stained sections and tetracycline fluorescence. Histological 
analysis and confocal images of the cultured scaffolds showed a much better distribution 
of cells within the SPCL scaffolds than the SEVA-C scaffolds, which had limited pore 
interconnectivity, under flow perfusion conditions. In the scaffolds cultured under static 
conditions, only a surface layer of cells was observed. These results suggest that flow 
perfusion culture enhances the osteogenic differentiation of marrow stromal cells and 
improves their distribution in three-dimensional starch-based scaffolds. They also indicate 
that scaffold architecture and especially pore interconnectivity affect the homogeneity of 
the formed tissue.  
 
 
 
* This chapter is based on the following publication: 
ME Gomes, VI Sikavitsas, E Behravesh, RL Reis, AG Mikos. Effect of Flow Perfusion on the Osteogenic 
Differentiation of Bone Marrow Stromal Cells Cultured on Starch Based Three-Dimensional Scaffolds.  
Journal of Biomedical Materials Research (2003) 67A:87-95 
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1. INTRODUCTION 
 
One of the most widely studied tissue engineering approaches involves the seeding and 
extended in vitro culturing of cells within a biodegradable scaffold prior to implantation. The 
bioresorbable scaffold must be biocompatible and porous to facilitate rapid vascularization 
and growth of newly formed tissue.[1-8] During the in vitro culture period, the seeded cells 
proliferate and secrete tissue specific extracellular matrix (ECM). Following implantation, 
the scaffold gradually degrades and is eventually eliminated from the body. [1-8] 
The selection of an appropriate scaffold material is a primary consideration in such a tissue 
engineering strategy.[9] Besides the obvious demands of biocompatibility and 
biodegradability, an ideal tissue engineering scaffold should have appropriate mechanical 
properties[1,10-14] and a suitable degradation rate.[2,10,12-15] Furthermore, the scaffold must 
possess adequate porosity, interconnectivity and permeability to allow the ingress of cells 
and nutrients[12-15] as well as the appropriate surface chemistry for enhanced cell 
attachment and proliferation.[3,12,13,16] Several biodegradable polymers have been proposed 
to be used as three-dimensional scaffolds for bone tissue engineering, including a new 
range of natural origin polymers based on starch.[17] Starch-based polymers are 
degradable and biocompatible polymers,[18-20] with distinct structural forms and properties 
that can be tailored by the synthetic component of the starch-based blend, their processing 
methods, and the incorporation of additives and reinforcement materials. For this reason, 
together with their low cost and abundance of raw materials, starch-based polymers have 
been suggested for a wide range of biomedical applications. 
Another important consideration for tissue engineering approaches based on in vitro cell 
culture is the cell source and the ability to control cell proliferation and differentiation. 
Marrow stromal cells constitute a potential autogenous source of cells for bone tissue 
engineering as they can be expanded, differentiated into osteoblasts, and used to seed the 
scaffolds.[21] 
Besides the selection of the scaffold material and the cell source, several other issues 
should be considered, including the optimization of the in vitro culturing system. Static 
culturing conditions often result in inhomogeneous cell distribution, confining the majority 
of the cells to the outer surfaces of the scaffold. Accordingly, an inhomogeneous 
distribution of the extracellular matrix commonly results.[22-24] In order to overcome this 
limitation, several bioreactors have been developed,[22-28] attempting to maintain a uniform 
distribution of cells on the scaffolds, to provide adequate levels of oxygen, nutrients, 
cytokines and growth factors, and to expose the cultured cells to mechanical stimuli. Most 
bioreactors used in bone tissue engineering applications achieve good mixing of the 
culturing media near the construct outer surface, but not to its interior. This inability 
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represents a major drawback, particularly in the culturing of scaffolds for the reconstruction 
of large bone defects. Our laboratory has developed a flow perfusion bioreactor which 
provides uniform flow to the interior and exterior of the cultured scaffolds.[26] 
In this study we have investigated the influence of the cell culturing conditions generated 
by this flow perfusion bioreactor on the proliferation and osteogenic differentiation of rat 
bone marrow stromal cells seeded into two types of starch-based scaffolds. This study 
addresses the following questions: i) Are starch based scaffolds able to support adhesion 
and proliferation of rat bone marrow cells? ii) Does flow perfusion allow for enhanced 
osteogenic differentiation and homogenous spatial distribution of the seeded cells? iii) 
Does the different porosity and pore architecture of these scaffolds influence the 
proliferation, differentiation, and distribution of cells under flow perfusion culture 
conditions?  
 
 
 
2. MATERIALS AND METHODS 
 
2.1. Scaffold preparation and characterization 
Two different types of starch based polymer scaffolds were used in this study: i) a scaffold 
based on SEVA-C (a 50/50%wt blend of starch with ethylene vinyl alcohol) obtained by 
extrusion with a blowing agent and ii) a scaffold based on SPCL (a blend of starch with 
polycaprolactone, 30/70%wt) obtained by a fiber bonding process. Further information on 
starch based polymer scaffolds and their processing can be found elsewhere.[17] The 
morphology of the scaffolds was characterized by microcomputerized tomography (µCT) 
(ScanCo Medical µCT 80, Bassersdorf, Switzerland) at a resolution of 10 µm. All samples 
were cut into discs of approximately 8 mm diameter and 1.5 to 2 mm height and sterilized 
using ethylene oxide. Prior to cell seeding, the scaffolds were immersed in 30 ml of serum-
free media in 50 ml tubes. Air was removed from their pores by generating vacuum with a 
30 ml syringe equipped with an 18 gauge needle. The scaffolds were left in serum-free 
media overnight to allow swelling. 
 
2.2. Isolation and expansion of rat bone marrow cells 
Rat bone marrow stromal cells were isolated and cultured using methods previously 
described.[29] Briefly, cells were obtained from the femoras and tibias of male Wistar rats 
with weights ranging from 125 to 149 g (Harlan, USA). The epiphyses were cut off and the 
diaphyses flushed with 5 ml of complete media (α-MEM (Minimal Essential Medium) 
Eagle, Sigma, USA), supplemented with 10 % FCS (Fetal Calf Serum, Gemini, USA), 50 
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µg/ml ascorbic acid (Sigma, Chemical Co., St. Louis, MO, USA), 50 µg/ml gentamycin, 100 
µg/ml ampicillin, 0.3 µg/ml fungizone, 10 mM β-glycerophosphate (Sigma) and 10-8 M 
dexamethasone (Sigma)). Cells were cultured in complete media in a humidified 
atmosphere of 5 % CO2 at 37°C for 6 days. 
 
2.3. Cell seeding on starch-based scaffolds  
After 6 days of primary culture, the cells were detached using trypsin/EDTA (0.25% w/v 
trypsin/0.02% EDTA, Sigma), concentrated by centrifugation at 1500 rpm for 5 min and 
resuspended in complete media. Subsequently, the scaffolds (n=18 for flow and n=18 for 
static culture, for each scaffold type) were inserted into cassettes that were placed in 6-
well plates. Each scaffold was then seeded with 300 µl of a cells suspension containing 
5x105 cells and incubated for 2 hours. Then 10 ml of complete media was added to each 
well. The seeded scaffolds were further incubated overnight to allow for cell attachment. 
The following day, seeded scaffolds were placed into fresh 6-well plates for static culture 
conditions or into the flow perfusion bioreactor and cultured in complete media for 3, 7, and 
15 days (6 scaffolds per culture condition and per culture time). 
 
2.4. Cell culturing:  The flow perfusion culture system 
The flow perfusion bioreactor is described in detail elsewhere.[26] Briefly, the bioreactor 
consists of 6 flow chambers, each one containing a cassette in which the scaffold is press-
fitted. Gas permeable silicon tubing connects each flow chamber with a peristaltic pump 
and a medium reservoir. Each chamber has its own independent pumping circuit, but all 
pumps draw media from a common reservoir. For these experiments, culture media was 
pumped continuously at a flow rate of 0.3 ml/min through the cell/scaffold construct 
cassette/housing unit and recirculated back to the reservoir. The total volume of medium in 
the flow system was 210 ml. In the static culture, 10 ml was added to each scaffold. In both 
culture systems, media was changed every 3 days.  
The entire flow perfusion bioreactor was maintained in an environment of 37°C with 5% 
CO2. At the end of each culturing period, the cell/scaffold constructs were rinsed with 
phosphate buffered saline (PBS) and stored at -70°C in 10 ml tubes containing 1.4 ml of 
milliQ water for DNA, calcium, and alkaline phosphatase (ALP) analysis. At each time 
point, two scaffolds from each group were retrieved; one was fixed in a solution of 2.5% 
gluteraldehyde for SEM analysis and the other in a formalin solution for histological 
evaluation. 
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2.5. Characterization of the cultured scaffolds 
 
2.5.1.Cellularity of scaffolds 
The DNA content of each scaffold was measured using a PicoGreen DNA Quantification 
Kit (Molecular Probes). The samples were allowed to thaw at room temperature and then 
they were sonicated for roughly 15 min. A description of the assay can be found 
elsewhere.[30] The cellularity of each scaffold was then calculated by correlation with the 
DNA of a known amount of marrow stromal cells.  
 
2.5.2. Alkaline phosphatase activity  
Alkaline phosphatase activity was measured using a Sigma Diagnostic Kit #104; a 
colorimetric endpoint assay which measures the conversion of p-nitrophenol phosphate to 
p-nitrophenol by the enzyme alkaline phosphatase.[26]   
 
2.5.3. Calcium content of scaffolds 
Cell/scaffold constructs were incubated overnight in 1 N acetic acid to dissolve the 
deposited calcium. The calcium content was then measured using the Sigma Diagnostic 
Kit #587. This colorimetric endpoint assay measures the amount of calcium-
cresolphthalein complexone formed when cresolphthalein complexone binds to free 
calcium in an alkaline solution. The amount of deposited calcium was expressed as mg of 
Ca2+ equivalents per scaffold.[26] 
 
2.5.4. Scanning electron microscopy (SEM) 
For SEM analysis the samples were fixed in a solution of 2.5% glutaraldehyde (in PBS), 
dehydrated in a gradient series of ethanol solutions, dried with tetramethylsilane, and 
sputter coated with gold (Jeol JFC 1100, Jeol, USA). Samples were then observed using a 
scanning electron microscope (Leica Cambridge S360, Leica Cambridge, UK). 
 
2.5.5. Confocal microscopy 
To visualize the distribution of cells within the scaffolds, samples cultured for 15 days 
(previously fixed with glutaraldehyde) were cut in half (to expose the interior cross section), 
rinsed with PBS, incubated with picogreen dye (0.1%) for at least 15 min, and then 
observed under a confocal microscope (Zeiss LSM Axiovert, Carl Zeiss, Germany). Depth 
projections of the surface (up to 300 µm) were obtained and the cells were pseudo-
coloured as a function of their distance from the surface. 
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2.5.6. Histology and imaging of tetracycline fluorescence 
The cultured samples were rinsed with PBS, fixed in formalin, rinsed with water and 
embedded in frozen tissue embedding media (HistoPrepTM, Fisher Diagnostic, USA). 
Sections of approximately 30 µm were obtained using a cryotome (Microm 505) and 
stained with hematoxylin and eosin for histological evaluation. For visualization of 
mineralized tissue, additional sections were exposed to a 5% silver nitrate solution under 
UV light for 25 min and counter stained with a safranin O solution (0.5%). Mineral 
deposition was also observed in unstained sections under fluorescent light after adding 
tetracycline-HCl (10 µg/ml) to the culture media as described previously.[23] All the 
histological sections were observed with a light microscope Nikon E600 equipped with a 
Sony DXC-950P CCD camera and a fluorescence lamp. 
 
2.5.7. Statistics 
Results are presented as means ± standard deviation. Multiple pairwise comparisons were 
performed using the Tukey-Kramer method with a significance level of 95%. 
 
 
 
3. RESULTS AND DISCUSSION 
 
3.1. Characterization of the scaffolds 
The SPCL scaffold has a typical fiber-mesh structure, with a fiber diameter roughly 181 
µm, with highly interconnected pores and a porosity of approximately 75%, as determined 
by µCT analysis. (Figure V.1a). The SEVA-C based scaffolds were obtained by extrusion 
with a blowing agent creating pores within the polymer melt as the blowing agent releases 
CO2. The pores are not completely interconnected, as shown on the µCT scan of this 
scaffold (Figure 1b). The porosity of these scaffold was approximately 60% as determined 
by µCT analysis.  
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Figure V.1. Representative µCT scans of (a) SPCL based scaffold (top and side view) and (b) 
SEVA-C based scaffold (top and side view). 
 
 
3.2. DNA analysis 
Figures V.2a and V.2b depict the number of cells present in each scaffold at each time 
point, calculated from DNA measurements. In both static and flow perfusion cultures, cell 
proliferation occurred during the first week of culture. These results agree with the initial 
period of osteoblastic development characterized by active cellular proliferation.[31] Similar 
cellular growth patterns were observed for both static and flow cultures. Flow perfusion 
appears to enhance cell proliferation when compared to static culture. This trend was 
found to be significant (p<0.05) for SEVA-C scaffolds cultured for 15 days under flow 
perfusion. However, when cell proliferation between the two scaffolds cultured in flow 
perfusion is compared, enhanced proliferation is observed on the SPCL fiber meshes. This 
may be related to the different synthetic components of the starch-based blend or to the 
higher porosity and interconnectivity of the SPCL scaffolds.  
During the second week of culture, the cellularity of all scaffolds did not increase further. 
This period corresponds to the stages of matrix maturation, late osteoblastic differentiation, 
and mineralization. Similar cell proliferation patterns, characterized by an increase in cell 
number during the first period of culture followed by a period where the cell number 
a) 
b) 
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remained constant or even decreased have been observed in earlier studies with marrow 
stromal cells seeded into titanium fiber mesh scaffolds and cultured under flow perfusion 
and static conditions.[23,26] 
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Figure V.2. Number of cells on (a) SPCL fiber meshes and (b) SEVA-C based scaffolds after 3, 7 
and 15 days of culture under static and flow perfusion conditions.  Error bars represent means ± 
standard deviation for n = 3-5.  Asterisk (*) indicates that the cellularity of SEVA-C scaffolds cultured 
under flow perfusion conditions after 15 days of culture was significantly higher (p<0.05) than the 
cellularity of scaffolds cultured under static conditions for 15 days. 
 
 
3.3. Alkaline phosphatase analysis 
The alkaline phosphatase (ALP) activity of marrow stromal cells has been shown to 
indicate the commitment of these cells towards the osteoblastic lineage[31] and usually 
*
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reaches a maximum that coincides with the early osteoblastic differentiation stage of 
marrow stromal cells. After this period, the ALP activity usually decreases and 
mineralization starts to take place. In this study, a continuous increase in ALP activity was 
observed during the 15 days of culture on both scaffold types and culture conditions 
(Figure V.3). For the SPCL fiber meshes, the ALP (normalized to reflect the ALP activity 
per cell) was not statistically different between flow perfusion and static cultures. However, 
the ALP activity in SEVA-C scaffolds cultured under flow conditions after 15 days was 
higher (p<0.05) than ALP activity in static culture conditions for the same time period.  
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Figure V.3. Normalized ALP activity of marrow stromal cells after 3, 7 and 15 days of culture on (a) 
SPCL fiber meshes and (b) SEVA-C based scaffolds under static and flow perfusion conditions.  
Error bars represent means ± standard deviation for n = 3-5.  Asterisk (*) indicates that the ALP 
activity of SEVA-C scaffolds cultured under flow perfusion conditions after 15 days of culture was 
significantly higher (p<0.05) than the ALP activity of scaffolds cultured under static conditions for 15 
days. 
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3.4. Calcium deposition 
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Figure V.4. Calcium deposition on (a) SPCL fiber meshes and (b) SEVA-C based scaffolds after 7 
and 15 days of culture under static and flow perfusion conditions. Control samples without cells 
were also “cultured” under static conditions.  Error bars represent means ± standard deviation for n 
= 3-5.  Asterisk (*) indicates that calcium deposited on the scaffolds cultured under flow perfusion 
conditions after 15 days of culture was significantly higher (p<0.05) than calcium deposited on 
scaffolds cultured under static conditions for 15 days (and scaffolds cultured under flow perfusion 
conditions for 7 days). 
 
 
Calcium deposition in cultures of osteoblastic cells is a marker of their full maturation. 
Calcium measurements (Figure V.4) showed that during the first week of culture practically 
*
* 
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no calcium deposition had occurred in both culture conditions. In contrast, after 15 days, a 
dramatic increase in calcium deposition was observed on both types of scaffolds cultured 
under flow perfusion, clearly suggesting that flow perfusion is responsible for the enhanced 
mineralization of marrow stromal cells. Possible mechanisms responsible for the observed 
enhanced mineralization include the exposure of the seeded cells to fluid shear induced 
mechanical stimulation and the mitigation of potential nutrient transport limitations 
experienced by the cells cultured under static conditions.  
 
Enhanced mineralization under flow perfusion appeared in both scaffold types in 
agreement with earlier studies involving the culture of marrow stromal cells on titanium 
fiber meshes under flow perfusion with similar shear forces.[26] From the porosity and pore 
size of the scaffolds, a mean shear stress could be estimated for fluid flow through the 
pores.[25] Assuming a cylindrical pores model approximation for the geometry of the 
scaffold porosity, the shear forces experienced by the seeded cells in both scaffolds were 
estimated to be on the order of 0.1 dyn/cm2. 
 
 
 
3.5. Confocal Microscopy 
Confocal images obtained from depth projections of the surfaces of SPCL fiber meshes 
after 15 days showed the formation of cell monolayers on the surface of the scaffolds 
cultured under flow (Figure V.5a) and static (Figure V.5c) conditions, but the images 
suggested the presence of a thicker layer of cells on samples cultured in the flow perfusion 
bioreactor. The images obtained from the transversal section of the same samples 
demonstrated that the flow culture conditions (Figure V.5b) allow for a much better 
distribution of cells inside the fiber meshes than the static culture conditions (FigureV.5d).  
In the SEVA-C based scaffolds, the formation of cell monolayers on the surface of the 
scaffolds cultured under flow (Figure V.6a) and static conditions (Figure V.6c) was 
apparent. However, the images obtained from the transversal section of the samples 
(Figures V.6b and V.6d) demonstrated that, in this case, the limited pore connectivity of 
these scaffold did not allow the cells to spread throughout the scaffold interior. 
Nevertheless, in the samples cultured in the flow perfusion bioreactor, it was possible to 
visualize a small number of cells in the interior of the scaffold, indicating the existence of a 
preferential flow pathway through these scaffolds that allowed the presence of cells in 
specific locations. 
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Figure V.5. Confocal microscopy images of SPCL fiber meshes cultured for 15 days obtained from 
depth projections of the top surface (where cells were seeded) of samples cultured under (a) flow 
perfusion or (c) static conditions, and showing cell distribution along a transversal section from the 
surface (indicated by the arrow) to the interior of the scaffolds cultured under (b) flow perfusion or 
(d) static conditions. 
 
 
a) b)
c) d)
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Figure V.6. Confocal microscopy images of SEVA-C based scaffolds cultured for 15 days obtained 
from depth projections of the top surface (where cells were seeded) of samples cultured under (a) 
flow perfusion or (c) static conditions, and showing cell distribution along a transversal section from 
the surface (indicated by the arrow) to the interior of the scaffolds cultured under (b) flow perfusion 
or (d) static conditions. 
 
 
 
3.6. Histological evaluation 
 
3.6.1. Hematoxylin and eosin staining 
Histological sections of SPCL scaffolds after 15 days culture (Figures V.7a and V.7b) 
demonstrated the formation of a cell layer on the surface of the cultured fiber meshes, but 
not in the interior, under static conditions. In contrast, the constructs cultured under flow 
conditions (Figures V.7c and V.7d) exhibited a much better cell distribution. The 
histological analysis of SPCL scaffolds cultured for 15 days was in agreement with the 
conclusions drawn from confocal imaging. Once again, the presence of cells inside the 
scaffolds cultured under flow perfusion was observed, while scaffolds cultured under static 
a) b)
c) d)
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conditions resulted only in a surface layer of cells (Figure V.7). These results confirm that 
flow perfusion culture enhances cell distribution in three-dimensional starch-based 
scaffolds. 
 
 
 
 
 
Figure V.7. Histological sections of SPCL fiber meshes cultured for 15 days and stained with 
hematoxylin and eosin, at different magnifications, in static (a,b) and flow perfusion culture (c,d). 
 
 
 
 
3.6.2. Von Kossa staining 
Figures V.8a through V.8c showed no mineral deposition on scaffolds cultured under static 
conditions. However, Von Kossa stained sections revealed that the mineralized tissue was 
distributed throughout the scaffolds cultured under flow perfusion (Figures V.8d through 
V.8f) in agreement with the histological observations and the calcium deposition 
measurements. 
 
100 µm
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Figure V.8. Von Kossa stained histological sections of SPCL fiber meshes cultured for 15 days, at 
different magnifications, under static (a,b,c) and flow perfusion conditions (d,e,f). 
 
3.6.3. Tetracycline fluorescence 
In Figure V.9a the formation of a mineral layer on the surface of the scaffold is apparent. It 
is also possible to identify several regions in the interior of the scaffolds where mineral 
deposition has occurred. Once again, no mineral deposition is observed on the scaffolds 
cultured under static conditions (Figure V.9b). These results, together with the analysis of 
Von Kossa staining and calcium deposition, suggest that flow perfusion culture enhances 
the osteogenic differentiation of marrow stromal cells and improves their distribution in 
three-dimensional starch-based scaffolds by possibly improving nutrient delivery in the 
interior of the scaffolds or by stimulating the seeded cells by exposing them to fluid shear 
forces.  
 
  
 
Figure V.9. Sections of SPCL fiber meshes cultured for 15 days observed under fluorescent light, 
showing the tetracycline labelling of mineral in (a) flow perfusion and (b) static culture conditions. 
100 µm
500
a) 
100 µm
b) 
100 µm
c) 
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3.7. Scanning Electron Microscopy (SEM) 
Figure V.10 shows SEM micrographs depicting the top (where the cells were seeded) and 
bottom surface of SPCL fiber meshes cultured for 15 days under flow and static conditions, 
respectively. The scaffolds cultured under flow perfusion conditions were completely 
covered by a dense matrix coating on both bottom and top surfaces, which suggests that 
cells were able to migrate throughout the scaffold and fill the entire construct. In contrast, 
the top surface of the scaffolds cultured under static conditions exhibited a thin crusting 
layer of extracellular matrix, and on the bottom surface it is only possible to observe the 
coating of some of the fibers. These observations reinforce the conclusion that flow 
perfusion enhances cell distribution in scaffolds cultured in vitro. 
 
 
  
 
  
 
Figure V.10. SEM micrographs depicting the surface of SPCL fiber meshes cultured for 15 days: 
(a,c) top surface (surface where cells were seeded), (b,d) bottom surface (opposite to the surface 
where cells were seeded) of samples cultured under static (a,b) or flow perfusion conditions (c,d) 
 
 
 
 
a) b)
c) d)
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4. CONCLUSIONS 
 
The two types of starch based scaffolds selected for this study promoted the attachment 
and proliferation of rat bone marrow stromal cells. However, the SPCL fiber meshes 
showed increased cell proliferation due to the better interconnectivity of their porous 
structure. This study demonstrates the ability of the flow perfusion bioreactor to enhance 
the osteogenic differentiation and the homogeneous distribution of marrow stromal cells 
within starch-based polymer scaffolds. Accordingly, starch-based porous scaffolds seeded 
with mesenchymal stem cells and cultured under flow perfusion constitute a promising 
approach for the generation of osteoinductive bone tissue replacement constructs. 
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Chapter VI 
 
Influence of the Porosity of Starch-based Fiber Mesh Scaffolds on the Proliferation 
and Osteogenic Differentiation of Bone Marrow Stromal Cells 
 Cultured in a Flow Perfusion Bioreactor*  
 
 
Abstract 
This study aims to investigate the influence of the porosity of fiber mesh scaffolds obtained 
from of a blend of starch and poly(ε-caprolactone) on the proliferation and osteogenic 
differentiation of marrow stromal cells cultured under static and flow perfusion conditions. 
For this purpose, biodegradable scaffolds were fabricated by a fiber bonding method into 
mesh structures with two different porosities, namely 50 and 75%. These scaffolds were 
then seeded with marrow stromal cells harvested from Wistar rats and cultured in a flow 
perfusion bioreactor or in 6-well plates for up to 15 days. The increased scaffold porosity 
significantly enhanced proliferation of cells cultured under both static and flow perfusion 
conditions. The expression of alkaline phosphatase activity was higher in flow cultures, but 
only for cells cultured onto the higher porosity scaffolds. Calcium deposition patterns were 
similar for both scaffolds, showing a significant enhancement of calcium deposition on cell-
scaffold constructs cultured under flow perfusion, as compared to static cultures. An 
enhancement of calcium deposition was observed in scaffolds with higher porosity but this 
difference was not statistically significant. Scanning electron microscopy observation 
showed the formation of pore-like structures in the higher porosity scaffolds. Fourier 
transformed infrared spectroscopy-attenuated total reflectance and thin-film X-ray 
diffraction analysis of the cell-scaffold constructs after 15 days of culture in a flow perfusion 
bioreactor revealed the presence of a mineralized matrix, similar to bone. These findings 
indicate that starch-based scaffolds in conjunction with fluid flow bioreactor culture enable 
the creation of culture environments with minimal diffusion constraints and the ability to 
provide mechanical stimulation to the marrow stromal cells, leading to enhancement of 
their differentiation towards the development of bone-like mineralized tissue. These results 
also demonstrate that scaffold structure, namely the porosity, influences the sequential 
development of osteoblastic cells and in combination with the culture conditions may affect 
the functionality of in vitro formed tissues. 
 
 
 
* This chapter is based on the following publication: 
ME Gomes, HL Holtorf , RL Reis, AG Mikos. Influence of the Porosity of Starch-based Fiber Mesh Scaffolds 
on the Proliferation and Osteogenic Differentiation of Bone Marrow Stromal Cells Cultured in a Flow Perfusion 
Bioreactor . Tissue Engineering (2004) submitted 
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 1. INTRODUCTION 
 
In bone tissue engineering strategies based on cell-scaffold constructs, the macro and 
microstructural properties of the scaffolds in conjunction with the cell culture environment 
may play a very important role in the proliferation and differentiation of cells into the 
desired phenotype and consequently, the performance of the construct after implantation. 
Adequate porosity and surface area are widely recognized [1-4] as important parameters in 
the design of scaffolds to be used in the development of tissue engineered substitutes. 
Other architectural features such as pore morphology and interconnectivity between pores 
of the scaffolding materials are also suggested to be important for cell seeding, migration, 
growth, mass transport, gene expression and new tissue formation in three 
dimensions.[1,2,5] Scaffolds with fiber mesh structures, for example, typically exhibit large 
surface area for cell attachment and a high interconnectivity among pores that enables a 
better diffusion of nutrients, enhancing cell survival and growth.  
Bone tissue formation by osteogenic cells, such as marrow stromal cells, is characterized 
by sequential events involving cell proliferation, expression of osteoblastic markers and 
synthesis, deposition and mineralization of a collagenous matrix.[6] These events are 
greatly affected by the type of scaffold material in which the cells are seeded[7-11]  but also 
by the culture environment[8,9,12]  
In traditional cell culture systems, i.e., static systems, the cells within the constructs 
receive nutrients only by diffusion from the surrounding media[8,12] In this case, even in 
highly interconnected porous scaffolds, it is typical to observe a high cell density on the 
exterior of the scaffold that may deplete the nutrient supply before they can diffuse to the 
interior of the scaffold.[8] Consequently, the cells that are able to migrate to the interior of 
the scaffold may ultimately become necrotic due to the inaccessibility to the nutrients and 
also to the difficulty of removing metabolic wastes.[4,8] Furthermore, it is well known that 
bone cells are sensitive to mechanical stimulation[13,14] a constant in their natural 
environment, and that the absence of stresses may therefore negatively affect their 
development in vitro.[13] These findings have motivated the development of enhanced 
culture systems, such as the flow perfusion bioreactor[8,15-17] which may simultaneously 
provide sufficient and continuous level of oxygen and nutrient supplies and appropriate 
mechanical stimulation on cells,[8,17,18] creating 3-D culture environments that may support 
the formation of 3-D bone-like tissue in vitro. 
Previous studies[19] demonstrated that biodegradable starch based scaffolds were able to 
support attachment, proliferation and differentiation of bone marrow stromal cells. The 
present study analyzed the influence of the porosity of fiber meshes based on the 
biodegradable blend of starch with poly(ε-caprolactone) on the proliferation and 
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differentiation of seeded rat bone marrow stromal cells cultured in a flow perfusion 
bioreactor and in 6-well plates. In this paper, the following questions are addressed: 1) 
What is the role/influence of scaffold porosity in the sequential development of cell-scaffold 
constructs cultured under flow perfusion as compared to static culture? 2) Does the 
porosity of the scaffolds and/or culture conditions affect the structure and composition of 
the tissue formed in vitro?  
 
 
2. MATERIALS AND METHODS 
 
2.1. Scaffold preparation and characterization 
Two different scaffolds based on SPCL (a 30/70 wt% blend of starch with poly(ε-
caprolactone)) were prepared by a fiber bonding process consisting of cutting and sintering  
fibers with a diameter of about 180µm, obtained by melt-spinning. The different porosity of 
the fiber meshes was obtained using different weight/amounts of fibers. The porosity of the 
scaffolds was determined by microcomputerized tomography (µCT) (ScanCo Medical µCT 
80, Bassersdorf, Switzerland) at a resolution of 10 µm, and using at least 3 samples per 
group (of different porosity). The morphology of the porous structure was further 
characterized using a scanning electron microscope (Leica Cambridge S360, Leica 
Cambridge, UK), after sputter coating the samples with gold (Jeol JFC 1100, Jeol, USA).  
All samples were cut into discs of approximately 8 mm diameter and 1.5 to 2 mm height 
and sterilized using ethylene oxide. Prior to cell seeding, the scaffolds were immersed in 
30 ml of serum-free media in 50 ml tubes. Air was removed from their pores by generating 
vacuum with a 30 ml syringe equipped with an 18-gauge needle. The scaffolds were left in 
serum-free media overnight to allow swelling. 
 
 
2.2. Isolation and expansion of rat bone marrow stromal cells 
Rat bone marrow stromal cells were obtained from the femora and tibiae of male Wistar 
rats with weights ranging from 125 to 150 g (Harlan, USA). The isolation and culturing 
procedures of the rat bone marrow stromal cells were previously described.[20] Briefly, 
femora and tibiae were removed and washed in medium with a ten-fold higher 
concentration of antibiotics than normal culture medium. The epiphyses were cut off and 
the diaphyses flushed with 5 ml of complete media. The bone marrow obtained from all the 
rats was pooled and plated in 80cm2 flasks. The cells were cultured at 370C in a humidified 
atmosphere with 5% CO2 and the culture medium during the entire experimental period 
consisted of minimum essential medium (α-MEM Eagle, Sigma, USA), supplemented with 
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10% FCS (Fetal Calf Serum, Gemini, USA), 50 µg/ml ascorbic acid (Sigma, Chemical Co., 
St. Louis, MO, USA), 50 µg/ml gentamycin, 100 µg/ml ampicillin, 0.3 µg/ml fungizone, 10 
mM β-glycerophosphate (Sigma) and 10-8 M dexamethasone (Sigma). The culture medium 
was refreshed after 24h and thereafter every 2 days until day 6. 
 
2.3. Cell seeding on starch-based scaffolds  
At near confluence, after 6 days of primary culture, the adherent cells were enzymatically 
released using trypsin/EDTA (0.25% w/v trypsin/0.02% EDTA, Sigma), concentrated by 
centrifugation at 400g for 5 min and resuspended in complete media. Subsequently, the 
scaffolds (n=12 for flow and n=12 for static culture, for each scaffold type) were inserted 
into cassettes that were placed in 6-well plates. Each scaffold was then seeded with 300 µl 
of a cell suspension containing 5x105 cells and incubated for 2 hours. Then 10 ml of 
complete media was added to each well. The seeded scaffolds were further incubated 
overnight to allow for cell attachment. The following day, seeded scaffolds were placed into 
fresh 6-well plates for static culture conditions or into the flow perfusion bioreactor and 
cultured in complete media for 7 and 15 days (6 scaffolds per culture condition and per 
culture time). 
 
2.4. Cell culture: The flow perfusion culture system 
In this study a flow perfusion bioreactor was used which is described in detail 
elsewhere.[15,16]  Briefly, this bioreactor consists of 6 flow chambers, each one containing a 
cassette in which the scaffold is press-fitted. Gas permeable silicon tubing connects each 
flow chamber with a peristaltic pump and a medium reservoir. Each chamber has its own 
independent pumping circuit, but all pumps draw media from a common reservoir. For 
these experiments, culture media was pumped continuously at a flow rate of 1 ml/min 
through the cell/scaffold construct cassette/housing unit and re-circulated back to the 
reservoir. The total volume of medium in the flow system was 210 ml. In the static culture, 
10 ml was added to each scaffold. In both culture systems, media was changed every 3 
days. The entire flow perfusion bioreactor was maintained in an environment of 37°C with 
5% CO2. 
 
At the end of each culture period, the cell/scaffold constructs were rinsed with phosphate 
buffered saline (PBS) and stored at -70°C in 10 ml tubes containing 1.4 ml of distilled, 
deionized water for DNA, calcium, and alkaline phosphatase (ALP) analysis. Before 
performing the assays, the samples were allowed to thaw at room temperature and then 
sonicated for about 15 min. Simultaneously, at each time point, two scaffolds from each 
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group were retrieved and fixed in a solution of 2.5% gluteraldehyde for SEM analysis and 
FTIR-ATR and TF-XRD. 
 
 
2.5. Characterization of cultured scaffolds 
 
2.5.1. Cellularity of scaffolds 
The DNA content of each scaffold was measured using a PicoGreen DNA Quantification 
Kit (Molecular Probes). A description of the assay can be found elsewhere.[16] The 
cellularity of each scaffold was then calculated by correlation with the DNA of a known 
amount of marrow stromal cells.  
 
2.5.2. Alkaline phosphatase activity  
The alkaline phosphatase activity was measured using a colorimetric endpoint assay 
which measures the conversion of p-nitrophenyl phosphate to p-nitrophenol by the enzyme 
alkaline phosphatase[16] (Sigma Diagnostic Kit #104).  
 
2.5.3. Calcium content of scaffolds 
Cell/scaffold constructs were incubated overnight in 1N acetic acid to dissolve the 
deposited calcium. The calcium content was then measured using a colorimetric endpoint 
assay which measures the amount of calcium-cresolphthalein complexone formed when 
cresolphthalein complexone binds to free calcium in an alkaline solution (Sigma Diagnostic 
Kit #587). The amount of deposited calcium was expressed as mg of Ca2+ equivalents per 
scaffold.[16] 
 
2.5.4. Scanning electron microscopy (SEM) 
For SEM analysis the samples were fixed in a solution of 2.5% glutaraldehyde (in PBS), 
dehydrated in a gradient series of ethanol solutions, dried with tetramethylsilane, and 
sputter coated with gold (Jeol JFC 1100, Jeol, USA). Samples were then observed using a 
scanning electron microscope (Leica Cambridge S360, Leica, Cambridge, UK). 
 
2.5.5. Fourier transformed infrared spectroscopy with attenuated total reflectance (FTIR-
ATR) 
The composition of the cell-scaffolds constructs cultured for 15 days in the perfusion 
bioreactor was analyzed by Fourier Transformed Infrared Spectroscopy with Attenuated 
Total Reflectance (FTIR-ATR). The samples were fixed in a solution of 2.5% 
gluteraldehyde and dried at room temperature. All spectra were recorded using at least 64 
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scans and 2cm-1 resolution in a FTIR spectrophotometer (Perkin-Elmer 1600 Series, USA) 
with a single reflection ATR system (MKII Golden GateTM, Specac, UK). Results were 
compared to cell-free scaffolds, which were kept under the same conditions as the static 
cultures and received the same treatment before performing the analysis, in order to 
exclude the contributions from the culture medium. 
 
2.5.6. Thin-film X-ray diffraction (TF-XRD) 
Thin-film X-ray diffraction (TF-XRD, Philips X'Pert MPD, The Netherlands) was used to 
identify any mineral phase present in cell-scaffolds constructs cultured in the perfusion 
bioreactor for 15 days. As for the FTIR-ATR analysis, the samples were dried at room 
temperature after being fixed in a solution of 2.5% gluteraldehyde. The data collection was 
performed by the 2θ scan method with 1º as incident beam angle using CuKα X-ray line 
and a scan speed of 0.05º/min in 2θ. Again, the results were compared to cell-free 
scaffolds, which were kept in the same conditions and submitted to same treatment as 
samples resulting from static cultures. 
 
2.5.7. Statistics 
Results from DNA, ALP and calcium assays are presented as means ± standard deviation 
for n=4. Multiple pairwise comparisons were performed using the Tukey-Kramer method 
with a significance level of 95%.  
 
 
 
 
 
 
3. RESULTS AND DISCUSSION 
 
3.1. Characterization of scaffold porosity 
The two types of SPCL scaffolds produced for this study, exhibited a typical fiber-mesh 
structure (figure VI.1), and presented a porosity of 50,5±1,9 (figure 1a) and 74,5±1,2 
(figure 1b), respectively, as determined by µCT analysis. The two scaffolds will be referred 
in this paper as 50% and 75% scaffolds, respectively.  
Chapter VI: Influence of the Porosity of Starch-based Fiber Mesh Scaffolds  
- 137 - 
a)            b)  
 
Figure VI.1. Representative µCT scans of (a) 50% porous SPCL based scaffold and (b) 75% 
porous SPCL based scaffold. 
 
 
3.2. DNA analysis 
The number of cells per scaffold (calculated from DNA measurements) at the end of each 
culture period studied is represented in figure VI.2. For both scaffolds (of different porosity) 
and for both culture conditions it is possible to distinguish a first period of active 
proliferation, correspondent to the first week of culture. This is followed by a period in 
which it is typical to observe the decrease of proliferation reflected by the decline in DNA 
synthesis, normally associated with matrix maturation and late stage differentiation of 
osteoblastic cells.[6] This behavior has been observed previously in marrow stromal cells 
seeded both into starch based scaffolds[19] and into titanium fiber meshes,[16,21] cultured 
under similar conditions. 
The cellularity of SPCL scaffolds with 75% porosity after 7 and 15 days of culture was 
significantly higher (p<0.05) than the cellularity of scaffolds with 50% porosity cultured 
under the same conditions (static or flow perfusion conditions) for the same period of 
culture. These results suggest that higher porosity provides more space for cell 
proliferation but may also enhance diffusion of nutrients and facilitate metabolic waste 
removal that enables cell survival within the scaffolds.  
Both 50% and 75% scaffolds cultured under flow perfusion show significantly higher 
(p<0.05) cellularity than the same type of scaffolds cultured under static conditions, for 
both culture periods studied. In a previous study,[19] in which the flow rate during perfusion 
culture was lower, it was demonstrated histologically that flow perfusion enables a better 
distribution of cells and matrix within the constructs due to the better diffusion of nutrients 
provided by this culture system. The present study is in accordance with this result. In 
addition, the comparison of the cellularity of 75% porous scaffolds with the previous 
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results[19] obtained for the same type of scaffold,  demonstrates that increasing flow rate 
leads to enhanced cell proliferation, as was previously shown for titanium fiber meshes 
cultured under similar conditions.[16]  
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Figure VI.2. Number of cells on SPCL fiber meshes 75% porous and 50% porous after 7 and 15 
days of culture under static and flow perfusion culture. 
Error bars represent means ± standard deviation for n = 4. 
The results assigned with different symbols are statistically different (p<0.05), indicating:  (*) the 
higher cellularity in 75% porous scaffolds as compared to 50% in static cultures after 7 days of 
culturing; 
(**) the higher cellularity in 75% porous scaffolds as compared to 50% in static cultures after 15 
days of culturing; 
(+) the higher cellularity in 75% porous scaffolds as compared to 50% in bioreactor cultures after 7 
days of culturing; 
(++) the higher cellularity in 75% porous scaffolds as compared to 50% in bioreactor cultures after 
15 days of culturing. 
The cellularity is also significantly higher in the bioreactor cultures, as compared to static cultures 
on both scaffolds, but this is not represented in order to simplify the data displayed. 
 
 
3.3. Scanning electron microscopy  
SEM micrographs obtained from the top surface (where cells were seeded) and the bottom 
surface of 50% and 75% porous scaffolds after 15 days of culture in the flow perfusion 
bioreactor (figure VI.3), show the presence of a dense cell matrix filling the constructs. 
However, the bottom surface of the 50% porous scaffolds is not completely covered with 
the dense cell layer observed on the bottom surface of the 75% porous scaffolds. This 
means that in 50% scaffolds the lower porosity hinders the penetration and distribution of 
**
*
*
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+
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+ 
++ 
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cells throughout the entire construct, as compared to 75% scaffolds. This observation is in 
agreement with the results obtained from DNA measurements, which indicate a higher cell 
number present in the 75% porous meshes. Additionally, in the higher porosity scaffolds 
the flow perfusion induced de novo tissue modeling with the formation of pore-like 
structures. The same is not observed in the 50% porous scaffolds. This result suggests the 
importance of the macrostructure, namely the porosity, not only on the amount of cells and 
matrix formed within the construct, but also on the structure of new tissue developed by 
tissue engineering approaches that involves an in vitro culturing stage prior to the 
implantation of the construct. 
 
a1)  a2)   
 
a3)  
 
b1)  b2)  
 
Figure VI.3. SEM micrographs depicting the surface of SPCL fiber meshes with a) 75% porosity 
and b) 50% porosity - cultured for 15 days in the flow perfusion bioreactor:  a1 and b1) top surface 
(surface where cells were seeded) and a2 and b2) bottom surface (opposite to the surface where 
cells were seeded) of samples; a3) represents a magnification of a1, showing in detail the pore like 
structure formed in 75% scaffolds. 
200 µm 
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3.4. Alkaline phosphatase analysis 
Figure VI.4 depicts the normalized ALP activity of marrow stromal cells seeded onto 
scaffolds with different porosity, after 7 and 15 days of culture under static and flow 
perfusion conditions. Alkaline phosphatase is a protein associated with bone cell 
phenotype, and its expression is found to increase significantly upon the stage of active 
proliferation of osteoblastic cells.[6] During the stage of matrix maturation, the extracellular 
matrix undergoes several modifications in composition and organization that ultimately 
lead to its mineralization. At this point, every cell becomes alkaline phosphatase positive.[6] 
In the present study, a significant increase of the ALP activity from day 7 to day 15 of 
culture was observed for all samples cultured under static and flow perfusion conditions, in 
agreement with the patterns described in the literature.[6] In this case, the scaffold porosity 
does not have a strong influence in this marker of osteoblastic differentiation, as no 
significant difference was found between the ALP levels correspondent to samples of 
different porosity. However, comparing the ALP activity of cells on 75% meshes cultured in 
static and flow perfusion systems, significantly higher expression of ALP was found in 
perfusion cultures for the same period of culture. The enhanced ALP of perfusion cultures 
has been observed before for titanium fiber meshes[21], but finding this difference only in 
the 75% scaffolds suggests that porosity (combined with flow culture conditions) has an 
important role in the sequential development of osteogenic cells. Additionally, ALP is 
known to be a transient marker of osteoblastic differentiation, being up-regulated initially 
and down-regulated as differentiation progresses. Because of this phenomenon and 
because samples were analyzed at only two time points, the presence or lack of statistical 
difference in ALP levels between meshes or time points may be a result of ALP activity 
peaking in between time points. This also explains why it is possible to see a statistical 
difference in end-stage markers such as calcium deposition when none was seen for the 
earlier stage marker ALP. 
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Figure VI.4. Normalized ALP activity of marrow stromal cells after 7 and 15 days of culture on 
SPCL fiber meshes 75% porous and 50% porous.  
Error bars represent means ± standard deviation for n = 4.  
Asterisk (* and **) assign statistically different results (p<0.05), indicating: 
(*) the significantly higher level of ALP activity observed for 75% scaffolds cultured under flow 
perfusion, compared to static cultures for 7 days of culture. 
(**) the significantly higher level of ALP activity observed for 75% scaffolds cultured under flow 
perfusion, compared to static cultures for 15 days of culture. 
 
 
3.5. Calcium deposition 
The calcium deposition per scaffold, in 50% and 75% scaffolds cultured under static and 
flow perfusion conditions after 7 and 15 days, is graphically represented in figure 5. The 
mineral accumulation is a consequence of the progression of pre-osteoblastic cells through 
the proliferation and matrix maturation stages of differentiation and it is an essential step 
for the further up-regulation or expression of genes responsible for the mineralization of 
the extracellular matrix.[6] In this study, calcium measurements show that by the end of the 
first week of culture there is practically no calcium deposition for both scaffolds and for 
both culture conditions. At the end of the second week, however, a dramatic increase in 
calcium deposition was observed in the scaffolds cultured in the flow perfusion bioreactor. 
In fact, the calcium deposited on the scaffolds cultured under flow perfusion conditions 
(both for 75% and 50% porous scaffolds) after 15 days of culture was significantly higher 
(p<0.05) than calcium deposited on scaffolds cultured under static conditions, in 
agreement with previous results.[19]  
*
*
**
**
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Calcium deposition in 75% porous scaffolds was higher than for 50% scaffolds, but the 
difference was not significant, although the shear forces experienced by cells are expected 
to increase in fiber meshes exhibiting lower porosity. These forces can be calculated 
assuming a cylindrical pore model approximation for the scaffold pore morphology.[22] The 
shear forces experienced by the cells seeded into 75% and 50% porous scaffolds were 
estimated to be on the order of 0.2 dyn/cm2 and 0.3 dyn/cm2, respectively. The higher 
calcium deposition reported for the scaffolds of higher porosity may be explained by the 
higher number of cells and cell density registered in these scaffolds (as demonstrated by 
the DNA analysis), which is a very important factor in mineralization. These results further 
support the importance of scaffold structure and culture conditions on the osteogenic 
differentiation of bone marrow stromal cells. The results obtained for the 75% scaffolds 
using a flow rate of 1ml/min are also significantly higher than those obtained in a previous 
study[19] for similar scaffolds cultured at lower flow rates (0.3 ml/min). This effect has been 
observed in other studies[16,21] and is associated with increased mechanical stimulation 
induced by the increased fluid shear stresses experienced by the cells cultured under 
higher flow rates. 
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Figure VI.5. Calcium deposition on SPCL fiber meshes 75% porous and 50% porous after 7 and 15 
days of culture under static and flow perfusion conditions. 
Error bars represent means ± standard deviation for n = 4. 
Symbols (* and +) assign statistically different results (p<0.05), indicating: 
(*) the significantly higher calcium deposition after 15 days of culture in flow cultures as compared 
to static cultures of 50% porous scaffolds. 
(+) the significantly higher calcium deposition after 15 days of culture in flow cultures as compared 
to static cultures of 75% porous scaffolds. 
+*
+
*
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3.6. FTIR-ATR 
To demonstrate the clinical feasibility of tissue engineered bone and to sufficiently match 
the intrinsic properties of autogenous bone-graft material, rapid mineralization of osteoid 
tissue grown in vitro must be achieved.[12] Nevertheless, the analysis of mineral deposition 
occurring in in vitro cultures is frequently based on Von Kossa or Alizarin red staining or by 
calcium uptake.[23] However, the results arising from these analyses can be misinterpreted, 
as the matrix is known to uptake calcium independently of mineral deposition. Therefore, 
these methods should be complemented with diffraction or spectroscopy methods.[23]  
In this study, FTIR-ATR spectra were obtained from 75 and 50% porous meshes cultured 
for 15 days in the perfusion bioreactor (Figure VI.6). These spectra showed very intense 
amide bands at about 1634 cm-1 (amide I) and 1525 cm-1 (amide II), that can be assigned 
to the protein matrix formed.  
The FTIR-ATR spectrum also displays reflectance peaks associated with the phosphate 
group in carbonated apatite (group bands at 1041 cm-1 and 562 cm-1 ), clearly suggesting 
the presence of mineralized extracellular matrix. 
The spectra collected for both 50% and 75% porous scaffolds were identical. 
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Figure VI.6. FTIR-ATR spectra of a) Control – cell-free scaffold kept in the same conditions as for 
static cultures and treated with the same fixative solution.  b) 50% porous scaffolds cultured in the 
flow perfusion bioreactor for 15 days c) 75% porous scaffolds cultured in the flow perfusion 
bioreactor for 15 days. 
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3.7. TF-XRD  
Figure 7 shows the TF-XRD patterns of cell/scaffold constructs of different porosities after 
15 days of culture in the flow perfusion bioreactor, using cell-free scaffolds as controls. In 
these diffraction patterns, several characteristic peaks of hydroxyapatite were evidenced, 
that were confirmed by comparing with XRD of standard hydroxyapatite (JCPDS 9-432). 
The apatite formed seems to be mainly amorphous, as it is observed for minerals 
occurring in the presence of proteins, such as apatite in bone.[24] 
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Figure VI.7. TF-XRD patterns of the a) Control – cell-free scaffold, kept in the same conditions as 
for static cultures and treated with the same fixative solution. b) 50% porous scaffolds cultured in 
the flow perfusion bioreactor for 15 days c) 75% porous scaffolds cultured in the flow perfusion 
bioreactor for 15 days. 
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intensity in 50% scaffolds and one of the peaks, correspondent to the plane (210), 
assigned in the patterns of the 75% porous scaffold, is not evidenced in the patterns 
correspondent to 50% porous scaffolds. This might be a further indication of the influence 
of porosity in the development of the mineralized extracellular matrix by marrow stromal 
cells cultured under flow perfusion conditions. These results, together with the FTIR-ATR 
spectra, confirm that the mineral formed by marrow stromal cells seeded in SPCL fiber 
meshes and cultured under flow perfusion conditions is, in fact, a carbonated apatite 
mineral similar to the major mineral component of bone.[25] 
 
 
 
 
 
4. CONCLUSIONS 
 
This study showed that biodegradable starch-based fiber mesh scaffolds in conjunction 
with fluid flow bioreactor culture enable the creation of culture environments with minimal 
diffusional constraints and the ability to provide mechanical stimulation to seeded marrow 
stromal cells, leading to enhancement of their differentiation towards the development of a 
bone-like extracellular matrix and its mineralization, forming a carbonated apatite mineral 
similar to the major mineral component of bone. 
This study demonstrated that increased scaffold porosity significantly enhances the 
proliferation of marrow stromal cells cultured under static and flow perfusion conditions and 
influences the sequential development of the seeded cells. Furthermore, the flow perfusion 
induces de novo tissue modeling with the formation of pore-like structures in the scaffolds 
with higher porosity, demonstrating that this structural aspect of scaffolding materials, in 
combination with the culture environment determines, to a great extent, the structure and 
possibly the functionality of bone-like tissue substitutes formed in vitro. 
In summary, the culturing of highly porous starch based fiber mesh scaffolds, seeded with 
marrow stromal cells, under flow perfusion conditions may allow for the development of 
adequate in vitro engineered substitutes for the repair of bone tissue. 
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In Vitro Expression of Bone Growth Factors by Marrow Stromal Cells Cultured in 
Starch/Poly(ε-Caprolactone) Scaffolds Using a Flow Perfusion Bioreactor * 
 
 
Abstract 
Tissue engineering strategies aim at controlling the behaviour of individual cells to 
stimulate tissue formation. This control is achieved by mimicking signals that manage 
natural tissue development or repair. Flow perfusion bioreactors that create culture 
environments with minimal diffusion constraints and provide cells with mechanical 
stimulation, may closely resemble in vivo conditions for bone formation. Therefore, these 
culturing systems, in conjunction with an appropriate scaffold and cell type, may provide 
significant insight towards the development of in vitro tissue engineering models leading to 
improved strategies for the construction of bone tissue substitutes. 
The objective of this study was to investigate the in vitro expression of several bone growth 
factors that are usually associated with bone formation in vivo by culturing rat bone marrow 
stromal cells seeded onto starch-based biodegradable fiber meshes in a flow perfusion 
bioreactor. The expression of several bone related growth factors, namely transforming 
growth factor-β1 (TGF-β1), platelet derived growth factor-A (PDGF-A), fibroblast growth 
factor-2 (FGF-2), vascular endothelial growth factor (VEGF) and bone morphogenetic 
protein-2 (BMP-2), was observed on two different time points in scaffolds cultured under 
perfusion conditions at different flow rates, using an immunohistochemistry technique. The 
results show the presence of regions positively stained for all the growth factors analysed, 
except for PDGF-A. Furthermore, the images obtained from the positively stained sections 
suggest an increase in the immunohistochemically stained area with increasing flow rate 
and also a trend of enhanced growth factor expression with culturing time. These 
observations demonstrate that flow perfusion augments the functionality of scaffold/cell 
constructs grown in vitro as it combines both biological and mechanical factors to enhance 
cell differentiation and cell organization within the construct. This study also shows that 
flow perfusion bioreactor culture of marrow stromal cells combined with the use of 
appropriate biodegradable fiber meshes may constitute a useful model to study bone 
formation and assess bone tissue engineering strategies in vitro. 
 
 
* This chapter is based on the following publication: 
 
ME Gomes, CM Bossano, CM Johnston, RL Reis, AG Mikos.. In Vitro Expression of Bone Growth Factors by 
MSCs Cultured on Starch/poly(ε-caprolactone) Scaffolds Using a Flow Perfusion Bioreactor. Tissue 
Engineering (2004) submitted 
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1. INTRODUCTION 
 
Bone tissue engineering approaches based on biodegradable scaffolds seeded with cells 
and cultured in vitro prior to implantation, aim at creating in vitro environments that mimic, 
to a certain extent, the biochemical and mechanical signals responsible for natural bone 
development and repair. Therefore, in order to design successful strategies, that enable 
the development of functional bone-like tissue substitutes, it is important to understand the 
mechanisms of cell growth and differentiation involved in the formation of bone tissue. 
Although techniques for studying bone formation in vivo have been well developed for 
many years, there are not adequate in vitro models available. This is due in part to the 
complexity of the bone formation process. It is unlikely that osteoblastic cells in culture will 
express and secrete all of the proteins necessary for the formation of normally mineralized 
bone in vitro [1] as it is difficult to model all the complexities of the in vivo environment [2]. 
Nevertheless, the available data, most of which are based on observations of normal fetal 
rat calvarial osteoblasts in prolonged culture, suggest that the process of bone formation 
depends on the sequential expression and interaction of a number of growth factors [1,3]. 
 
Growth factors are proteins secreted by cells that act on an appropriate target cell or cells 
to carry out a specific action. They function as part of a vast cellular communications 
network that influences critical functions such as cell division, matrix synthesis and tissue 
differentiation [4,5]. According to the type of action they produce, growth factors can be 
classified as i) autocrine, when the growth factor influences the cell of its origin or other 
cells identical in phenotype to that cell (eg., a growth factor produced by an osteoblast 
influences the activity of another osteoblast), ii) paracrine, when the growth factor 
influences an adjacent or neighbouring cell that is different in phenotype from its cell of 
origin (e.g., growth factor produced by an osteoblast stimulates differentiation of an 
undifferentiated cell), and iii) endocrine, when the growth factor influences a cell that is 
different in phenotype from the cell of its origin and located at a remote anatomical site 
(e.g., a growth factor produced by neural tissue in the central nervous system stimulates 
osteoblast activity). Thus, a growth factor may affect multiple cell types and may induce an 
array of cellular functions in a variety of tissues [4,5]. 
 
The results of experimental studies have established that growth factors play an important 
role in bone and cartilage formation, fracture-healing and the repair of musculoskeletal 
tissues [4-8]. Among the most widely studied bone growth factors are transforming growth 
factor-β1 (TGF-β1), platelet derived growth factor (PDGF), bone morphogenetic proteins 
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(BMPs), fibroblast growth factors (FGFs) and insulin-like growth factors (IGFs) [4-9].  
However, other growth factors have also been shown to have an effect on bone cells [10]. 
These include members of the epidermal growth factor (EGF) family, transforming growth 
factor-α (TGF-α) and vascular endothelial growth factor (VEGF) [10]. In fact, the total 
number of growth factors that can affect proliferation, differentiation and secretory 
functions of bone related cells is unknown, but the number increases continually as a 
result of new advanced techniques in protein biochemistry and molecular biology [5]. 
Therefore, assessment of bone growth factors expression may provide important 
information on the functionality of bone-like tissue substitutes developed by in vitro bone 
tissue engineering systems. Additionally it may provide clues for a better understanding of 
bone formation mechanisms. 
 
In previous studies [11-13] we have used a flow perfusion bioreactor as a culturing system for 
rat bone marrow stromal cells seeded onto starch-based biodegradable scaffolds in order 
to evaluate the potential of this tissue engineering approach for the generation of 
osteoinductive bone tissue replacement constructs. The results show that biodegradable 
starch-based scaffolds in conjunction with fluid flow bioreactor culture enable the creation 
of culture environments with minimal diffusional constraints and the ability to provide 
mechanical stimulation to marrow stromal cells[11-13]. This leads to enhancement of their 
differentiation and development of a bone-like extracellular matrix consisting of a 
carbonated apatite mineral similar to the major mineral component of bone [11,12]. The 
design of this flow perfusion bioreactor enhances the distribution of nutrients because it 
allows the transport of medium through the interconnected pores of the scaffold. In 
addition, it offers a convenient way of providing mechanical stimulation to cells by means 
of fluid shear stress, which is particularly important in bone tissue engineering since bone 
cells are known to be stimulated by mechanical signals [14,15]. Furthermore, the magnitude 
of the shear stresses experienced by the cells can be varied by adjusting the medium flow 
rate through the system [16]. Therefore, the characteristics of the flow perfusion bioreactor 
in conjunction with scaffolds of suitable properties and porous structure may facilitate the 
in vitro development of tissue-like constructs for the regeneration of bone tissue defects.  
 
The present study aims to investigate the in vitro expression of several bone growth 
factors that are usually associated with bone formation in vivo by culturing rat bone marrow 
stromal cells seeded onto SPCL (a blend of starch with poly(ε-caprolactone)) fiber meshes 
in a flow perfusion bioreactor at different flow rates and culture periods.  
This research work describes the use of an immunohistochemical technique to assess the 
expression of several bone related growth factors by cells seeded onto a biodegradable 
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scaffold and cultured in vitro, using a specific bioreactor previously developed for bone 
tissue engineering applications. Specifically, this study was designed to obtain answers to 
the following questions: i) is it possible to use immunohistochemical techniques to analyze 
expression of bone growth factors on samples cultured in vitro? ii) are bone growth factors, 
usually found in vivo,  expressed by marrow stromal cells cultured in a flow perfusion 
bioreactor iii) is the in vitro tissue engineering approach described suitable to be used as a 
model for studies on bone formation? 
 
 
2. MATERIALS AND METHODS 
 
2.1. Scaffold preparation  
The starch-based polymer scaffold used in this study was based on SPCL (a blend of corn 
starch with poly(ε-caprolactone), 30/70 %wt) obtained by a fiber bonding process 
consisting of the spinning, cutting and sintering of fibers with a diameter of about 180µm. 
The porosity and porous structure of these scaffolds were characterized previously by 
microcomputed tomography (µCT) and scanning electron microscopy (SEM), showing that 
the scaffolds exhibit a typical interconnected fiber mesh structure, with a porosity of about 
75%[13].  
 
All samples were cut into discs of approximately 8 mm diameter and 1.5 to 2 mm height 
and sterilized using ethylene oxide. Prior to cell seeding, the scaffolds were immersed in 
30 ml of serum-free medium in 50 ml tubes. Air was removed from their pores by 
generating vacuum with a 30 ml syringe equipped with an 18-gauge needle. The scaffolds 
were left in serum-free medium overnight to allow for swelling. 
 
2.2. Isolation and expansion of rat bone marrow stromal cells 
Rat bone marrow stromal cells (MSCs) were obtained from the femora and tibiae of male 
Wistar rats with weights ranging from 125 to 149 g (Harlan, USA). The isolation and 
culturing procedures of the rat bone marrow stromal cells were described in detail 
elsewhere[13]. Briefly, femora and tibiae were removed and washed in medium with an 
antibiotic concentration 10 times higher than in the complete culture medium used in the 
remaining experiments. The epiphyses were cut off and the diaphyses flushed with 5 ml of 
complete media (see bellow). The bone marrow obtained from all the rats was pooled and 
plated into 75cm2 flasks. The cells were cultured at 370C in a humidified atmosphere with 
5% CO2 and the complete culture medium during the entire experimental period consisted 
of minimum essential medium (α-MEM Eagle, Sigma, St. Louis, MO, USA), supplemented 
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with 10% FCS (Fetal Calf Serum, Gemini, USA), 50 µg/ml ascorbic acid, 50 µg/ml 
gentamycin, 100 µg/ml ampicillin, 0.3 µg/ml fungizone, 10 mM β-glycerophosphate, and 
10-8 M dexamethasone (Sigma). The culture medium was refreshed after 24h and 
thereafter each 2 days until day 6. 
 
2.3. Cell seeding on starch-based scaffolds  
At near confluence, after 6 days of primary culture, the adherent cells were enzymatically 
released using trypsin/EDTA (0.25% w/v trypsin/0.02% EDTA, Sigma), concentrated by 
centrifugation at 400g for 5 min and resuspended in complete medium. Subsequently, the 
scaffolds were inserted into flow system cassettes that were placed in 6-well plates. Each 
scaffold was then seeded with 300 µl of a cells suspension containing 5x105 cells and 
incubated for 2 hours. Then 10 ml of media was added to each well and the seeded 
scaffolds were incubated overnight to allow further cell attachment. The following day, 
seeded scaffolds were placed into the flow perfusion bioreactor and cultured in complete 
media for 10 and 16 days (6 scaffolds per culture time). Seeded scaffolds, cultured in static 
conditions (6-well plates) were used as controls. 
 
2.4. Cell culturing: The flow perfusion culture system 
The flow perfusion bioreactor used in this study is described in detail elsewhere [16,17]. 
Briefly, this bioreactor consists of 6 flow chambers, each one containing a cassette in 
which the scaffold is press-fitted. Gas permeable silicon tubing connects each flow 
chamber with a peristaltic pump and a medium reservoir. Each chamber has its own 
independent pumping circuit, but all pumps draw media from a common reservoir. For 
these experiments, two bioreactor systems were used simultaneously, at two different flow 
rates, namely 1 ml/min and 0.3 ml/min. The total volume of medium continuously flowing in 
the system was 210 ml and the whole volume was changed every 3 days. The entire flow 
perfusion bioreactor was maintained in an environment of 37°C with 5% CO2. 
 
 
2.5. Immunohistochemistry analysis 
 
2.5.1. Samples processing: 
At the end of each culturing period, the cell-mesh constructs were removed from the 
bioreactors, rinsed with a phosphate buffer saline solution (PBS, 0.01M, pH 7.4) and fixed 
in a 10% formalin solution (Sigma). The constructs were then rinsed with PBS, cut in 
halves, embedded in optimal freezing temperature (O.C.T.) compound (Tissue-Tek, USA) 
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and frozen on dry ice. Serial sections (10 µm in thickness) were prepared and stored at –
80ºC until staining. 
 
2.5.2. Immunostaining procedure:  
The sections were immunostained using previously established protocols [18] using the 
avidin-biotin immunoperoxidase staining technique which is based on the ability of egg-
white glycoprotein avidin to non-immunologically bind four molecules of the vitamin biotin 
[19]. This technique uses 3 main reagents: the first is a primary antibody specific for the 
antigen to be localized; the second is antimouse/antigoat polyclonal antibody (secondary) 
which is covalently linked to a molecule of biotin and the third is a complex of peroxidase 
conjugated with biotin and avidin. The free sites on the avidin molecule allow binding to the 
biotin on the second antibody. The peroxidase enzyme, and therefore the original antigen, 
is identified with an appropriate chromogen [19]. 
 
The experimental staining procedure can be briefly described as follows: the sections were 
first incubated with a hydrogen peroxide solution to block against endogenous peroxidase 
activity and then incubated with normal serum to block against random secondary antibody 
binding. Afterwards, the sections were incubated with primary antibody for the antigen of 
interest and then incubated with the avidin-biotin secondary antibody system and with 3,3’-
diaminobenzidin developing reagent (DAB, Vector Laboratories). As a last step, the 
sections were counterstained with hematoxylin and mounted. The negative staining 
controls consisted of sections incubated with 0.01M PBS instead of the primary antibody. 
A group of samples received conventional hematoxilin and eosin staining. 
 
2.5.3. Primary antibodies: 
For this study, the following antibodies were selected: anti-transforming growth factor-β1 
(anti-TGF-β1, goat polyclonal antibody, sc-146-G), anti-platelet derived growth factor-A 
(anti-PDGF-A, mouse monoclonal antibody, sc-9974), anti-fibroblast growth factor-2 (anti-
FGF-2, goat polyclonal antibody, sc-79-G), anti-vascular endothelial growth factor (anti-
VEGF, mouse monoclonal antibody, sc-7269) and anti-bone morphogenetic protein-2 
(anti-BMP-2, goat polyclonal antibody, sc-6895). All the antibodies were purchased from 
Santa Cruz Biotechnology (California, USA) and used at a concentration of 2µg per ml of 
0.1 PBS. The diluted antibody solutions were used in the same day they were prepared. 
The mouse monoclonal antibodies were used in conjunction with an anti-mouse avidin-
biotin complex ABC kit and the goat polyclonal antibodies were used in conjunction with an 
anti-goat ABC kit (both Vectastain Elite® ABC kit, Vector Laboratories).  
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2.5.4. Image acquisition:  
All the stained sections were observed with an Eclipse E600 light microscope (Nikon, 
Melville, NY, USA) equipped with a CCD camera (Sony DXC-950P, NY, USA). For each 
stained section, 3 digital images were taken, corresponding to the opposite ends and 
center of the sample, as shown in figure VII.1 at a magnification of x4. 
 
 
 
 
Figure VII.1. Schematic representation of image acquisition scheme used: for each stained section 
that was observed, 3 digital images were taken, corresponding to the opposite ends and center of 
the sample, as it is indicated. 
 
 
3. RESULTS & DISCUSSION 
 
Histological analysis of SPCL scaffold/cell constructs stained for H&E showed the 
presence of cells and matrix distributed throughout the interior of the three-dimensional 
starch-based scaffolds and also the formation of a thick surface layer of cells, as shown of 
figure VII.2. Furthermore, these images suggest an increase in the amount of cell and 
matrix with increasing flow rate, in agreement with previous studies[13,15,17] which have 
demonstrated that flow perfusion culture enhances the osteoblastic differentiation of 
marrow stromal cells (MSCs) and improves their distribution in the scaffolds in a dose-
dependent manner by improving nutrient delivery to the interior of the scaffolds and 
stimulating the seeded cells by exposing them to fluid shear forces. As expected, an 
increase in the amount of cells and matrix with increasing culture time was observed. 
  stained section 
      Photo I 
Photo II 
   Photo III 
 Glass slide 
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Figure VII.2. Light microscopy images (original magnification x4) of SPCL scaffold/cell constructs 
cultured under flow perfusion for 10 and 16 days, at two different flow rates and stained with 
hematoxilin and eosin: a) Constructs cultured for 10 days at a flow rate of 0.3 ml/min;  b) Constructs 
cultured for 10 days at a flow rate of 1 ml/min; c) Constructs cultured for 16 days at a flow rate of 
0.3 ml/min; d) Constructs cultured for 16 days at a flow rate of 1 ml/min. 
 
 
Figure VII.3 shows images obtained from the control sections, which were incubated with 
PBS instead of the antibody. No positive staining was detected in these sections. 
 
a) 
b) 
c) 
d) 
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Figure VII.3. Light microscopy images (original magnification x4) of SPCL scaffold/cell constructs 
cultured under flow perfusion for 10 and 16 days, at two different flow rates and incubated with PBS 
instead of a primary antibody (controls): a) Constructs cultured for 10 days at a flow rate of 0.3 
ml/min; b) Constructs cultured for 10 days at a flow rate of 1 ml/min; c) Constructs cultured for 16 
days at a flow rate of 0.3 ml/min; d) Constructs cultured for 16 days at a flow rate of 1 ml/min 
 
 
3.1. Vascular endothelial growth factor (VEGF) 
 
VEGF is a polypeptide growth factor that specifically promotes the proliferation of vascular 
endothelial cells [10]. Studies have shown that both rodent and human osteoblast-like cells 
a) 
b) 
c) 
d) 
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express the mRNA for VEGF and also produce the VEGF protein [20-22]. Because blood 
vessels and endothelial cells are found in close proximity to osteoblasts, the VEGF 
produced by these cells may promote both endothelial cell proliferation and the paracrine 
production of other growth factors [10].  
 
 
 
 
 
 
 
 
 
Figure VII.4. Light microscopy images (original magnification x4) of SPCL scaffold/cell constructs 
cultured under flow perfusion for 10 and 16 days, at two different flow rates and immunostained for 
VEGF: a) Constructs cultured for 10 days at a flow rate of 0.3 ml/min; b) Constructs cultured for 10 
days at a flow rate of 1 ml/min; c) Constructs cultured for 16 days at a flow rate of 0.3 ml/min; d) 
Constructs cultured for 16 days at a flow rate of 1 ml/min 
 
d) 
c) 
b) 
a) 
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The images in figure VII.4 represent typical light microscopy pictures resulting from 
immunohistochemical staining for VEGF of sections obtained from samples cultured in the 
flow perfusion bioreactor for 10 and 16 days under two different flow rates. These images 
show the presence of stained areas in sections analysed for VEGF Furthermore, these 
images suggest an increase in the immunohistochemically stained area with increasing 
flow rate. This effect might be related to enhanced differentiation due to increased 
mechanical stimulation of the cells. It has been previously demonstrated that the increase 
of fluid flow in this flow perfusion bioreactor leads to enhanced differentiation and 
mineralization of marrow stromal cells cultured in 3-D starch-based scaffolds[13]. In addition 
there was also a trend of enhanced growth factor expression with culturing time, which is 
probably associated with increased cell and matrix content within the constructs. 
 
The presence of VEGF in these constructs may enhance vascular tissue formation upon 
their implantation, increasing the viability of the transplanted cells and tissue within the 
scaffold. In fact, the induction of rapid vascular ingrowth has been a major limitation in 
bone tissue engineering [23,24], particularly when the aim is to restore a large tissue defect. 
This is because when a tissue engineered construct is implanted, the transplanted cells as 
well as the host cells that migrate into the scaffold from the native tissue depend on the 
transport of nutrients and waste products between the cells and the host tissue for survival; 
as the transport, in this first stage, is carried out exclusively by  diffusion, cells that are 
more than several hundred microns from blood vessels in the surrounding tissue frequently 
either fail to engraft or die rapidly due to oxygen deprivation [25]. Therefore, the presence of 
VEGF in the constructs might be extremely beneficial for the development of new bone 
tissue as it is likely to increase the neovascularization of the scaffold/cell composite upon 
implantation and thus provide adequate delivery of nutrients and oxygen via the blood into 
the developing tissue. 
 
 
3.2. Platelet-derived growth factor (PDGF-A ) 
 
Platelet derived growth factors (PDGF) have been isolated from a variety of normal and 
neoplastic tissues, including bone matrix and osteosarcoma cells although its original 
source was platelets [6]. PDGF stimulates bone DNA and protein synthesis, and may be a 
systemic or local regulator of skeletal growth [5,6]. As a systemic growth factor, it could be 
released during platelet aggregation and have important effects in the early stages of 
fracture healing; as a local factor, it may interact with other hormones and growth factors. 
In addition to its effect on bone formation, PDGF has been shown to stimulate bone 
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resorption, so that it appears to have a complex effect on bone remodelling [6]. Contrary to 
what was observed in the sections immunostained for VEGF, the sections stained for 
PDGF-A look similar to the control samples, which were incubated with PBS instead of the 
antibody, as shown on figure 5. There was no positive staining for this growth factor, 
demonstrating that PDGF is not expressed by marrow stromal cells cultured under the 
described conditions. However, it is not possible to conclude, using the presently available 
data, if this growth factor is expressed in this system at earlier or later stages of culture. 
 
 
 
 
 
 
Figure VII.5. Light microscopy images (original magnification x4) of SPCL scaffold/cell constructs 
cultured under flow perfusion for 10 and 16 days, at two different flow rates and immunostained for 
PDGF-A: a) Constructs cultured for 10 days at a flow rate of 0.3 ml/min; b) Constructs cultured for 
10 days at a flow rate of 1 ml/min; c) Constructs cultured for 16 days at a flow rate of 0.3 ml/min; d) 
Constructs cultured for 16 days at a flow rate of 1 ml/min 
a) 
c) 
d) 
b) 
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3.3. Transforming growth factor β1 (TGF-β1) 
 
 
 
 
 
 
 
 
 
 
Figure VII.6. Light microscopy images (original magnification x4) of SPCL scaffold/cell constructs 
cultured under flow perfusion for 10 and 16 days, at two different flow rates and immunostained for 
TGF-β1: a) Constructs cultured for 10 days at a flow rate of 0.3 ml/min; b) Constructs cultured for 10 
days at a flow rate of 1 ml/min; c) Constructs cultured for 16 days at a flow rate of 0.3 ml/min; d) 
Constructs cultured for 16 days at a flow rate of 1 ml/min 
 
 
d) 
c) 
b) 
a) 
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The transforming growth factor-β1 belongs to a family of related proteins called the TGF–β 
superfamily, that includes five isoforms of TGF–β  and the BMPs, among others.  TGF–β1 
is found in many tissues but is particularly enriched in bone, platelets and cartilage[4,5]. It 
influences a broad range of cellular activities including growth, proliferation, differentiation 
and extracellular matrix synthesis and is probably the most potent multifunctional regulator 
of bone cell metabolism[5,6]. Previous studies suggest that occurrence of a sequential 
cascade of expression of members of the TGF–β superfamily during bone cell proliferation 
and differentiation that may influence all of the events involved in bone formation[26]. 
Therefore, TGF-β1, by itself or in conjunction with other growth regulators, has a major 
function in bone formation[6,26,27]. 
Figure 6 depicts images that represent typical light microscopy pictures of sections 
obtained from samples cultured in the flow perfusion bioreactor for 10 and 16 days under 
two different flow rates and immunohistochemically stained for TGF-β1. In the sections 
correspondent to samples cultured for 10 days at the lower flow rate, there are only some 
regions that are positively stained while for the remaining groups, there is widespread 
expression of this growth factor.  This indicates that expression of this growth factor can be 
related to a specific period of cell development, which is enhanced by increasing the 
stimulation due to higher flow rate used in the perfusion bioreactor. 
 
 
 
3.4. Fibroblast growth factor (FGF-2) 
 
Fibroblast growth factors (FGFs) are a family of nine structurally related polypeptides 
which are known to play a critical role in angiogenesis and mesenchymal cell mitogenesis 
[4]. The most abundant FGFs in normal adult tissue are acidic fibroblast growth factor 
(FGF-1) and basic fibroblast growth factor (FGF-2). Both promote growth and 
differentiation of a variety of cells, including epithelial cells, myocytes, osteoblasts and 
chondrocytes. The mitogenic effects of FGF-1 have been associated with chondrocyte 
proliferation, while FGF-2 is expressed by osteoblasts and is generally more potent than 
FGF-1 [4]. 
 
 
 
 
 
Chapter VII: In Vitro Expression of Bone Growth Factors by Marrow Stromal Cells Cultured in SPCL Scaffolds 
  
- 163 - 
 
 
 
 
 
 
 
 
Figure VII.7. Light microscopy images (original magnification x4) of SPCL scaffold/cell constructs 
cultured under flow perfusion for 10 and 16 days, at two different flow rates and immunostained for 
FGF-2: a) Constructs cultured for 10 days at a flow rate of 0.3 ml/min; b) Constructs cultured for 10 
days at a flow rate of 1 ml/min; c) Constructs cultured for 16 days at a flow rate of 0.3 ml/min; d) 
Constructs cultured for 16 days at a flow rate of 1 ml/min. 
 
 
FGFs have mainly a proliferative effect on osteoblasts and a lesser less effect on protein 
synthesis. Consequently, they probably enhance bone formation by increasing the number 
of cells capable of synthesizing bone matrix[5,28,29]. FGF-2 can also stimulate the TGF-β 
synthesis by osteoblasts and may therefore exert some stimulatory effects through other 
b) 
a) 
c) 
d) 
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growth factors[5,28]. Like VEGF, FGFs are also angiogenic factors which are important for 
neovascularization during bone healing[5]. Therefore, the expression of these growth 
factors in the scaffold/cell constructs cultured under flow perfusion can have a positive 
impact on the functionality of these tissue engineered substitutes upon implantation. 
 
The images depicting sections obtained from scaffold/cell constructs cultured under 
previously described conditions and stained for FGF-2, are shown in figure 7. They 
demonstrate the presence of several regions, corresponding to cells and matrix formed 
within the construct that are positively stained for this growth factor. Once again, it is 
visible a larger stained area in the samples cultured under higher perfusion rates, 
demonstrating the capability of influencing cell behaviour through the selection of different 
levels of mechanical stimulation provided by the flow perfusion bioreactor. 
 
 
3.5. Bone morphogenetic protein (BMP-2) 
 
Bone morphogenetic proteins (BMPs) induce the differentiation of undifferentiated 
mesenchymal cells into chondrogenic and osteogenic cells, and promote their 
differentiation [5,7]. In vivo, this action may result in bone generation and thus fracture repair 
by the newly formed bone [30]. At the cellular level, undifferentiated mesenchymal cells 
proliferate from the periosteum, bone marrow and muscle surrounding the fracture and 
begin to migrate. As a result, new bone is produced in conjunction with their differentiation 
into chondrogenic and osteogenic cells. In fact, it has been demonstrated that certain 
BMPs (BMP-2 and/or BMP-4) are present at the initial stage of this fracture healing 
process and seem to play an important role in several events of the bone formation 
cascade that leads to bone repair [1].  
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Figure VII.8. Light microscopy images (original magnification x4) of SPCL scaffold/cell constructs 
cultured under flow perfusion for 10 and 16 days, at two different flow rates and immunostained for 
BMP-2: a) Constructs cultured for 10 days at a flow rate of 0.3 ml/min; b) Constructs cultured for 10 
days at a flow rate of 1 ml/min; c) Constructs cultured for 16 days at a flow rate of 0.3 ml/min; d) 
Constructs cultured for 16 days at a flow rate of 1 ml/min 
 
 
On figure VII.8 one may see the light microscopy pictures of sections obtained from 
constructs cultured for 10 and 16 days in the flow perfusion bioreactor, using flow rates of 
0.3 and 1 ml/min and immunohistochemical stained for BMP-2. In these pictures it is 
possible to identify areas positively stained for BMP-2, mostly localized in the cells and 
d) 
c) 
b) 
a) 
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their surrounding matrix.  The sections stained for BMP-2 that correspond to samples 
cultured using higher flow rates, exhibit higher levels of expression of this growth factor, 
demonstrated by the presence on a higher number of spots/areas positively stained. This 
was observed in the all the samples positively analysed for the growth factors previously 
described, indicating that it is possible to modulate cell development by tailoring the 
culturing parameters. Specifically, this result suggests that higher flow rates enhance the 
development of rat bone marrow cells and therefore mechanical stimulation induced by 
this culturing parameter to the cells can be adjusted to lead to the development of tissue 
engineering constructs in useful (i.e., shorter) culturing times and/or to obtain bone tissue-
like constructs with enhanced functionality.  
 
Due to its capability of eliciting new bone formation, BMPs have been widely used in bone 
tissue engineering strategies[30,31] using a carrier device to deliver this growth factor at the 
implantation site. Although the efficacy of this approach in enhancing new bone formation 
has been shown both orthotopically and heterotopically in several different experimental 
animal models[30-35], the inability to find an ideal delivery system has limited the use of this 
approach[30,32,35].   
 
This study shows that osteoprogenitor cells seeded in a starch-based biodegradable 
matrix and stimulated by flow perfusion culturing may be able to deliver growth factors, 
including BMP-2 after implantation, providing an osteoinductive scaffold for bone 
regeneration in critical size defects. 
 
 
 
 
4. CONCLUSIONS  
 
In summary, the light microscopy images obtained from 3 different regions of each of the 6 
samples studied per group (culturing period/flow rate) that were immunohistochemically 
analysed consistently showed the presence of regions positively stained for all the growth 
factors examined, (namely for BMP-2, FGF-2, VEGF and TGF-β1) except for PDGF-A. 
These images suggest an increase in the immunohistochemically stained area with 
increasing flow rate, which was observed for all positively stained sections, as well as a 
trend of enhanced growth factor expression over culturing time. These results provide 
evidence that growth factors can be delivered into a scaffold via co-transplantation of cells 
that can naturally release them when cultured in stimulating conditions and thus accelerate 
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the healing and/or neotissue development upon implantation of the construct. In this 
sense, flow perfusion augments the functionality of scaffold/cell constructs grown in vitro 
as it combines both biological and mechanical factors to enhance cell differentiation and 
cell organization within the construct. 
 
This study also shows that flow perfusion bioreactor culture of marrow stromal cells 
combined with biodegradable starch-based fiber meshes may constitute a useful model for 
in vitro research on the biological mechanisms associated with bone formation and 
regeneration. In fact, the true biological environment of a bone cell is derived from a 
dynamic interaction between responsively active cells experiencing mechanical forces and 
a continuously changing 3D matrix architecture, which can be simulated, obviously to a 
limited extent, in this type of bioreactor. Therefore, one can not exclude the additional 
influence of the biodegradable scaffold used in this system. In this case, it seems that 
starch-based fiber meshes support the expression of the different growth factors by rat 
bone marrow stromal cells cultured within these scaffolds, providing further evidence of 
their suitability for bone tissue engineering applications. In fact, the knowledge of how a 
specific scaffold material affects the gene expression of extracellular matrix molecules may 
lead to increased ability to customize a scaffold for a specific tissue-engineering 
application.  
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Chapter VIII 
 
GENERAL CONCLUSIONS 
 
 
 
The work developed allowed to obtain several conclusions related to the main aims of this 
thesis, which are summarized bellow:   
 
i) Development of starch based scaffolds: 
 
• It was possible to develop a wide range of processing methods to obtain starch 
based tissue engineering scaffolds. These methodologies allow tailoring, to an 
extended degree, the pore sizes and poring structure of the scaffolds as well as 
their degradation rates. In fact, it was shown that the degradation rates can be 
significantly different, depending on the processing method and on the final 
porosity obtained. This may allow to tailor the properties and/or porous structure of 
the scaffolds, according to the specific target applications within the bone tissue 
engineering field. 
• Although only few data on mechanical properties of scaffolds for tissue engineering 
is found in the literature, it is possible to conclude that mechanical properties of all 
the tested scaffolds are very promising, when compared to scaffolds obtained from 
other biodegradable polymers. In addition, these properties are not significantly 
affected in the first 30 days of in vitro degradation, which suggests that the scaffold 
will be able to provide the necessary structural support in the first period of in vitro 
culturing and subsequent implantation. 
 
In conclusion, it has resulted clear that the processing technologies and starch based 
polymers that were described present an outstanding potential for providing the adequate 
scaffold structures to be used in a new generation of tissue engineering strategies and 
may therefore constitute an important alternative to the materials currently used, providing 
the necessary support (from the materials science point of view) to new and under 
development bone tissue engineering strategies. 
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ii) Ability of starch based scaffolds to promote adhesion and proliferation of rat bone 
marrow stromal cells:  
 
• The developed starch based scaffolds selected for the cell culturing experiments, 
namely the scaffolds based on SEVA-C obtained by extrusion and SPCL obtained 
by a fiber bonding methodology, promoted the attachment, proliferation and 
differentiation of rat bone marrow stromal cells. However, the SPCL fiber meshes 
showed increased cell proliferation due to the better interconnectivity of their 
porous structure. 
 
iii) Effect of culture conditions, namely static versus flow perfusion, and scaffold’s porosity 
on the proliferation, distribution and differentiation of RBM cells seeded onto starch based 
scaffolds: 
  
• It was clearly demonstrated that the culturing conditions induce significant 
differences in the resulting cell-scaffold constructs. Specifically, it was 
demonstrated the ability of the flow perfusion bioreactor to enhance the osteogenic 
differentiation and the homogeneous distribution of marrow stromal cells within 
starch-based polymeric scaffolds, as compared to static culturing.  Flow perfusion 
ensures fresh medium to cells, voids the accumulation of harmful metabolic 
products and provides cells with mechanical stimulation, providing a constant 
microenvironment for a high degree of cellular differentiation and better tissue 
development. 
 
• It was also demonstrated (for SPCL fiber-mesh scaffolds) that increased scaffold 
porosity significantly enhances the proliferation of marrow stromal cells both 
cultured under static and flow perfusion conditions and influences the sequential 
development of the seeded cells. Furthermore, the flow perfusion induces de novo 
tissue modeling with the formation of pore-like structures in the scaffolds with 
higher porosity (75%), demonstrating that this structural aspect of scaffolding 
materials, in combination with the culture environment determines, to a great 
extent, the structure and possibly the functionality of bone-like tissue substitutes 
formed in vitro. In fact, it was shown that biodegradable starch-based fiber mesh 
scaffolds in conjunction with fluid flow bioreactor culture enable the creation of 
culture environments with minimal diffusional constraints and the ability to provide 
mechanical stimulation to seeded marrow stromal cells, leading to enhancement of 
their differentiation towards the development of a bone-like extracellular matrix and 
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its mineralization, forming a carbonated apatite mineral similar to the major mineral 
component of bone. 
 
iv) Ability of RBM cell to express bone proteins when seeded in starch based scaffolds and 
cultured in a flow perfusion bioreactor: 
 
• Immunohistochemical analysis of cell-scaffold constructs cultured in the flow 
perfusion bioreactor for different time periods consistently showed the presence of 
regions positively stained for all the growth factors examined, (namely for BMP-2, 
FGF-2, VEGF and TGF-β1) except for PDGF-A. The growth factor expression is 
enhanced with increasing flow rate due to the enhanced differentiation induced by 
mechanical stimulation of the cells. A trend for increased immunohistochemically 
stained area over culturing time was also observed. These results provide evidence 
that growth factors can be delivered into a scaffold via co-transplantation of cells 
that can naturally release them when cultured in stimulating conditions and thus 
accelerate the healing and/or neotissue development upon implantation of the 
construct. In this sense, flow perfusion augments the functionality of scaffold/cell 
constructs grown in vitro as it combines both biological and mechanical factors to 
enhance cell differentiation and cell organization within the construct. This study 
also shows that flow perfusion bioreactor culture of marrow stromal cells combined 
with biodegradable starch-based fiber meshes may constitute a useful model for in 
vitro studies on the biological mechanisms associated with bone formation and 
regeneration. In fact, the true biological environment of a bone cell is derived from 
a dynamic interaction between responsively active cells experiencing mechanical 
forces and a continuously changing 3D matrix architecture, which can be 
simulated, obviously to a limited extent, in this type of bioreactor. Therefore, one 
can not exclude the additional influence of the biodegradable scaffold used in this 
system. In this case, it seems that SPCL fiber meshes support the expression of 
the different growth factors by rat bone marrow stromal cells cultured within these 
scaffolds, providing further evidence of their suitability for bone tissue engineering 
applications.  
 
Final concluding remarks: 
In summary, microscopic, spectroscopic, biochemical and gene expression studies 
demonstrated that the proposed culturing system achieved enhanced proliferation and 
differentiation of bone marrow stromal cells, suggesting that this method achieved tissue 
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culture rather than cell culture. Combining this culture method with a highly porous starch 
based fiber mesh scaffolds scaffold has allowed for the in vitro development of tissue 
engineered constructs with high functionality, in useful periods of time. 
 
Accordingly to all the above mentioned findings it is possible to conclude that the tissue 
engineering strategy proposed in this thesis, consisting in the culturing of starch based 
scaffolds seeded with bone marrow stromal cells and cultured in a flow bioreactor, allows 
to obtain a bone tissue-like substitute with high osteogenic potential for the repair of bone 
tissue. 
 
 
 
 
 
